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ABSTRACT
DEVELOPMENT OF CORE PHARMACY ROLES WITH
COMPETENCY/EPA ALIGNMENT AND LEVELS OF ENTRUSTMENT
Kimberly K. Daugherty
October 6, 2020
The purpose of this two-phase embedded mixed-method project was to investigate the
extent to which a consensus exists among pharmacy professionals regarding core
practice-ready roles for graduates that align with current pharmacy competencies/EPA
statements with entrustment levels. Current competencies/EPAs were perceived as
mapping to the core roles developed during this study, with some missing competencies.
Some of the EPA levels of entrustment varied depending on the role to which it was
mapped. Some levels were different than the current recommended EPA entrustment
level recommended to be used by schools/colleges. The development of a set of core
roles with the mapping of pharmacy competencies and EPAs is the first step in pharmacy
developing an education model like medicine.
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CHAPTER 1: INTRODUCTION
A critical issue in pharmacy education is the production of practice-ready entry-level
graduates equipped to engage in 21st-century healthcare (Frenck et al., 2010). Vogenberg
and Santilli (2018) identified themes describing the current healthcare trends driving the
US healthcare system. These themes include the use of technology (e.g., telehealth,
telemedicine), as well as changes in (a) healthcare insurance, (b) workforce, (c)
healthcare cost, (d) drug supply chains, and, lastly, (e) government and regulatory
changes (e.g., Affordable Healthcare Act). Just as the healthcare world has changed, so
has the definition of a practice-ready pharmacy graduate. As of today, a practice-ready
entry-level graduate is a pharmacist that is not only prepared for current practice but also
has life-long learning skills (Wolff, Pesut, & Regan, 2010). These themes and changing
definition of practice-readiness require schools/colleges of pharmacy to prepare practiceready entry-level graduates for pharmacy’s place in this shifting healthcare world
(Barnett, 2000b). To prepare practice-ready graduates, schools/colleges of pharmacy need
to know the core roles students need to execute upon graduation. Competency statements
and entrustable professional activities (EPAs), mapped to these core roles, could then be
used to create the pedagogies and assessments to prepare practice-ready graduates.
Due to continuous healthcare changes, shortages in primary care physicians, and the
aging population, the role of the pharmacist is in the transition from a product-centered
focus (just dispensing medication as prescribed) to a now patient-centered focus (Frenck
et al., 2010; Isasi & Krofah, 2015). This shift to a patient-centered focus means
1

pharmacists are no longer working in a silo to dispense medications. Instead, they serve
as an integral part of the healthcare team initiating and modifying drug therapies,
reviewing patient mediation problems to identify issues, performing lab tests, and
collaborating with other healthcare providers. Adding a pharmacist to a healthcare team
can improve healthcare outcomes and decrease costs (Isasi & Krofah, 2015). For
example, one retrospective analysis conducted in North Carolina community pharmacies
found that medication therapy management (MTM) services (e.g., patient assessments,
creating medication treatment plans) improved outcomes and reduced costs ($9444
annual cost savings; Michaels, Jenkins, Pruss, Heidrick, & Ferreri, 2010). Pharmacy
education needs to continue to adapt to better prepare students to be practice-ready for the
new and uncertain roles occurring with this transition to a patient-centered focus.
Establishing a set of core practice-ready roles may help ensure that all schools/colleges of
pharmacy produce graduates with minimal knowledge, skills, and attitudes to allow the
graduate to be successful as a practitioner.
With this new patient-centered focus, practice-ready entry-level pharmacy
graduates will need to mobilize knowledge, think critically to modify drug therapies, and
collaborate with other healthcare providers on both local and global teams (e.g.,
conducting medication therapy management services; Frenk et al., 2010; Leadbeatter &
Peck, 2017). Graduates also need soft skills such as ethics, concern for others, and
engaging perspectives different from their own (e.g., working with physicians to modify
patients' chronic medications; Frenk et al., 2010; Leadbeatter & Peck, 2017). Pharmacists
need these skills to provide more intensive patient care, such as health
improvement/wellness counseling, disease-prevention services, and even primary care
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services (Isasi & Krofah, 2015). The job of schools/colleges of pharmacy is to ensure that
all students meet these skills by being professionally competent. The definition of
professional competence is “the habitual and judicious use of communication,
knowledge, technical skills, clinical reasoning, emotions, values, and reflection in daily
practice for the benefit of the individual and community served” (Epsetin & Hundert,
2002, p. 226). To aid pharmacy programs in creating pedagogies and assessments that
ensure minimum professional competence, the concepts discussed in the professional
competency definition need to be included not just in the outcomes but also in the roles
pharmacy graduates prepare to perform. The current lack of defined roles leads
schools/colleges to define these practice-ready roles based on their interpretations of the
existing pharmacy competencies, leading to students being prepared differently for
practice.
Pharmacy Accreditation Standards 2016 adopted the CAPE (Center for the
Advancement of Pharmacy Education) 2013 (Medina et al., 2013) outcomes as the
competencies that all schools/colleges of pharmacy need to teach and assess
(Accreditation Council for Pharmacy Education [ACPE], 2015). CAPE 2013 is the fourth
version of educational outcomes created to guide curricular and assessment discussions
within schools/colleges of pharmacy (Medina et al., 2013). Pharmacy chose a different
competency development path from other professional programs such as medicine.
Medicine developed its competencies after developing a set of broad abilities (roles) that
physicians should acquire at graduation and continue to grow throughout their career to
meet the healthcare needs of their patients (Accreditation Council for Graduate Medical
Education [ACGME], 2017; Frank, Snell, & Sherbion, 2015; General Medical Council,
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2017). Pharmacy chose to update the 2004 version of the CAPE outcomes (previous
versions in 1992 and 1998) through a pharmacy and other healthcare literature review
instead of defining roles first (Medina et al., 2013). The final CAPE outcomes center on
four large domains that subdivide into 15 specific subdomains (Appendix A). The four
broad domains include Foundational Knowledge, Essentials for Practice and Care,
Approach to Practice and Care, and Personal and Professional Development (Medina et
al., 2013). While the CAPE outcomes divide into four broad domains, these domains are
student learning outcomes instead of roles that student pharmacists should prepare for
upon graduation. Schools/colleges of pharmacy are also not provided a framework for
pedagogy and assessment of the CAPE outcomes, which leaves it up to the school/college
how they want to implement these outcomes to meet the accreditation standards. The
pharmacy accreditation standards only require that schools/colleges maintain a specific
pass rate on the pharmacy licensure exam [North American Pharmacy Licensure Exam
(NAPLEX)], which is a knowledge-based exam as opposed to holding schools/colleges to
specific assessment standards related to the CAPE outcomes (ACPE, 2015), which is why
each school can set their outcome attainment level.
One way that schools/colleges might show achievement of the CAPE outcomes is by
using EPAs (Appendix B) developed by the AACP (American Association of Colleges of
Pharmacy) Academic Affairs Standing Committee (Jarrett, Berenbrok, Goliak, Meyer, &
Shaughnessy, 2018). EPAs are considered “units” of professional practice designed to be
independent, executable, observable, and measurable activities to aid in assessing
professional competency by translating competencies into clinical practice (ten Cate,
2013). Usage of the 15 pharmacy EPAs occurs in a variety of ways in schools/colleges of
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pharmacy. Some schools/colleges use the EPAs to assess students' progression
throughout the curriculum by defining different EPA entrustment levels based on a
student’s professional year in the curriculum. Other schools/colleges use the EPAs to
assess students during only the curriculum's experiential portions to tie the didactic
competencies with the professional activities seen in the clinical setting (Jarrett et al.,
2018). This lack of standardization allows schools/colleges to define their level of
entrustment required for graduation.
Assessment of EPAs occurs using entrustment levels, which students should
complete, like climbing rungs of a ladder (Modi, Gupta, & Singh, 2015). Level 1
entrustment suggests a student can observe but not complete a task (e.g., a student may
observe but not do a patient's medication history). Level 2 is execution with direct and
proactive supervision (e.g., student will perform the medication history with the
pharmacist in the room providing advice). Level 3 is performance with quickly available
(reactive) supervision (e.g., the student will perform the medication history alone with the
pharmacist in the next room should help be needed). Level 4 is execution with
supervision from a distance or when asked for by the student (e.g., a student can be freely
trusted to perform the history without any help). Level 5 is the ability to teach someone
else the skill (ten Cate, 2013). The AACP Academic Affairs Standing Committee
recommends pharmacy graduates achieve a Level 3 (reactive supervision) on each of the
15 core EPAs upon graduation (Jarrett et al., 2018). Accreditation does not require a
specific entrustment level, so schools/colleges are free to define their own, making it hard
to compare student EPA achievement across programs.
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The lack of consistency on use and understanding of the pharmacy EPAs across
schools/colleges is seen in three studies (Moon, Lounsbery, Schweiss, & Pittenger, 2018;
Pittenger, Gleason, Haines, Neely, & Medina, 2019; VanLangen, Meny, Bright, &
Seiferlin, 2019). The first study by Moon et al. (2018) surveyed all pharmacy residency
program preceptors and residents using a Likert scale and free text at the University of
Minnesota. Moon et al. asked the preceptors and resident pharmacists to describe their
perceptions of using the EPAs to assess performance. Results showed that 66.7% of
residents and 78.3% of preceptors thought the EPA framework was more helpful than the
previously used assessment model for all but three EPAs (leadership skills,
developmental planning, and practice management skills). Resident pharmacists achieved
an entrustment level of 4 or 5 upon completion of the program. Research needs to be
done on the EPAs related to leadership skills, developmental planning, and practice
management skills to determine why both resident pharmacists and preceptors found
them hard to assess as well as on the level of entrustment that residents should achieve.
Suppose resident pharmacists should be achieving a 4 or 5 upon completion of the
residency year. In that case, it should make sense that student pharmacists should be
performing at an entrustment level of less than that upon graduation. However, literature
related to student entrustment level attainment does not seem to support this idea, making
it hard to use EPAs to assess graduate practice-readiness (Moon et al., 2018).
VanLangen et al. (2019) sought to examine faculty feelings on the importance of
the current EPAs and the expected entrustment level. Faculty at one school of pharmacy
were surveyed using a Likert scale to quantify the importance of the current EPAs and
the anticipated level of entrustment for each EPA. VanLangen et al. found a strong
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consensus (≥75% agreement) of importance for 13 out of the 15 EPAs. Two of the EPAs
only had a moderate consensus (50-74.9% agreement): appropriate use of medication in
a population and identifying risk for prevalent diseases in a population. Faculty also
could not come to a consensus on the appropriate level of entrustment. Only 10 of the 15
EPAs had a moderate consensus of a level three entrustment recommended by AACP.
The others had rates that spanned across all the entrustment levels (VanLangen et al.,
2019). VanLangen et al. is the first published article that has reviewed faculty perceptions
of what level of entrustment students should achieve on the EPAs outside of the
recommendation made by the standing committee at the time of EPA development.
Further research and consensus-building need to occur around the minimum entrustment
level that students should achieve before graduation. Without a minimum level of
entrustment that all schools/colleges should have students achieve, it leaves it up to each
school/college to define it for themselves. This lack of required level of entrustment
makes it hard for schools/colleges of pharmacy to explain to students how the EPAs will
prepare them for practice.
Pittenger et al. (2019) studied a student’s understanding of how the EPAs and
levels of entrustment fit into practice. Pittenger et al. surveyed student pharmacists to
determine if students across multiple programs felt the 15 EPAs were relevant to
pharmacy practice and if practice settings used the EPAs. Greater than 94% of students
perceived relevance for 14 out of the 15 EPAs in practice, with the lowest agreement
occurring on the EPA for continuous professional development (85% agreement). Greater
than 91% of students felt that nine out of the 15 EPA statements represented activities
performed in multiple practice settings. With the lowest level of agreement again on
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continuous professional development (67% agreement). Another one of the lower levels
of agreement was for the EPA to identify risk for prevalent diseases in a population (72%
agreement), which was also seen as a problem by faculty in VanLangen et al. (2019).
These results indicated that students do understand the usage of activities assessed with
the EPAs in pharmacy practice. However, they see less need for the EPA around
continuous professional development, which is an essential skill in this new healthcare
environment as outlined in the professional oath of a pharmacist that students take upon
graduation (American Pharmacists Association, 2020).
Pittenger et al. (2019) also asked students to rate their level of entrustment on the
EPAs as they moved through the pharmacy curriculum as well as areas they felt least
prepared to do upon graduation. Students did report feeling they required less supervision
in performing the EPAs as they progressed throughout the program with a median
entrustment level of 2 for 13 out of the 15 EPAs for first-year students and median
entrustment level of 3 for 10 out of the EPAs in the second year students. Third-year
students indicated an equal split on the EPAs between entrustment levels 3 and 4. Before
graduation, fourth-year students showed a median entrustment level of a 4 on 13 out of
the 15 EPAs. Students felt the least prepared for EPAs involving overseeing pharmacy
operations (57% felt prepared), developing plans for continuous professional
development (42% felt prepared), and establishing patient-centered goals and care plans
(32% felt prepared; Pittenger et al., 2019). The Pittenger et al. study shows gaps in
understanding how the current EPAs assess the skills needed for practice (i.e., continuous
professional development, establishing patient care plans, and overseeing pharmacy
operations). Without a set of core pharmacy roles on which to map the competencies and
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EPAs, it is hard to help students understand the big picture of how EPAs assessments will
determine they are ready for practice upon graduation and what level of entrustment they
should be obtaining.
Other healthcare professions have created a core set of roles for their professions to
define the abilities needed to care effectively for patients upon graduation and throughout
a professional’s career. These core roles help students understand how pedagogies and
assessments used by the school/college determine practice-readiness. For example, the
three large medical education groups, CanMeds (Frank et al., 2015), ACGME
(Accreditation Council for Graduate Medicine Education; ACGME, 2017), and the
General Medical Council (General Medical Council, 2017), have all created similar sets
of roles that describe the broad abilities physicians should acquire upon graduation.
These roles are the same regardless of the medical discipline or stage of professional
development. Specific competency statements and EPAs map then to each of these roles.
The competency statements and EPAs are discipline-specific (i.e., internal medicine
would have different competencies/EPAs compared to pediatrics), but all map back to the
broad roles. Levels of entrustment a student/professional should be achieving for a stage
of their career is then assigned (i.e., a medical student may be a level 3 for a competency
while a practitioner who just graduated residency is a level 4). This level of mapping of
competency/EPAs back to a broad set of roles is missing in pharmacy education, making
it hard to determine if all students have the minimal skills necessary to practice regardless
of the pharmacy discipline.
The medical competency statements and EPAs mapped to core roles aid in the
pedagogy and assessment of medical students (ACGME, 2017; Frank et al., 2015, &
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General Medical Council, 2017). For example, one of the competencies mapped to the
CanMeds Medical Expert role is: “Practice medicine within their defined scope of
practice and expertise” (Frank, Snell, & Sherbion, 2014, p. 1). This competency indicates
schools of medicine need to have pedagogies that discuss the knowledge and skills
required for a physician’s scope of practice. An example EPA for this competency would
be “Gather a history and perform a physical examination” (Englander et al., 2016, p.
1354). Assessment of student performance on EPAs occurs using the entrustment levels
described earlier with the goal entrustment level based on the stage of the student’s career
(i.e., lower for medical students, higher for residents). Students are said to have met the
competencies mapped to the specific EPA if they achieve the desired EPA level for the
particular stage in their training (ten Cate, 2013). This alignment of roles to competency
statements to EPAs shows a clear connection between the pedagogy and assessment used
in colleges of medicine and the roles students will be required to participate in upon
graduation. Pharmacy has not created a clear connection between the competencies and
EPAs used for pedagogy and assessment and the roles students should be prepared for
upon graduation, leaving it up to schools/colleges to determine the roles. This lack of
consistency across programs results in schools/colleges designing pedagogies and
assessments based on the program’s interpretation of the competencies, making it hard to
compare pedagogies and assessments across schools/colleges. It also makes it hard for
stakeholders to know what students should minimally be prepared for upon graduation, as
everyone is potentially prepared differently depending on where they graduate.
A range of academic, industry, and other stakeholders have discussed the
competencies and entrustable activities that pharmacists should be able to do upon
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graduation (Alston, Marsh, Castleberry, Kelley, & Boyce, 2017; American College of
Clinical Pharmacy, 2014; Augustine et al., 2018; Chanakit, Low, Wongpoowarak,
Moolasaran, & Anderson, 2015; Greinter & Knebel, 2003; Hester et al., 2014; KennieKaulback et al., 2012; McLaughlin et al., 2017; O’Sullivan, Sy, & Bacci, 2017; Saseen et
al., 2017; Thompson, Nuffer, & Brown, 2012; Vlasses et al., 2013). Employers and
student graduates agree students need to have the skills mentioned in the current CAPE
outcomes (Alston et al., 2017; Kennie-Kaulback et al., 2012; Thompson et al., 2012).
However, both employers and student graduates point towards the need for more skills in
other areas (Chanakit et al., 2015; McLaughlin et al., 2017; Noble et al., 2014; Vlasses et
al., 2013. Waite et al., 2018). Employers feel graduates need more development in human
resource skills, including conflict resolution, management/leadership, and the regulatory
aspects of pharmacy as well as in imagination, adaptability, and agility (Chanakit et al.,
2015; McLaughlin et al., 2017; Vlasses et al., 2013). The limited data from recent
graduates find that graduates would recommend more emphasis on professional identity
formation and how to handle performing services for patients in busy pharmacy practice
situations (Noble et al., 2014; Waite et al., 2018). Employers and student graduates' data
point to potential gaps in student training based on the current competencies. These gaps
may be due to a lack of core roles that define what students should do upon graduation.
Pharmacy organizations also agree the skills within the CAPE outcomes are
needed. However, pharmacy organizations feel additional systems-based and population
health-based outcomes such as practice-management, identifying systems-based errors,
resolving medication-related problems, and improving transitions of care need to be
added for practice (American College of Clinical Pharmacy, 2014; Hester et al., 2014;
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Saseen et al., 2017). Discussions with stakeholders demonstrate that despite having a set
of competency statements (CAPE outcomes), there are still some gaps for which
graduates are not prepared.
The other thing that makes it appear to stakeholders there are gaps in graduate
preparedness is the differences in state laws required for licensure. Some states require
students only to pass the NAPLEX and a law examination while others require students
also to pass other competencies such as non-sterile compounding or sterile compounding
(NABP, 2020). Confusion also occurs due to the extra credentials that pharmacists can
achieve both before and after graduation. Credentials like additional master’s degrees and
medication management certificates can be received before graduation, while others like
residency training and Board Certification have to wait until after graduation (Salahudeen
and Nishtala, 2015). The lack of defined core roles upon graduation leads stakeholders to
determine skill students should have upon graduation for themselves, which may explain
some of the gaps discussed in the literature.
To aid healthcare professions in developing competencies for their curricula
regardless of the profession, Englander et al. (2013) developed a competency template.
The purpose of the competency template is to provide a common taxonomy for
competency domains to ensure that all healthcare professions prepare students to practice
in an ever-changing healthcare world. After reviewing 153 competency lists from across
all healthcare professional education, the competency template was put together,
including nursing, pharmacy, chiropractic, optometry, public health, physician assistants,
dentistry, and veterinary medicine. The eight competency domains included in the final
competency template were patient care, knowledge for practice, practice-based learning
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and improvement, interpersonal and communication skills, professionalism, systemsbased practice, interprofessional collaboration, and personal and professional
development (Englander et al., 2013). Comparing the pharmacy competencies to the
Englander list shows about 80% of the competencies are within the CAPE 2013
outcomes just under different competency headings (Englander et al., 2013). Missing
areas in the pharmacy competencies include systems-based practice, transitions of care,
and providing role modeling as well as specifics related to handling difficult
conversations, uncertain situations, conflict management, and stress management. These
missing areas may be due to a lack of mapping to a core set of roles that pharmacists
should be prepared for upon graduation, as many of these missing areas are mentioned in
the pharmacy stakeholder literature.
Aligning the pharmacy competencies with those on the health professional
competency template by Englander et al. (2013) may help ensure a common language
between pharmacy and other health professions. This common language will help
develop interprofessional education opportunities because all professionals will teach and
assess common competencies. This common language will also help demonstrate where
pharmacy fits into the broader healthcare system, which will be important as the
profession continues to advocate for increasing roles on the healthcare team (Englander et
al., 2013). Aligning pharmacy competencies with those of other health professionals, like
medicine, may also help pharmacy transition to competency-based education seen in
medicine.
One of the biggest benefits of competency-based education is ensuring all
students have the same baseline level of skills upon graduation due to the definition of
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consistent competencies and milestones that all students would need to meet. The move
to full competency-based education would also provide schools with a minimum set of
acceptable levels of performance for all competencies, thus leading to all students having
the same minimum level of skills upon graduation. Lastly, competency-based education
allows students to achieve competencies at their own pace instead of relying solely on the
passage of time (i.e., just because you move from one professional year to another
because you passed all courses does not mean you meet all competencies). However,
pharmacy is far from moving to full competency-based education due to multiple factors.
One factor is assigning experiential rotations when current state laws dictate a maximum
level of students per preceptor. Schools may not have enough preceptors available with
the move to competency-based education, depending on how fast or slow students are
moving through the curriculum.
Another problem is how to handle faculty workload and assessments when the
number of students is not consistent moving through the curriculum and how to handle
lock-step curricula that require students to move from one course to another in a specific
order. Lastly, opponents of competency-based education fear that this move would mean
more emphasis on skills and less on the knowledge. This move could be a problem in a
content-heavy profession like pharmacy, thus moving pharmacists back to the productcentered role as oppose to the patient-centered role (Medina, 2017).
Defining core roles from which pharmacy could derive competency and EPA
statements needed for pedagogy and assessment is one way to help with this move to
competency-based education. It will be important when defining the core roles for
pharmacy graduates to consider the knowledge and skills needed for current practice and
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the role of life-long learning, which will be necessary for a pharmacist to succeed in this
ever-changing healthcare world (Leadbeatter & Peck, 2017). In healthcare, research
telling pharmacists what influences patients' health conditions continuously updates, and
a pharmacist needs to keep up with this new information and integrate it into their
practice throughout their career (Leadbeatter & Peck, 2017). This example makes it
essential to ensure pedagogy and assessments used by schools/colleges of pharmacy
prepare students for the ability not just to regurgitate knowledge and skills that they have
learned but enable students to apply knowledge and skill domains in new and different
ways due to continuously changing practice (Barnett, 2000b). It is essential students and
faculty understand how the competencies and EPAs used to derive program pedagogy
and assessment link to core roles that students should prepare to execute upon graduation.
This linkage will help schools/colleges of pharmacy better prepare students for the
changing healthcare world.
Theory For Role Development
The theory of “learning in a supercomplex world” (Barnett, 2000a) represents an
educational theory to use to define core pharmacy roles and the alignment of the
competency/EPA statements (Leadbeatter & Peck, 2017). This theory stems from the
undergraduate higher education literature and seeks to explain how learning changes
based on how society perceives the world: complex or supercomplex (Barnett, 2000a). A
complex world is one where handling of facts, data, evidence, tasks, and arguments occur
within a framework known by the person (Barnett, 2000a). The complexity arises when
demands exceed the resources needed to meet them, which leads to an overload of data
(Barnett, 2000b). For example, in a complex pharmacy world, patients' disease states
were treated without regard to a patient’s social or cultural traits, so a pharmacist only
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had to think within their professional knowledge scope to diagnose and treat a patient
(Leadbeatter & Peck, 2017). For student pharmacists, this meant that they only had to fill
the prescribed medications and only had to know information about the drug itself. The
complex world (product-centered focus) did not require the student to learn to work with
other healthcare disciplines nor to think much about the patient’s social or cultural
situation before providing treatment.
In contrast, in a supercomplex world (patient-centered focus), problems are not as
identifiable. This lack of problem identification is because, in a supercomplex world,
knowledge and skills are continually changing (Barnett, 2000a, 2000b). For example,
research telling pharmacists what influences different health conditions in patients
continuously updates, and a pharmacist needs to keep up with this new information and
integrate it into their practice (Leadbeatter & Peck, 2017). The ability to keep up with and
incorporate further knowledge into practice takes a different teaching and assessment
type to prepare students to learn in this type of ever-changing world. Student pharmacists
now must work in interprofessional teams, learn new information continuously, and
apply old data in new ways. The knowledge/skills that one develops in school will
become irrelevant over time, which requires continuous learning skills (Barnett, 2000b;
Bengtsen, 2017). Continuous learning skills are an area that needs better emphasized to
students as, according to the study by Pittenger et al. (2019), students felt the least
prepared for continuous learning and did not see this EPA as relevant to pharmacy
practice.
To help students learn to function in a supercomplex world, pharmacy roles need
to take on three components: knowing, action/skills, and self-identity/attitude (Barnett,
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2000a; Bengtsen, 2017). While the current CAPE Outcomes (Appendix A) contain
knowledge (Domain 1), skills (Domains 2 and 3), and attitudes (Domain 4; ACPE, 2015),
the problem becomes that many times, the concepts are looked at in silos as opposed to
teaching and assessing things holistically. The other problem is that because pharmacist’s
roles upon graduation have not been precisely defined, schools/colleges are left to
determine the knowledge, skills, and attitudes that students should be taught and assessed
for themselves as long as they align with the current pharmacy outcomes.
Pharmacy created competencies and EPAs to mirror medicine to help define and
assess the knowledge, skills, and attitudes needed by students upon graduation
(Englander et al., 2016). While the CAPE Outcomes are required to be used by
schools/colleges for accreditation, EPAs are not. EPAs also do not have an accreditation
required defined level of entrustment, allowing programs to set this for themselves. This
lack of standardization means that students may be prepared differently for practice
depending on where they graduate and may lead to graduates not being as prepared for
safe and effective practice as seen in other professions (Frank, Snell, Englander, &
Holmboe, 2017; Josiah Macy Jr. Foundation, 2017). Having a defined set of pharmacy
roles with competency and EPA mapping and a set level of entrustment based on
progression through a professional’s career may be one way to help ensure minimal
preparation for all graduates. The purpose of this project is to investigate the extent to
which a consensus exists, if any, among pharmacy professionals regarding core practiceready roles for graduates that then align to current pharmacy competencies and EPA
statements, with levels of entrustment. The creation of a core set of roles with
competencies/EPAs that align with them and a standardized level of EPA entrustment
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would help ensure consistency of student knowledge, skills, and attitudes upon
graduation. It would also allow schools/colleges of pharmacy to work together to develop
pedagogies and assessments that would ensure all students are practice-ready upon
graduation. Achievement of consensus may occur for pharmacists' roles, and no
agreement may be found on the competency/EPA mapping and/or the entrustment
attainment levels. The lack of consensus on the competency/EPA mapping or the
entrustment attainment level would signal the need for more research on the
competencies/EPAs and levels of entrustment.
Research Questions
This project will answer the following research questions:
1. What are the core professional roles pharmacy programs believe students should
be able to demonstrate competency in upon graduation?
2. What is the alignment of the current pharmacy competencies and entrustable
professional activities (EPAs) to the core professional roles?
3. What level of entrustment should pharmacy graduates be expected to achieve for
each EPA?
Methodology
This project will be conducted in two phases, using an embedded mixed-method
design for each phase (Creswell & Clark, 2011). Different consensus development
techniques will be used to collect data during each phase (Delbecq, van de Ven, &
Gustafsen, 1975). The use of two different consensus development techniques is
preferred for this study. All three research questions require a combination of subjective
judgments from multiple people to form one agreed-upon answer and require different
data types, group sizes, and anonymity (Delbecq et al., 1975).
18

The first phase will address Research Question One, developing a set of core roles
that define what student pharmacists should prepare to do upon graduation. In Phase One,
qualitative data collection occurs via a nominal group technique on the strengths and
modifications needed on a core role proposal (discussed in Chapter 3) provided to the
study participants. Quantitative data is supportive because the nominal group participants
rate the importance of the strengths and modifications discussed (Creswell & Clark,
2011). Conduction of the Nominal Group Technique (NGT) for the proposal review
process occurs in four key stages. It typically occurs during a single scheduled meeting:
silent generation, round-robin, clarification, and voting (Delbecq et al., 1975). The use of
the NGT review process via an internet conference call with an outside facilitator will
allow 6-7 experts to provide input into the core roles and ensures no one person
dominates the conversation as each group member provides input one at a time. This
process will also allow the experts to react to each other’s ideas, leading to better quality
and quantity of ideas, which is essential when developing a set of core roles for pharmacy
practice (Linstone & Turoff, 1975). By the end of the conference call, a set of core roles
that define what student pharmacists should prepare to do upon graduation will occur.
Phase Two will use the final core roles created in Phase One to answer Research
Questions Two (alignment of competencies and EPAs) and Three (setting the level of
entrustment) with simultaneous quantitative and qualitative data collection occurring
using a cross-sectional survey via the Delphi technique. In this phase, the qualitative data
(constructed-response questions) are supportive of the quantitative data (selectedresponse questions; Creswell & Clark, 2011). For example, if one of the core roles were
Patient Care skills, panelists would be asked their level of agreement regarding the
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competency “Provide-patient-centered care as the medication expert” (Medina et al.,
2013, p. 3-4) mapped to this role. A larger, more diverse group of pharmacists (i.e.,
around 40-to 50 with multiple different types of pharmacy practice & different times
since graduation) is needed for consensus on the competency/EPA mapping (Research
Question Two) and levels of entrustment (Research Question Three) to ensure as many
areas of pharmacy have a chance to review the mappings and levels of entrustment. The
anonymity provided by the Delphi survey process is crucial as it allows everyone to
provide their opinion regarding the mapping and levels of entrustment without feeling
pressured to give a particular answer as the surveys are conducted individually with no
discussion among the participants (Linstone & Turoff, 1975). The lack of pressure to
provide a specific answer is essential, given the lack of consensus currently related to
levels of entrustment (VanLangen et al., 2019). By the end of the three-round Delphi
process, an exploratory mapping of the current pharmacy competencies and EPAs to the
roles defined in Research Question One, along with a level of entrustment for each EPA,
will have occurred. After completing Phases One and Two, the data to all three research
questions will tie to the broad objective of exploring the development of graduate core
practice-ready roles aligned to competencies and EPAs with entrustment levels.
Limitations/Reducing Bias
There are several limitations to a multi-phase mixed methods study, including the
number of resources needed, time, and lack of meaningful connection between phases
(Creswell & Clark, 2011). Resources will not be an issue with this study as it will be
conducted via video conference call for Phase One and via an electronic survey for the
second phase. The only resources needed are available free through the University: the
conference call platform and access to Microsoft® Word and Forms. The amount of time
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required to complete both phases may be an issue. Still, mitigation will occur using the
NGT process, which requires only one scheduled meeting and only conducting a
maximum of three rounds of the Delphi process. The lack of meaningful connections
between the phases can occur in some studies; for example, it may not be clear how the
data collected in Phase One is used for the next phase of the project (Creswell & Clark,
2011). A meaningful connection will not be a problem in this project as Phase Two
(alignment of competencies/EPAs to the core roles) cannot be completed without Phase
One (creation of the core roles).
Disadvantages of the consensus development techniques for Phase Two need
considering as well, such as organizing a meeting time, the domination of the
conversation by one participant or group of participants, and lack of inter-rater reliability
(Delbecq et al., 1975; McMillan et al., 2016). The video conference call should allow for
the organization of a meeting time that will suit everyone. Mitigation of one person or
group of people (people from one school of pharmacy) dominating the conversation
occurs by choice of the NGT method of this project over a focus group methodology.
NGT protocol is set-up so that every member of the group gets the opportunity to express
their thoughts one at a time in an organized order, thus allowing everyone the chance to
express their ideas. The researchers chosen for this project by the Deans will be wellversed in the literature related to this study's topic. They will not be inclined to defer to
others’ opinions on the subject if they disagree. Once everyone has responded to the
question once, the process starts again until no new ideas generate. Another potential area
of bias would be having the researcher who developed the proposal lead the NGT
process. Mitigation of researcher bias will occur through the use of a facilitator who did
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not participate in the development of the proposal but is well known in the field of
pharmacy and assessment, so those on the NGT panel will respect her ability to lead the
discussion (Delbecq et al., 1975).
Some of the Delphi method's disadvantages include the time it takes to do the
process (it can take weeks or months) and the potential for a low response rate to the
surveys (McMillan et al., 2016). The time it takes to do the Delphi method will be one
big negative to this process, but by combining Research Questions Two and Three into
one Delphi survey, it will help limit some of the timetable. The potential for a low
response rate will need monitoring and reminders sent to help improve the results. The
last drawback is the researcher's potential for bias who is reviewing and combining the
results (McMillan et al., 2016). Mitigation of the risk of bias will occur by providing the
original and the changed mappings and levels of entrustment in each round of the Delphi
process, thus allowing Delphi participants to serve as reviewers.
Besides the limitations of the consensus processes chosen for this study, threats to
internal and external validity also need to be considered (Campbell & Stanley, 1963). The
risks for external validity that need consideration in this study are sample bias and
reactive effects of arrangements (Campbell & Stanley, 1963). Reactive effects of
arrangements refer to the inability to generalize to non-experimental settings because the
experimental setting is artificial. Reactive effects of arrangements could potentially be a
problem in this study since no actual testing of the alignments and levels of entrustment
will be happening, and results are from practitioners’ thoughts about the appropriate
alignments and achievement levels of entrustment. Future studies would need to be
conducted in real-world educational settings to determine if this process's entrustment
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levels are correct. There is less of an issue with this validity threat as the consensus
participants are active practitioners with various experiences. They should be capable of
accurately determining what graduates need to perform as an entry-level pharmacist.
Sample bias is the other threat to external validity. Sample bias occurs when there is a
chance that the sample chosen for the study may not represent the population of interest.
Sample bias is a potential threat in this study, given only a small number of pharmacists
will be used for the consensus development process. One way this will be mitigated is to
use a non-randomized sample to ensure that the sample chosen consists of a diverse mix
of pharmacy practice types and levels of experience (Campbell & Stanley, 1963).
The following threats to internal validity also need to be considered: (a) history,
(b) maturation, (c) testing, and (d) experimenter bias (Campbell & Stanley, 1963).
History is when events occur during the study that may impact the results, which could be
an issue between the Delphi rounds if participants were to change jobs or learn different
information that may alter the way they think about the alignments and levels of
entrustments between the rounds. Maturation could be a problem as processes with the
participants (aging, experience) could impact the outcomes. History and maturation will
be mitigated by keeping the time between the rounds to no more than two-three weeks.
Another potential internal threat is testing itself. Results are affected when participants do
multiple rounds of “testing.” Testing will be mitigated by only using two to three rounds
of the Delphi process. The last threat to internal validity is experimenter bias. This bias is
when the experimenter’s expectations of the results may consciously or unconsciously
affect the results. The experimenter’s expectations will be mitigated through the design of
the NGT process for research question one and then through the use of the participants
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from the NGT process to review the results of the Delphi process (Campbell & Stanley,
1963).
Significance of the Study
The lack of clarity on pharmacists' roles leads to schools/colleges of pharmacy
defining these for themselves, thus leading to differences in curricula and assessment.
Secondly, currently, EPAs are not required to be used or assessed per 2016 ACPE
Accreditation Standards, and the standards do not provide a level of obtainment needed
upon graduation (Medina, 2017). Without this standardized set of roles with the EPAs
aligned to them and an agreed-upon level of entrustment, it may mean that not all
students are graduating with the same minimal expectations potentially to practice.
The development of pharmacists’ roles for practice-readiness will impact
pharmacy education and practice in several ways. For pharmacy education the roles,
competency alignment, and EPA entrustment levels should help to ensure that all
graduates possess the same minimal level of competence in knowledge, skills, and
attitudes upon graduation that are needed to function in both today’s healthcare
environment and the future (ACGME, 2017; Frank et al., 2015, & General Medical
Council, 2017). Creating a standard set of roles should help move the pharmacy
profession forward and expand its role in the healthcare team (Isasi & Krofah, 2015).
Having minimal EPA entrustment levels that are consistently agreed upon by the
profession will also allow schools/colleges of pharmacy to specialize in areas requiring
higher EPA attainment levels before graduation or additional specialty EPAs that are
program-specific.
Results from this study will also impact pharmacy research in multiple areas. The first
area is the types of assessments that will be useful to determine students have met the
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appropriate level of EPAs as well as other assessments that may be required to ensure
that students are meeting the full definition of each role. Pharmacy will need to look for
ways to ensure that assessments are holistic and review students across the curriculum
and not just at one point in time. Arising will also be a need to develop pedagogies
appropriate to teach students how to achieve the competencies and EPAs associated with
each role.
Definitions/Terminology
Multiple terms and abbreviations need defining to aid in the reading of this
dissertation.
1. AACP: American Association of Colleges of Pharmacy; This national pharmacy
organization represents pharmacy education in the United States with a mission to
advance pharmacy education, scholarship, practice, and service to improve the
health of society through partnerships with its members (AACP, 2019a).
2. ACGME: Accreditation Council for Graduate Medical Education; This national
medical organization sets and monitors the professional educational standards for
physician preparation to ensure delivery of safe, high-quality medical care to all
people living in the United States (ACGME, 2019).
3. ACPE: Accreditation Council for Pharmacy Education; The US Department of
Education recognizes this national pharmacy organization as the governmental
agency for professional degree accreditation in pharmacy. Its mission is to set the
pharmacy education standards for schools/colleges of pharmacy to prepare
students for the delivery of pharmacists-provided patient care (ACPE, 2019).
4. CanMEDS: This is a physician training framework developed by the Royal
College to define competencies for all medical practice areas to provide a medical
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education and practice foundation in Canada. This framework was developed
based on empirical research, educational principles, and broad consultation of
stakeholders. The framework was initially adopted in 1996 and has undergone
two revisions since 2005 and 2015 (CanMeds, 2019).
5. CAPE: Center for the Advancement of Pharmacy Education; This is a group of
educators and practitioners nominated by practitioner organizations to create
outcomes that pharmacy curriculum should aim for students to achieve. CAPE
2013 is the fourth iteration of these outcomes (1992, 1998, and 2004; AACP,
2019b).
6. Competency: Competency is the ability of a health professional to integrate and
apply the multiple components of knowledge, skills, attitudes, and values (Frenck
et al., 2010; Orgill & Simpson, 2014).
7. Complex world: This is a world where clearly and fundamentally identifiable
problems occur even if a clear solution is not immediately seen (Bengtsen, 2017).
8. Delphi process: This approach used self-completed questionnaires instead of
face-to-face communication to develop consensus from large groups of
participants (Linstone & Turoff, 1975).
9. Embedded mixed methods: In an embedded mixed methods design, one type of
data collection is predominant with quantitative and qualitative data collection
occurring simultaneously (Subedi, 2016).
10. Entrustable professional activities (EPAs): EPAs are considered “units” of
professional practice that define the tasks and/or responsibilities that a trainee
should be entrusted to perform have he/she has attained sufficient competence in
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an area. EPAs are independent, executable, observable, and measurable activities
that aid in assessing competencies by translating competencies into clinical
practice (ten Cate, 2013).
11. Entrustment: Determination of entrustment occurs by assessing the level an
individual can trust someone to complete the tasks. Level 1 is the student can
observe but not do, level 2 is execution with direct and proactive supervision,
level 3 is the performance with reactive supervision (quickly available), level 4 is
execution with supervision from a distance or when asked for, and level 5 is the
ability to teach someone else the skill (ten Cate, 2013).
12. Nominal group technique: This technique allows for the collection of qualitative
data through semi-structured interview questions. Four key stages comprise NGT:
silent generation, round-robin, clarification, and voting (usually done by ranking
or rating) (Delbecq et al., 1975).
13. Practice-ready: This is a complex, commonly used term that as many meanings
depending on the context to which it occurs. In this paper, the word will be used
to mean practitioners prepared for current practice, but that also have the life-long
learning skills needed to function in this ever-changing healthcare environment
(Wolff et al., 2010).
14. Professional competency: Professional competency is “the habitual and judicious
use of communication, knowledge, technical skills, clinical reasoning, emotions,
values, and reflection in daily practice for the benefit of the individual and
community served” (Epsetin & Hundert, 2002, p. 226).
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15. Supercomplex world: In a supercomplex world, overloads of data are not
manageable by merely adding more resources, and problems are not as
identifiable (Barnett, 2000a, 2000b).
Outline of the Dissertation
The remainder of the dissertation will have four chapters. Chapter 2 provides a
thorough literature review on the current state of pharmacy and medical education,
discusses why changes are occurring and needs to continue to occur in healthcare
education, and describes the areas currently missing in pharmacy education that make the
need to define practice-ready roles so important. Chapter 3 provides the step by step
methods for how the research questions are answered in this project. It discusses the
sampling methodology used for the Phase One NGT process and the Delphi process used
for Phase Two. It also explains data collection and analysis for each method as well as
the timelines for each procedure. It also explains how the two phases of this project are
intertwined. Chapter 4 provides the empirical findings that answer each research
question. Finally, Chapter 5 will interpret the findings from Chapter 4, explain how the
Chapter 4 findings contribute to the body of research in this area and how the results may
lead to improvements and future areas of research in pharmacy pedagogy and assessment.
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CHAPTER 2: LITERATURE REVIEW
A critical issue in pharmacy education is the production of practice-ready entrylevel graduates equipped to engage in 21st-century healthcare (Frenck et al., 2010). The
healthcare world is transforming with the use of technology (e.g., telemedicine) and
changes in healthcare insurance, the workforce, and regulations (e.g., Affordable
Healthcare Act; Vogenberg & Santilli, 2018). The definition of a practice-ready
pharmacy graduate has also transitioned to include preparation for current practice and
the development of life-long learning skills (Wolff et al., 2010). The job of
schools/colleges of pharmacy is to ensure that students are practice-ready, and they
possess and can demonstrate the key professional competencies required to meet the
needs of an increasingly diverse population. The definition of professional competence is
“the habitual and judicious use of communication, knowledge, technical skills, clinical
reasoning, emotions, values, and reflection in daily practice for the benefit of the
individual and community served” (Epsetin & Hundert, 2002, p. 226). Preparation of
practice-ready, professionally competent graduates is a requirement that must be met for
schools/colleges of pharmacy to receive accreditation. However, accreditation standards
do not provide a true definition of entry-level practice-readiness (ACPE, 2015). To
prepare practice-ready graduates, pharmacy needs to define the core roles students need
to do upon graduation. The current pharmacy competency statements and entrustable
professional activities (EPAs), mapped to these core roles, could then be
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used to drive pedagogies and assessments used by schools/colleges to prepare practiceready graduates.
Schools/colleges of pharmacy use the current pharmacy competencies (Appendix
A; Medina et al., 2013) and EPAs (Appendix B; Jarrett et al., 2018) in various ways
depending on the pharmacy's program mission and goals. For example, some
schools/colleges use the EPAs to assess student’s progression throughout the curriculum
by defining different levels of EPA entrustment based on a student’s professional year in
the curriculum. Other schools/colleges use the EPAs to assess students during only the
curriculum's experiential portions to tie the didactic competencies with the professional
activities seen in the clinical setting (Jarrett et al., 2018). These different usages may
mean that students are prepared differently for practice depending on where they
graduate. These different uses of the competencies and EPAs also make it hard for
schools/colleges to share pedagogies and assessment methods. The purpose of this project
is to investigate the extent to which a consensus exists among pharmacy professionals
regarding core practice-ready roles for graduates that then align to pharmacy
competencies and EPA statements, with levels of entrustment. The creation of a core set
of roles with competencies/EPAs that align to them and a standardized level of EPA
entrustment would help ensure students' minimal competency upon graduation. Still, it
would allow schools/colleges of pharmacy to develop pedagogies and assessments that
could be compared across programs to ensure all students are practice-ready upon
graduation.
The development of pharmacists’ roles for practice-readiness will impact pharmacy
education and practice in several ways. For pharmacy education, development of a set of
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core pharmacy roles as proposed in this project that then align with the current pharmacy
competencies and EPAs (including a standardized level of entrustment for assessment)
may help to ensure all pharmacy school graduates possess the same minimal knowledge,
skills, and attitudes upon graduation (ACGME, 2017; Frank et al., 2015; General Medical
Council, 2017). A standardized level of entrustment is necessary as EPA assessment
occurs using five levels of entrustment (described in detail later) that assess increased
independence in skill conduction as the level increases (ten Cate, 2013). Still, currently,
the pharmacy accreditation standards do not require the use of the EPAs, nor do they
define a set level of EPA attainment upon graduation. This lack of required usage and a
set level of minimal entrustment makes it hard to compare pharmacy graduate skill
attainment across different schools/colleges. Creating core roles upon which the
pharmacy competencies, EPAs, and levels of entrustment align may aid schools/colleges
in developing shared pedagogies and assessments. This alignment may also provide
stakeholders with the ability to compare students' knowledge, skills, and attitudes upon
graduation across programs since all schools/colleges would be ensuring all students
meet the same minimum standards. Having minimum EPA levels may also allow
schools/colleges of pharmacy to specialize (prepare students for residencies or
fellowships, prepare students for specific disciplines such as pediatrics) as they can
require higher EPA attainment levels before graduation or add additional specialty EPAs
that are program-specific without compromising minimal competency. The creation of a
core set of pharmacy roles may also help to move the pharmacy profession forward as the
profession continues to expand its role on the healthcare team (Isasi & Krofah, 2015) as
the core roles will provide a clear definition to other healthcare professions of what
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pharmacists can do (knowledge, skills, and attitudes). Lastly, establishing a set of core
roles from which all competencies and EPAs evolve will provide a firm basis from which
to start the move to full competency-based education, as seen in other healthcare
professions (Medina, 2017).
The development of pharmacists’ roles for practice-readiness will impact pharmacy
research in multiple areas as well. The first research area is the types of assessments that
will help determine students have met the appropriate EPA entrustment level as currently
there is a lack of data related to the assessment of the EPAs (discussed in detail later).
Pharmacy will need to look for ways to ensure that assessments are holistic and review
students across the curriculum and not just at one point in time. For example, creating
assessments that would assess a student’s communication skills at the beginning, middle,
and end of the program to ensure skills improved as the student moved through the
program. Arising will also be a need to develop pedagogies appropriate to teach students
how to achieve the competencies and EPAs associated with each role. For example, in
medicine, one of the competencies mapped to the CanMeds Medical Expert role is:
“Practice medicine within their defined scope of practice and expertise” (Frank et al.,
2014, p. 1). This competency indicates schools of medicine need to have pedagogies that
discuss the knowledge and skills required for a physician’s scope of practice. An example
EPA for this competency would be “Gather a history and perform a physical
examination” (Englander et al., 2016, p. 1354). Assessment of student performance on
the EPA occurs using the entrustment levels described later with the goal entrustment
level based on the stage of the student’s career (i.e., lower for medical students, higher
for residents). Pharmacy has not created such a concrete mapping that aligns core
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pharmacy roles, competencies, and EPAs with entrustment levels. This lack of alignment
means schools/colleges are left to determine alignment independently, which may lead to
different student preparation for practice depending on where they graduate. Suppose a
consensus is not reached during this study on mapping the competencies/EPAs and/or on
entrustment attainment levels. In that case, there will be a need for more research on the
viability of the current competencies/EPAs and entrustment levels.
The subsequent chapter is organized into five sections. Section 1 reviews
healthcare and the role of pharmacy education. The second and third sections review
pharmacy and medical education. The fourth section discusses the elements missing from
pharmacy education. The last section discusses the theory of learning in a supercomplex
world and how this might be used along with the current pharmacy competencies and
EPAs to develop pharmacist’s roles. This review will then explain the study's purpose
and how it will impact pharmacy education and future research areas.
Healthcare and the Role of Pharmacy Education
Vogenberg and Santilli (2018) recently identified multiple themes describing the
current healthcare trends driving the US healthcare system's transformation. These
themes include changes in (a) technology (e.g., telehealth, telemedicine), (b) healthcare
insurance (move to high deductible plans), (c) workforce, (d) drug supply chains, and,
lastly, (e) regulatory (Affordable Health Care Act; Vogenberg & Santilli, 2018).
Pharmacy needs to consider these healthcare trends when developing core roles that
students should be prepared for upon graduation so schools/colleges can design curricula
and assessments that ensure students' minimal preparation for practice in this changing
healthcare system.
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One of the themes driving today’s healthcare system involves increasing technology
use to improve healthcare (Vogenberg & Santilli, 2018). Healthcare needs to use more
technology to reach rural populations and integrate care for larger populations due to the
shift to more primary preventive services. Technology is one way to deal with the current
rate of rural hospital closures. One in three rural hospitals is at financial risk due to the
decline (loss of 200,000 people between 2010-2016) in people living in rural counties
(Vogenberg & Santilli, 2018). Technologies, including telehealth and telemedicine, allow
rural hospitals to provide specialty services (e.g., post-operate care) to patients without
having to have the service in the town itself (Vogenberg & Santilli, 2018). Telehealth and
telemedicine would allow a rural hospital to take advantage of the cost-savings that have
been found by having a pharmacist on a healthcare team without having the pharmacist
actual on-site. De Rijdt, Williems, and Simoens (2008) conducted a literature review of
the economic evaluations of clinical pharmacy interventions in a hospital setting between
1996-2007. To be included, studies had to be in hospital pharmacies, compare the
provision of clinical pharmacy services versus no clinical pharmacy services, and
compare both costs and outcomes. De Rijdt et al. found when pharmacists participated in
multidisciplinary teams, there was more intensive and direct care of patients, which
reduced preventable adverse drug events and prescribing errors, thus leading to decreased
costs. Without a core set of pharmacy roles that define what pharmacists should do upon
graduation, there is no way to ensure student preparation for this move to telehealth
practice.
The move to a more primary preventive focus will require a better way for patients to
monitor and communicate with pharmacists from their own homes. Technologies such as
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consumer wearables or smartphones allow patients to monitor blood pressure and blood
sugar at home and send this information electronically to healthcare providers who can
make changes in the patient’s care without needing to see the patient (Vogenberg &
Santilli, 2018). These new technologies will allow pharmacists to provide medication
therapy management (MTM) as well as other primary care services (e.g., diabetes
medication adjustment), which improve healthcare outcomes and decrease costs (Isasi &
Krofah, 2015). Michaels et al. (2010) conducted a retrospective analysis in North
Carolina community pharmacies to determine the economic impact of a Medicaid MTM
program and assess pharmacist recommendations' acceptance and implementation.
Ninety-two pharmacies from one pharmacy chain in North Carolina from August 2006July 2007 were used for this retrospective review. Medicaid recipients who had received
at least 12 prescriptions each month and who completed four quarterly medication
reviews by the pharmacists were eligible for the retrospective review. A review of 88
recipients occurred to assess the rate of acceptance of pharmacist recommendations and
the overall impact of changing from brand-name medications to more cost-effective
alternatives. There was a 62-86% acceptance rate of the pharmacists’ recommendations
during one year of the research, and this resulted in an average cost savings of $107 per
Medicaid beneficiary. The pharmacists’ recommendations led to a total of $9444 in
annual cost savings during the study (Michaels et al., 2010). These technologies will lead
to the need for tech-savvy pharmacists and will create potential new career options for
pharmacists trained to take advantage of these new areas of practice. One way to
potentially ensure students are ready for changing practice is to develop a core set of
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pharmacy roles that all graduates should prepare for regardless of the type of pharmacy
the student chooses to practice.
Another trend is the changes in healthcare insurance, which has led to consumerism
in healthcare. This consumerism is due to the increasing cost of employee healthcare
benefits (move to high deductible insurance plans meaning the employee pays more out
of pocket before benefits start), cost of physician and hospital visits, and the cost of
pharmaceutical medication, especially with the rise of specialty drugs (Vogenberg &
Santilli, 2018). The millennial generation will need to share more of the burden of the
cost of healthcare. This increase in cost-sharing leads to consumers being more engaged
in ensuring they receive the most value for their money. The cost-sharing is also leading
to more transparency in healthcare costs, including the cost of prescription medications
(Vogenberg & Santilli, 2018). This change will require pharmacists to be more involved
in finding cost-effective therapies for patients and educating patients so they receive the
best benefit from the therapies they are using and will require pharmacists to be an
integral part of interprofessional teams (Frenck et al., 2010). Defining core roles for
pharmacists that align with the roles seen in medicine will show other professions what
pharmacists can do. Aligning pharmacy competencies and EPAs to these roles will help
schools/colleges ensure that all graduates are minimally competent to practice on
interprofessional teams.
Another theme involves changes in the current general workforce (Vogenberg &
Santilli, 2018). The current workforce is more diverse and has more education than ever
before (Pew Research Center, 2016). According to a Pew Research Center report (2016),
occupations that require average (associate degree or one-two years of job experience) to
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above-average education (college-degree plus additional years of experience or training)
has increased from 49 million in 1980 to 83 million (68%) in 2015. The gender
demographics are also changing as 47% of the workforce in 2015 were women,
increasing over previous years. The age groups that make up the workforce are also
changing, with less than half of 16-24-year-olds being employed in 2015 compared to
57% in 2000. Older adults are also staying longer in the workforce, with approximately
62% still working (Pew Research Center, 2016). This make-up requires better
communication and different employee benefits then previous generations as healthcare
benefits needed by older adults look different than those required for younger adults. The
ability to communicate with multiple different entities (patients, caregivers, providers,
insurance companies) will be an essential skill to ensure is incorporated into core role
development as this is a skill that goes across all pharmacy disciplines.
The last set of themes center around the changes in drug supply chains and
government/regulatory changes. Over the last year or two, several new entities have
emerged into the drug delivery system. While these new entities provide more options to
patients to receive medications at lower costs, they do challenge the healthcare system to
have access to all the patient’s accurate medical records as patients could receive care and
medications through multiple places. The lack of accurate patient medical records makes
it even more critical that pharmacists have excellent communication skills, the ability to
mobilize knowledge from various sources to formulate a patient’s treatment plan, think
critically to modify drug therapies, and collaborate with other healthcare providers on
both local and global teams (Frenk et al., 2010; Leadbeatter & Peck, 2017). These
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knowledge and skills need consideration when developing the core roles for pharmacists
as they are essential regardless of the type of pharmacy a student chooses to practice.
The uncertainty of the status of the Affordable Care Act and the withdrawal of many
insurance plans from the Affordable Care Act exchanges is also affecting the way
patients are seeking care and how healthcare workers are getting paid for providing care
(Vogenberg & Santilli, 2018). The change in the way people seek care may open new
opportunities for pharmacists in primary care areas since pharmacists are easily
accessible. Pharmacists will need soft skills such as ethics and concern for others and be
able to engage with perspectives different from their own to participate in these new areas
(Frenk et al., 2010; Isasi & Krofah, 2015; Leadbeatter & Peck, 2017). These attitudes
will be important to consider when designing the core roles for pharmacy as they are just
as important as knowledge and skills regardless of the type of pharmacy practice.
To function as a productive member of a healthcare team based on these themes, a
pharmacist will need the ability to imagine entirely new roles for the profession (Barnett,
2000b). Historically, the pharmacist’s role was only to dispense medication and devices
prescribed by the physician, which tied the pharmacist to the product (medicine).
However, today, the role of the pharmacist is in the transition from a product-centered to
a patient-centered focus with the pharmacist no longer working in a silo to dispense
medication but instead as an integral part of the healthcare team initiating and modifying
drug therapies, performing lab tests, and collaborating with other health care providers.
These changes in practicing pharmacists' responsibilities and the knowledge, skills, and
attitudes needed to execute them have important implications for pharmacy education
programs (Barnett, 2000b; Epsetin & Hundert, 2002).
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Pharmacy Education
Pharmacy has created a set of professional competency and EPA statements to
help schools/colleges of pharmacy educate students. However, the derivation of the
professional competency statements did not occur from a defined set of core roles,
indicating what graduates should perform. This lack of defined roles leads
schools/colleges to define these practice-ready roles based on their interpretations of the
competencies. The lack of standardization could lead to students being prepared
differently for practice depending on the school/college they choose to attend. The
pharmacy education section of this paper will review the current competencies used in
pharmacy education, review pharmacy’s current use of the EPAs, and discuss knowledge
and skills that stakeholders feel need to be taught and assessed to prepare future
graduates.
Pharmacy Accreditation Standards 2016 adopted the CAPE 2013 outcomes as the
competencies that all schools/colleges of pharmacy need to teach and assess (ACPE,
2015). CAPE 2013 is the fourth version of educational outcomes created to guide
curricular and assessment discussions within pharmacy schools/colleges. The CAPE
committee for the revision included seven members from the central pharmacy educator
organization (American Association of Colleges of Pharmacy [AACP]) and eight
members from the Joint Commission Pharmacy Practitioners (JCPP). Rather than starting
the development of outcomes based on a set of core roles that students should prepare for
upon graduation, the CAPE committee chose to update a previous version of the CAPE
outcomes after conducting a literature review from pharmacy and other health
professions (Medina et al., 2013). The 15 CAPE outcomes, with one-word descriptors
(Appendix A), center around four large domains: Foundational Knowledge, Essentials
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for Practice and Care, Approach to Practice and Care, and Personal and Professional
Development (Medina et al., 2013). While the CAPE outcomes do roll-up into four broad
domains, these domains are student learning outcomes as opposed to roles that student
pharmacists should prepare for upon graduation, as is seen with medicine (ACGME,
2017; Frank et al., 2015; General Medical Council, 2017). Secondly, schools/colleges of
pharmacy are not provided a framework for pedagogy and assessment for the CAPE
outcomes, which leaves it up to the school/college of pharmacy how they want to
implement these outcomes to meet the accreditation standards.
Running alongside the CAPE outcomes is the JCPP patient care process, which
better defines CAPE outcome 2.1 (Caregiver). The development of the patient care
process occurred through a review of several resources on pharmaceutical care and
medication therapy management. The method was adopted in May of 2014 as a process
to set clear expectations for a patient-pharmacist visit and is a required component of the
2016 Accreditation standards (ACPE, 2015; Bennett, Kilethermes, Derr, & Irwin, 2015).
This five-step process is a foundational framework designed to promote students’
professional competence in working with other healthcare providers to provide optimum
medication use and improved patient outcomes (Kolar, Hager, & Losinski, 2017). It
includes: collect, assess, plan, implement, and monitor/evaluate. Collection involves the
initial collecting of data from various sources to determine the focus and intensity of the
service. Assessment is the use of the data collected to determine the patient’s needs as
well as reviewing the appropriateness, safety, efficacy, and adherence to the patient’s
current and anticipated medication therapy. The plan is creating a patient-specific
treatment plan in collaboration with the full health care team, patient, and caregivers.
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Addressing of medication problems and goals of treatment occur in this step. The
implement step is where the plan starts, and patient/caregiver education about the plan's
specifics happens. The last step of monitor and evaluate is where the patient is followed
over time to monitor for relevant parameters (e.g., lab tests, blood pressure, blood sugar)
of care, and when needed, new data are collected to restart the process (Bennett et al.,
2015). This process's steps provide a roadmap for pedagogies and assessments for
schools/colleges of pharmacy, but it does not stand alone. It is one of the foundations of
patient care (CAPE Domain 2) related to other pieces of knowledge, skills, and attitudes
(Boyce, 2017). Without a core set of roles defining what graduates should prepare for
upon graduation, it is hard to determine what other pieces of knowledge, skills, and
attitudes students would need to go along with the patient care process.
A lack of core roles agreed upon by all schools/colleges leaves it up to each school to
define these roles for themselves. The lack of core roles also allows each school/college
to establish its assessments to determine student preparation for these goals and
achievement of the CAPE outcomes as the pharmacy accreditation standards only require
that schools/colleges maintain a specific passing rate on the pharmacy licensure exam
[North American Pharmacy Licensure Exam (NAPLEX)] which is a knowledge-based
exam. Schools/colleges are not held to specific assessment standards related to the CAPE
outcomes, making it hard to compare the assessment of the outcomes between programs
(ACPE, 2015). One of the problems with assessing competencies like the CAPE
outcomes is no assessment method to date can reliably measure competencies separately
from one another as independent constructs (Ginsburg, Mcllory, Oulanova, Eva, &
Reghr, 2010). The EPAs are used by pharmacy and medicine to separate competencies
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into measurable units assessable over time and provide a consistent assessment method
for comparison across all schools/colleges.
The profession of pharmacy created a set of EPAs to describe what pharmacists
do as well as to set expectations and guide future actions in practice. The creation of
EPAs occurred because patients, practitioners, and policymakers more easily understand
EPAs as opposed to competencies (outcomes) since EPAs assess workplace activities.
EPA creation for pharmacy started in 2015-16 with the Academic Affairs Standing
Committee of AACP. The AACP president charged this committee to identify EPAs for
pharmacy graduates as they transition from completion of their advanced pharmacy
practice experiences into professional practice and other postgraduate opportunities.
Work continued with the 2016-17 Academic Affairs committee, which compiled
comments and input from stakeholders regarding the draft EPAs and completed the final
edits (Haines et al., 2017). A list of the fifteen pharmacy EPAs is in Appendix B.
After EPA creation, it was essential to demonstrate the EPAs were valid for
schools/colleges to use as an assessment tool. Haines, Pittenger, Gleason, Medina, &
Neely (2018) conducted a face validity study on the fifteen core EPAs using a 28-item
questionnaire sent to experience pharmacy practitioners affiliated with four
schools/colleges of pharmacy. Participants had to be pharmacy practitioners with at least
five years of experience that oversaw and graded at least six student pharmacists on
experiential rotations in the previous 24 months. Of the participants involved, 89% said
the patient care provider domain was where they spent most (61%) of their time,
followed by being an interprofessional team member. Seventy-one usable surveys were
returned (52% response rate). Participants agreed, with ≥ 75% agreement, that the current
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15 EPA statements describe activities pertinent to pharmacy practice and that pharmacists
should perform. A consistent level of agreement occurred regardless of the preceptor’s
employment, board certification status, or postgraduate training completion. Overall, the
survey shows that the EPAs developed and vetted by AACP have face validity (Haines et
al., 2018).
EPAs are measured using entrustability scales. An entrustability scale is a
behaviorally anchored ordinal scale from progression to competence (Rekman, Gofton,
Dudeck, Gofton, & Hamstra, 2016). Pharmacy uses the same definition for the five levels
of EPA entrustment as the field of medicine (ten Cate, 2013). Level 1 entrustment
suggests a student can observe but not complete a particular task. For example, a student
may observe the pharmacist do a patient's medication history, but the student is not yet
ready to do the history themselves. Level 2 is execution with direct and proactive
supervision. For this level, the student will perform the medication history, but the
pharmacist is in the room and can provide advice or add in missing pieces to the history if
needed. Level 3 is performance with reactive supervision (quickly available). At this
level, the student will perform the medication history alone with the pharmacist in the
next room quickly available should help be needed. Level 4 is execution with supervision
from a distance or when asked for by the student. For this level, the student is performing
the medication history without a pharmacist in the nearby room or even building. The
student can be freely trusted to perform the history without any help unless he/she asks
for it. Level 5 is the ability to teach someone else the skill (ten Cate, 2013). The AACP
Academic Affairs Standing Committee recommends that pharmacy graduates achieve a
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Level 3 (reactive supervision) on each of the 15 core EPAs upon graduation (Jarrett et al.,
2018).
Assessment of the EPAs needs to use levels of entrustment, not scores,
percentages, or letter grades, which is one of the hard parts in pharmacy education
implementation since many pharmacy schools/colleges still provide letter grades for
experiential rotations. Like medicine, there is also a lack of remediation plans for those
who are not satisfactorily meeting the required level of supervision (Jarrett et al., 2018).
The lack of standardization on grading and way to remediate makes it hard to determine
the appropriate use of EPAs in pharmacy education to assess student competency upon
graduation.
Pharmacy programs use EPA entrustment levels for two specific purposes. One
way is to link individual competencies and overall professional responsibilities (e.g.,
students would need to master each competency related to dispensing a medication before
being able to complete the EPA of fulfilling a medication order without supervision). The
other way is as a mechanism for faculty to assess the level of supervision for a student
(e.g., can a student be trusted to perform this activity alone or does the faculty need to be
in the room [no tie to a particular competency]; Jarrett et al., 2018).
Determination of entrustment occurs through assessment of the level one can trust
someone to complete the tasks. Determination of a trainee’s competence is by not only
their knowledge and skills but also their ability to recognize their limitations, their
willingness to seek help, and their conscientiousness. Other things that go into
entrustability are the context and culture of the workplace, the task complexity and
familiarity, and the relationship between the supervisor and trainee. Trust begins to
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develop as soon as a supervisor starts working with a student or resident, and judgments
of trust usually occur within hours or days based on direct clinical care and team
leadership observations. Often, decisions that students make in the clinical setting hold
real consequences such as improvement in a patient's health status or even death if a
mistake occurs. Because of these consequences, entrustment choices are not easy for
supervisors (Damodaran, Shulruf, & Jones, 2017; Hauer et al., 2015). For example, in
pharmacy, if a student is entrusted to counsel a patient on medication at a level 3
(pharmacist does not have to be present) and the student makes an error, it is the
pharmacist who is ultimately liable for the mistake because they allowed the student to
complete the task unsupervised. The consequences of entrustment decisions are one of
the negatives to EPA usage. The consequences also make it hard sometimes to get
everyone to agree on a specific level of attainment for a given EPA.
While EPAs help define a universal language of assessment for the pharmacy
competencies (Haines et al., 2017), there are multiple negatives to EPA usage. One
negative is that some see EPAs as just another mandate that schools/colleges of pharmacy
need to assimilate into their curricula and assess student progression. Another negative is
that some pharmacy educators do not feel that the EPAs reflect all specialized practice
areas. Lastly, others have difficulty seeing how the EPAs reflect the content they teach
(Haines et al., 2017).
To help schools/colleges understand how EPAs can aid pedagogy and assessment,
mapping the EPAs to the CAPE outcomes and JCPP Patient Care Process occurred.
Mapping to CAPE and the Patient Care Process occurred because both processes are
requirements for assessment in all schools/colleges per accreditation standards (ACPE,
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2015; Pittegner et al., 2017). Table 1 shows how the EPAs integrate with the CAPE
outcomes and the Patient Care Process. This mapping helps to demonstrated which
competencies and portions of the Patient Care Process, a student would be competent in
should they achieve the required level of entrustment (ten Cate, 2013).
Table 1
Mapping of Pharmacy EPA Domains to CAPE and JCPP Patient Care Process (PCPP)
EPA
Domain
Patient
Care
Provider

Interprofes
sional
Team
Member

Population
Health
Promoter

Informatio
n Master

Practice
Manager

PCPP

1.
1
Collect, X
Assess,
Plan,
Implem
ent,
Follow
-up
Collect, X
Assess,
Plan,
Implem
ent,
Follow
-up
Collect,
Assess,
Plan,
Implem
ent,
Follow
-up
Collect, X
Assess,
Plan,
Implem
ent,
Follow
-up
Assess,
Plan,
Follow
-up

2.
1
X

2.
2
X

2.
3
X

2.
4

3.
1
X

3.
2
X

3.
3
X

3.
4
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X
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3.
5
X

3.
6
X

4.
1

4.
2

4.
3

4.
4

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Selfdeveloper

Collect,
X
X
Assess,
Plan,
Implem
ent,
Follow
-up
Notes. Adapted from “Report of the 2016-2017 Academic Affairs Standing Committee:
entrustable professional activities implementation roadmap,” by A. L., Pittenger, et al.,
2017, American Journal of Pharmaceutical Education, 81(5), Article S4, p. 9.
To date, there is limited information on the extent to which pharmacy programs’
use of EPAs has driven our understanding of graduating student competency. Conduction
of one study occurred in a pharmacy residency program (Moon et al., 2018), another in
pharmacy faculty (VanLangen et al., 2019), and another in student pharmacists (Pittenger
et al., 2019). A pharmacy residency study conducted by Moon et al. (2018) surveyed all
pharmacy residency program preceptors and residents using a Likert scale and free text at
the University of Minnesota asking them to describe their perceptions of using the EPAs
to assess performance. Results showed that 66.7% of residents and 78.3% of preceptors
thought the EPA framework was more helpful than the previously used progressions
rating model for all but three of the EPAs with residents achieving an entrustment level
of 4 or 5 upon completion of the program. Moon et al. found that leadership skills,
developmental planning, and practice management skills were not as easy to assess with
the EPAs compared to the old residency progression model. EPAs were useful for
assessment in residents with an entrustment level of 4 or 5 being the goal. More research
needs to be done on the EPAs related to leadership skills, developmental planning, and
practice management skills to determine why residents and preceptors found them hard to
assess. The other area that needs more research is the level of entrustment attainment
because if residents should be achieving a 4 or 5 upon completion of their resident year,
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then it should make sense that student pharmacists should be performing an entrustment
level of less than that upon graduation as is recommended by the committee that created
the EPAs. However, literature related to student entrustment level attainment does not
support this idea. This lack of entrustment attainment standardization makes it hard to use
EPAs as an assessment for graduate practice-readiness.
A study by VanLangen et al. (2019) asked faculty to quantify the importance of
the current EPAs and their corresponding levels of entrustment. VanLangen et al. found a
strong consensus (≥75% agreement) of importance for 13 out of the 15 EPAs. Two of the
EPAs only had a moderate consensus (50-74.9% agreement): appropriate use of
medication in a population and identifying risk for prevalent diseases in a population.
Faculty also could not come to a consensus on the appropriate level of entrustment. Only
10 of the 15 EPAs had a moderate consensus of a level three entrustment recommended
by AACP. The others had rates that spanned across all the entrustment levels
(VanLangen et al., 2019). VanLangen et al. is the first published article that has reviewed
faculty perceptions of what level of entrustment students should achieve on the EPAs
outside of the recommendation made by the standing committee at the time of EPA
development. Further research and consensus-building are needed around the minimum
entrustment level that students should achieve before graduation. Without a minimum
level of entrustment that all schools/colleges should have students achieve, it makes it
hard to determine if all graduating students are practice-ready upon graduation as the
level of preparedness would depend upon where a student graduated.
Pittenger et al. (2019) studied students' understanding of how the EPAs and levels
of entrustment fit into practice. Pittenger et al. surveyed student pharmacists to determine
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if students across multiple programs felt the 15 EPAs were relevant to pharmacy practice
and if practice settings used the EPAs. Greater than 94% of students perceived relevance
for 14 out of the 15 EPAs in practice, with the lowest level of agreement occurring on the
EPA for continuous professional development (85% agreement). Greater than 91% of
students felt that nine out of the 15 EPA statements represented activities performed in
multiple practice settings. With the lowest level of agreement again on continuous
professional development (67% agreement). Another one of the lower levels of
agreement was for the EPA to identify risk for prevalent diseases in a population (72%
agreement), which was also seen as a problem by faculty in VanLangen et al. (2019).
These results indicated that students do understand the activities assessed with the EPAs
are used in pharmacy practice. However, they see less need for the EPA around
continuous professional development, which is essential in this new healthcare
environment.
Pittenger et al. (2019) also asked students to rate their level of entrustment on the
EPAs as they moved through the pharmacy curriculum as well as areas they felt least
prepared to do upon graduation. Students did report feeling they required less supervision
in performing the EPAs as they progressed throughout the program with a median
entrustment level of 2 for 13 out of the 15 EPAs for first-year students and median
entrustment level of 3 for ten out of the EPAs in the second year students. Third-year
students indicated an equal split on the EPAs between entrustment levels 3 and 4. Before
graduation, fourth-year students showed a median entrustment level of a 4 on 13 out of
the 15 EPAs. Students felt the least prepared for EPAs involving overseeing pharmacy
operations (57% felt prepared), developing plans for continuous professional
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development (42% felt prepared), and establishing patient-centered goals and care plans
(32% felt prepared; Pittenger et al., 2019). The Pittenger et al. study shows gaps in
understanding how the current EPAs assess the skills needed for practice (i.e., continuous
professional development, establishing patient care plans, and overseeing pharmacy
operations). Without a set of core pharmacy roles on which to map the competencies and
EPAs to it is hard to help students understand the big picture of how the assessments they
are doing will determine they are ready for practice upon graduation and what level of
entrustment they should be obtaining.
There is limited data on the use of EPAs, especially in student pharmacists, which is
not surprising given that the adoption of EPAs just occurred in 2017. Many of the
concerns mentioned regarding the use of the EPAs in their early adoption are similar to
the fears seen in the medical literature, especially regarding the EPAs not assessing all
the skills needed for professional practice (Krupat, 2018). The core EPAs developed by
AACP help move the new pharmacy identity from the traditional dispensing role to the
medication-related cognitive services roles. Currently, the EPAs are not required to be
used as an assessment tool by accreditation, however. The lack of standardization on the
use of EPAs and the level of entrustment needed upon graduation makes it hard for
schools/colleges of pharmacy to work together on creating assessments as currently, each
school/college establishes its assessments based on their interpretations of the
competencies and EPAs. The lack of standardization also makes it hard for stakeholders
to know what to expect from students upon graduation.
Several stakeholders have discussed the competencies and EPAs that pharmacists
should be able to do upon graduation, including employers, specialty practice groups, and
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student graduates. Overall, stakeholders support the current CAPE outcomes but discuss
additional areas that need adding, as will be discussed in detail in this section. (Alston, et
al., 2017; American College of Clinical Pharmacy, 2014; Augustine et al., 2018;
Chanakit et al., 2015; Greinter & Knebel, 2003; Hester et al., 2014; Kennie-Kaulbach et
al., 2012; McLaughlin et al., 2017; O’Sullivan et al., 2017; Saseen et al., 2017;
Thompson et al., 2012; Vlasses et al., 2013). It is important that stakeholders are
considered in the formation of the core roles, competency/EPA mapping, and levels of
entrustment as the stakeholders are the ones that will be hiring graduates. Most pharmacy
graduates are employed immediately upon graduation, unlike medical students who are
required to complete a residency where additional training occurs.
Employers and pharmacy organizations. In 2017 the Hiring Intent Reasoning
Examination (HIRE) study was conducted to explore the utility of the 2013 CAPE
outcomes from the perspective of practicing pharmacists, examining how each attribute
influences hiring and identifying which attributes are the most and least valuable (Alston
et al., 2017). An electronic questionnaire was developed and distributed to licensed
pharmacists in four states (Arkansas, California, Ohio, and North Carolina). Respondents
ranked their thoughts about the CAPE outcomes and five other business-related attributes
(marketer/sale builder, business manager, producer, team builder, and business operator).
A total of 3723 pharmacists responded (10% response rate). Of the fifteen CAPE
outcomes and five-plus attributes, ten ranked as being necessary for most or all
pharmacist jobs by more than 80% of respondents with the following characteristics have
the highest rankings: professional, communicator, problem solver, learner, self-aware,
patient advocate, and team builder. These were also areas in which 90% or higher of
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employers said had a higher impact on hiring decisions. Areas that were considered less
important and were less likely to disqualify a person from employment were: innovator,
medication system-manager, business manager, business operator, and marketer/sales.
(Alston et al., 2017). Alston et al. (2017) provide information on attributes, based on the
CAPE outcomes that practicing pharmacists feel are essential when hiring graduates. This
information will be helpful when creating the core roles student pharmacists should be
prepared for as it provides information regarding skills employers feel are essential for a
practicing pharmacist.
The results of the HIRE study mirror results found in Kennie-Kaulbach et al.
(2012) and Thompson et al. (2012). Kennie-Kaulbach et al. was a modified Delphi
process to develop and validate primary healthcare pharmacists' competencies in Canada.
Core primary health care competencies for pharmacists were drafted based on innovative
pharmacy practice, existing entry-level competencies/education outcomes, and a
literature review. The competency formatting used the CanMeds template for medicine
(Frank et al., 2015). Validation of the competencies occurred by ten pharmacists (leaders
in patient care, education, and research in primary care). Once validated, first and second
round surveys were sent to 87 pharmacists identified as proficient or expert in primary
care. Sixteen pharmacists responded to the first Delphi round, and 33 pharmacists replied
to the survey's second round. Pharmacists confirmed the most important primary care
responsibilities as being related to direct patient care, including communication,
collaboration, and professionalism (Kennie-Kaulbach et al., 2012), all of which are part
of the current pharmacy competencies.
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Thompson et al. (2012) also discussed the need for skills found in the current
competency statements. Thompson et al. conducted a study to determine the most valued
characteristics when hiring a new pharmacist using a survey sent to Colorado
pharmacists. Pharmacists selected and prioritized the top five characteristics out of 20
that were considered the most important in hiring a new pharmacy graduate. Responses
were then reviewed by the practice site (retail vs. hospital) and by role (manager vs.
staff). Three hundred eighteen surveys were received, with communication skills be
characterized as the highest priority in all groups. Professional behavior and adaptability
were also highly ranked in all groups. Critical thinking was considered more important in
hospital pharmacy over retail versus efficiency, ranked higher in retail than in a hospital
(Thompson et al., 2012). Similar to Kennie-Kaulbach et al. (2012), Thompson et al.
found the skills that were most important for pharmacists to have were communication,
collaboration, and professionalism, as well as adaptability with critical thinking being
essential, depending on the position (Kennie-Kaulbach et al., 2012; Thompson et al.,
2012). These skills echo in the pharmacy organization literature; however, the pharmacy
organizations due discuss some gaps.
Many pharmacy organizations agree with the stated competencies in HIRE
(Alston et al., 2017) for graduates entering clinical practice. Pharmacy organizations
discuss the need for additional competencies in systems-based and population health and
continuing professional development (American College of Clinical Pharmacy, 2014;
Hester et al., 2014; Saseen et al., 2017). Overall, most stakeholders agree that the current
pharmacy competencies based on CAPE are an excellent start to train pharmacy
graduates, but some studies show potential gaps.
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In contrast to the HIRE (Alston et al., 2017) study, Augustine et al. (2018) and
O’Sullivan at al. (2017) used semi-structured interviews or focus groups to look at the
critical business, management, and human resource skills needed by pharmacy graduates
since many graduates assume management positions shortly after graduation. Augustine
et al. conducted a focus group study to identify key business, management, and human
resource skills needed by pharmacy graduates. Recruitment of twenty-seven preceptors
with management positions and 10.5 years of experience from one college of pharmacy
in Arizona occurred to participate in the focus groups. Augustine et al. found seven
themes related to pharmacy graduates' skills, including communication, time
management, conflict resolution, and leadership. O’Sullivan et al. conducted semistructured interviews with community pharmacy practitioners to design and sequence
experiential curricula to prepare students for community practice. Fourth-two individuals
were interviewed (11 individually and 31 in focus groups). Upon reviewing the interview
data, participants identified the outcomes from CAPE and outcomes related to
organizational competence, relationship-building, adaptability, and having a provider
mentality (O’Sullivan et al., 2017). Skills such as time management, conflict resolution,
adaptability, and organization competence are not clearly outlined in the pharmacy
competencies.
Another study by Chanakit et al. (2015) echoed similar gaps, as seen in Augustine
et al. (2018) and O’Sullivan at al. (2017). Chanakit et al. conducted a cross-sectional
survey in 180 hospital pharmacists in Thailand to explore whether students graduating
with PharmD degrees were prepared for practice in a hospital pharmacy. Ninety-eight
surveys were received (55.6% response rate), and the majority of pharmacists (76.5%)
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felt PharmD graduates were prepared for practices. Hospital pharmacists, however, did
think that graduates are currently competent in-patient care services and readiness for
work but could use more training in health promotion and human relations skills
(Chanakit et al., 2015). According to stakeholders, the CAPE outcomes do cover most of
the skills needed by students upon graduation. However, there is a need for more
competencies in the area of human relation skills (e.g., communication, relationshipbuilding, and management skills (e.g., adaptability, management, conflict resolution).
Human relations and management need consideration as some of the core roles that
students need preparing for according to stakeholders.
A study by McLaughlin et al. (2017) discusses yet other potential competency
gaps. McLaughlin et al. conducted facilitated group discussions to identify core
competencies and skills that pharmacists need in today’s healthcare environment. Six
discussion groups of 15-20 preceptors, pharmacists, and other North Carolina College of
Pharmacy partners described the competencies and skills they thought graduating
students needed. Identification of eight themes occurred from the discussions, including
skills related to initiative, curiosity, imagination, and analyzing information.
The other thing that makes it hard for stakeholders to know what entry-level skills
students should have upon graduation is the differences in state laws regulating licensure
requirements. Some states require students only to pass the NAPLEX and a law
examination, while others require students to pass other competencies such as
compounding or medication safety (NABP, 2020). Confusion also occurs due to the extra
credentials that pharmacists can achieve both before and after graduation. Credentials like
additional master’s degrees and medication management certificates can be received
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before graduation, while others like residency training and Board Certification have to
wait until after graduation (Salahudeen & Nishtala, 2015). It is essential to consider all
the skills mentioned by employers and pharmacy organizations needed for employment
when considering activities that students should be able to do upon graduation.
Employer/pharmacy organization data should then be triangulated with student graduate
perception data to help determine the roles that students need to prepare for upon
graduation since the employers are the ones who will be hiring students upon graduation.
Student perceptions. Noble et al. (2014) and Waite et al. (2018) reviewed student
perceptions of their practice readiness after graduation. Noble et al. examined the
formation of professional identities by Australian student pharmacists using focus groups.
Eighty-two students from all levels of a four-year Australian undergraduate pharmacy
course were asked questions related to their perceptions of their curricular experiences
and how these experiences influenced the development of their professional identities.
Many students did not come into pharmacy school with a firm idea of what pharmacy
was, making the transition into school difficult. Noble et al. concluded that identity
formation needs to be taught from the beginning of the degree program throughout the
curriculum, especially for students who may not be thoroughly familiar with all the
aspects of pharmaceutical education (Noble et al., 2014). Professional identity formation
is essential to know in developing student pharmacists, but it is hard to teach professional
identity when the profession has not identified its core roles.
A more recent study by Waite et al. (2018) in Canada examined how recent PharmD
graduates feel about providing full-scope pharmacy services using a cross-sectional
survey. Recent graduates from two pharmacy schools who worked in community
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pharmacy settings in Ontario, Canada, were asked to complete a survey regarding how
they felt about performing 14 full-scope pharmacist services (less/more able and
less/more sure about completing the task). Many recent graduates said their practice site
was “busy” and that they participated in direct patient care 26-50% of the time. For every
one-year increase in age, there was an increased chance of the new graduate feeling they
were able to perform four services: prescribe or renew prescriptions until a physician
visit, prescribe or renew appropriate therapy for three months supply or more, conduct
medication reviews, and administer a flu vaccine. Every unit increase in the busyness of a
recent graduate’s practice setting, the likelihood of the graduate feeling able to provide a
pharmaceutical opinion decreased, and to conduct a medication review increased. Every
unit of increase in age was also associated with the likelihood of recent graduates feeling
2.17 times more sure of providing a pharmaceutical opinion and 2.57 times more sure
about administering flu vaccines. New graduates had high levels of feeling sure about
providing services as long as it is a standard service. Overall, they felt that pharmacy
school prepared them for the full scope of their pharmacy practice. Feelings of being sure
were affected by age, the busyness of the practice, and the frequency of service
performance (Waite et al., 2018). Despite the lack of data in U.S. students, the studies by
Nobel el al. (2014) and Waite et al. (2018) show the need for professional development
and time management skills in graduating students.
Employes, graduates, and pharmacy organizations all have essential ideas of what
roles pharmacists should engage in and the competencies and EPAs that align with these
roles. Data from these groups show students need to have CAPE outcomes and human
relation skills (e.g., communication, relationship-building) and management skills (e.g.,
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adaptability, management, conflict resolution, time-management). Students also need
innovation, curiosity, and professionalism. It will be necessary to use a diverse set of
stakeholders to form a consensus on the roles and competencies/EPAs created in this
project to ensure students' preparedness as generalists upon graduation. Medical
education as more recently completed a process of creating broad roles for physicians
that then map to competencies and EPAs, which are used for pedagogy and assessment
for medical schools and residency programs.
Medical Education
It is essential to remember that both medicine and pharmacy seek to develop
professional competence in their students. Professional competence dimensions break
down into cognitive, technical, integrative, relational, and affective/moral constructs. The
cognitive dimension includes the core knowledge and skills needed to problem-solve
(e.g., Learner domain in the pharmacy CAPE Outcomes). The technical dimension
consists of those skills that are hands-on and required for a specific type of physician or
pharmacy practice (i.e., medication history taking, blood pressure taking). Integration
includes linking basic and clinical knowledge to other disciplines and managing
uncertainty within the defined clinical setting and place in the physicians’ or pharmacist’s
career. The relationship domain includes the communication skills, teamwork, and
conflict-management skills needed to form relationships within the healthcare domain as
well as the patient and their families. The affective/moral domain includes emotional
intelligence and ethics, consisting of the physicians’ and pharmacists’ ability to observe
their emotional intelligence, curiosity, and willingness to acknowledge and correct errors.
These domains all work together to produce a physician and pharmacist capable of
functioning in the ever-changing healthcare world to manage ambiguous problems,
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tolerate uncertainty, and make decisions with sometimes limited knowledge (Epstein &
Hundert, 2002).
The Royal College of Physicians and Surgeons of Canada (CanMEDS), General
Medical Council (GMC) in the United Kingdom, and the Accreditation Council for
Graduate Medical Education (ACGME) have created roles that all medical school
graduates should be competent in upon graduation. These roles center around the
cognitive, technical, integrative, relational, and affective/moral dimensions of
professional competency. While pharmacy education has started the move towards
professional competence and has developed competencies, there is no clear set of roles
centered around the concepts that define what graduates should be competent in upon
graduation. This lack of standardization makes it hard to determine if all students are
minimally prepared to be professionally competent upon graduation regardless of the
school/college from which they graduate. This section will discuss the current medical
roles that all medical graduates should prepare for upon graduation and how they can
formulate the pharmacy roles. Then it will review how medicine built their competencies
and EPAs are around these roles.
The medical graduate roles created by CanMEDS, GMC, and ACGME develop a
consistent education approach that embeds outcomes and content across all medical
curricula and defines the abilities needed for all domains of medical practice regardless of
discipline. These frameworks can serve as a template for pharmacy in developing our
core roles, as was done in Kennie-Kaulbach et al. (2012) with the creation of roles and
competencies for primary care pharmacists in Canada. The CanMEDs’ definition of a
medical expert is a good summary of all three organizations’ definitions of a practice-
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ready physician: “physicians integrate all of the roles, applying medical knowledge,
clinical skills, and professional values in their provision of high-quality and safe patientcentered care. Medical Expert is the central physician role and defines the physician’s
clinical scope of practice” (Frank et al., 2015, p. 3). All three definitions have roles that
fit into the cognitive, technical, integrative, relational, and affective/moral dimensions
needed for professional competence (Epstein & Hundert, 2002). Table 2 summarizes the
broad roles that represent a practice-ready physician according to the three physician
organizations (ACGME, 2017; Frank et al., 2015; General Medical Council, 2017). The
table lists the roles that all physicians should be prepared for upon graduation and beyond
broken down into the five professional competency areas. These three organizational sets
of roles are a good starting place for pharmacy when developing pharmacists’ roles since
pharmacists participate in many of the same functions as physicians in healthcare practice
with just more of medication focus.
Table 2
Medical Practitioner Roles Upon Graduation
CanMEDs 2015

ACGME
Cognitive

General Medical Council

Medical Expert

Medical knowledge

Professional knowledge

Health Advocate

Technical
Patient care and
procedural skills

Professional Skills

Manager

Integrative
Systems-based practice

Scholar
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Health promotion and illness
prevention
Patient Safety and quality
improvement
Education and Training
Research and Scholarship

Communicator

Relational
Interpersonal and
Communication skills

Safeguarding vulnerable
groups

Collaborator

Affective/Moral
Professionalism
Professional Values/behaviors
Practice-based learning
and improvement
Notes. Adapted from. “ACGME common program Requirements [Web page],” by
Accreditation Council for Graduate Medical Education., 2017, Retrieved from
https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRs_2017-0701.pdf; “CanMeds 2015 Physician Competency Framework”, by J. R. Frank et al., 2015,
Ottawa: Royal College of Physicians and Surgeons of Canada; “Generic professional
capabilities framework,” by General Medical Council, 2017, Retrieved from www.gmcuk.org.
Professional

The cognitive dimension includes the core knowledge and skills needed to problemsolve. It includes the roles of Medical Expert in CanMeds 2015 (Frank et al., 2015),
Medical Knowledge in ACGME (ACGME, 2017), and Professional knowledge in GMC
(General Medical Council, 2017). The CanMed 2015 role of Medical Expert is not as
explicit as the other two in defining cognitive knowledge. Still, the concept of needing to
know foundational knowledge before learning technical, integrative, relational, and
affective/moral skills and attitudes is a thread that runs through the Medical Expert
definition and the other six CanMeds domains (Frank et al., 2015). Both ACGME and the
GMC discuss the need for students to learn foundational knowledge before learning the
other concepts, and they have specific roles related to knowledge (Medical Knowledge
[ACGME] and Professional Knowledge [GMC]). Pharmacy has already created a
foundational knowledge competency (CAPE Outcome 1.1 [Learner]), so creating a role
around this would not be difficult.
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The technical dimension consists of those skills that are hands-on and required for a
specific type of physician or pharmacy practice (i.e., medication history taking, blood
pressure taking). CanMeds titles the role that fits into this dimension as Health Advocate,
which means a professional that adds their expertise and influence in the community to
improve population health (Frank et al., 2015). ACGME and GMC are a little more
descriptive in the title of their roles for this dimension: Patient care and procedural skills
(ACGME) and Professional skills (GMC). ACGME defines patient care and procedural
skills as the ability to provide compassionate, appropriate, and effective care for the
treatment of health problems and health promotion (ACGME, 2017). The GMC
definition of professional skills is practical skills, communication and interpersonal skills,
abilities needed to deal with complexity and uncertainty, and clinical skills (General
Medical Council, 2017). Pharmacy has competencies that also fit into this dimension
(Appendix A CAPE Outcomes 2.1, 2.3, 2.4, 3.2, 3.3, 4.2), but they cross several of the
CAPE outcome domains and do not concretely link to one professional role as is seen in
the medicine roles.
Integration includes linking basic and clinical knowledge to other disciplines and
managing uncertainty within the defined clinical setting and place in the physician’s or
pharmacist’s career. This dimension occurs in CanMEDS Manager and Scholar roles
(Frank et al., 2015), ACGME’s systems-based practice role (ACGME, 2017), and GMC’s
health promotion/illness prevention and patient safety/quality improvement roles
(General Medical Council, 2017). A CanMEDs Manager is a leader who engages with
others to contribute to a vision of a high-quality healthcare system and takes
responsibility for delivering excellent patient care through all activities. A scholar
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demonstrates a life-long commitment to excellence in practice through continuous
learning and teaching of others and contributions to scholarship (Frank et al., 2015).
GMC also has a role related to research and scholarship defined in the same way but also
adds a role related to education/training (General Medical Council, 2017). The definition
of systems-based practice in the ACGME roles is the awareness of and responsiveness to
a broader context and system of health care to provide optimal health care (ACGME,
2017). In the GMC roles, health promotion and illness prevention related to health
inequalities and social determinants of health such as income and social status, education,
healthy behaviors, and access to health services and patient safety and quality
improvement in compass capabilities of leadership/teamwork. Pharmacy does have
competencies related to management and leadership (CAPE Outcomes 2.2 and 4.2) and
competencies related to health promotion and patient safety (CAPE Outcomes 2.2 and
2.3). Once again, the pharmacy competencies related to these roles cross outcome
domains and do not concretely link to a specific pharmacist role. Pharmacy also does not
have competencies that explicitly describe scholarship and systems-based practice, which
are areas of weakness discussed in the pharmacy stakeholder literature.
The relationship domain includes the communication skills, teamwork, and conflictmanagement skills needed to form relationships within the healthcare domain as well as
the patient and their families. CanMEDS has two roles related to this domain,
communicator and collaborator (Frank et al., 2015). ACGME and GMC only have one
role associated with this dimension interpersonal and communication skills and
safeguarding vulnerable groups (ACGME, 2017; General Medical Council, 2017). The
CanMEDS definition of a communicator is forming relationships with patients and their
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families that allow the gathering and sharing of essential information needed for adequate
health care. A collaborator is a physician that works effectively with other healthcare
professionals to provide high-quality patient-centered care (Frank et al., 2015).
ACGME’s domain, interpersonal, and communication skills are defined as skills that lead
to the effective exchange of information with patients, families, and other healthcare
professionals (ACGME, 2017). The GMC role is to safeguard vulnerable groups related
to mental health, disabilities, human trafficking, and child and elder abuse (General
Medical Council, 2017). Pharmacy does have a CAPE Outcome (3.6) related to
communications and one related to interprofessional education (3.4) but does not have
one explicated related to safeguarding vulnerable groups.
The last dimension needed for professional competency is related to concepts around
affective/moral attitudes, including emotional intelligence and ethics, consisting of the
physicians’ and pharmacists’ ability to observe their emotional intelligence, curiosity, and
willingness to acknowledge and correct errors. All three medical groups have roles
related to professionalism or professional values, and ACGME adds a role related to
practice-based learning and improvement (ACGME, 2017; Frank et al., 2015; General
Medical Council, 2017). All three organizations define a professional similarly as one
who is committed to the health and well-being of individuals and society through ethical
practice, high personal standards of behavior, accountability to the profession, and
maintenance of personal health (ACGME, 2017; Frank et al., 2015; General Medical
Council, 2017). Pharmacy also has a similar competency (CAPE Outcome 4.4). The
definition of ACGME’s role related to practice-based learning and improvement is
evaluating the care of their patients, using scientific evidence, and improving patient care
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based on constant self-evaluation and life-long learning. This role is covered in the
pharmacy competencies as well under Outcome 4.1.
These derived medical roles play an important part in the development of the
medicine competencies statements used to drive pedagogy and assessment for medical
education. All three of the medical organizations have developed competencies for each
of the physician roles in their frameworks. A person achieving all the competencies for a
given role is said to be “competent” in that area. For example, CanMeds defines five key
competencies for the medical expert role. One of these competencies is “practice
medicine within their defined scope of practice and expertise” (Frank et al., 2014, p. 10).
The creation of assessments occurs from the enabling competencies that are under each
of the five broader competencies. For example, under the competency just mentioned,
there are six enabling competencies with one being “Integrate the CanMEDS Intrinsic
Roles into their practice of medicine” (Frank et al., 2014, p. 10). Pharmacy has developed
the competency statements similar to the three medical organizations but has never
mapped these to a set of roles to ensure coverage of all roles that pharmacists should be
competent in before graduation. This mapping of competencies to core roles would help
ensure that all students are prepared for the same core roles upon graduation regardless of
the school/college of pharmacy from which they graduated and would also allow the
development of assessments to share among schools/colleges pharmacy.
Assessment planning is a critical step to determine if students are practice-ready.
It is crucial when setting up assessments to remember that competencies are
developmental (Modi et al., 2015). Assessments also require appropriate comprehensive
periodic reviews, use of multiple assessors, avoidance of assessment fatigue (both student
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and faculty), and optimization of relationships between givers and receivers of formative
feedback (Holmboe, Sherbion, Long, Swing, & Frank, 2010; Loackyer et al., 2017). The
analogy used many times to describe competency assessment is a ladder where each rung
is a level of competency (Modi et al., 2015). Medicine has defined the “ladder rungs”
based on a student’s stage in their medical education (medical school, discipline-specific
residency, and learning practice). The competency levels in medical school are medical
school fundamentals and early clinical activity. Competency levels for residency are
transitions to discipline, foundations of the discipline, and core of the discipline. Lastly,
competency levels for learning in practice are transitions to practice and continuing
professional development (Frank et al., 2014). While pharmacy has created
competencies, it has not defined entrustment levels based on students' progress through
their careers. It is hard to develop these assessments when pharmacy has not determined
the core roles students should prepare for upon graduation as these are the starting point
for a practitioner's growth.
Just as discussed in the pharmacy education section, EPAs are a way to link
competencies to clinical practice and determine if a student is ready for practice (Rekman
et al., 2016). EPAs assess multiple competencies at one time in a holistic manner as they
mimic actual physician and pharmacy practice. The EPAs also help link competencies to
clinical practice because the EPAs are the tasks/activities that need accomplishment and
competencies are the knowledge and skills required to do the EPA (Englander et al.,
2016; Rekman et al., 2016). Some examples of the 13 EPAs from medicine include
gathering a history and performing a physical examination, prioritizing a differential
diagnosis following a clinical encounter, and recommending and interpreting standard
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diagnostic and screening tests. For performance activities like entrustable professional
activities to be useful, one needs to map the EPA's competencies and set the entrustment
level required for each stage of training (Modi et al., 2015). Medicine has created such a
mapping with their roles mapped to EPAs competencies with defined entrustment levels
for a particular time in a student’s learning career (medical school, residency). Pharmacy
has developed a set of EPAs (Appendix B), which map to the CAPE Outcomes (Table 1,
p.46). However, pharmacy has not created agreed-upon levels of entrustment for each
EPA, making it hard to share assessment data between programs.
The core EPAs developed in medicine were designed to be minimum standards
for schools/colleges, and then schools/colleges could add on to them as needed for their
specific programs. The Association of the American Medical Colleges initially drafted
the EPAs for residency, but medical schools are being encouraged to use them. There are
several arguments for not using EPAs in undergraduate medical education. One argument
is whether workplace activities are an appropriate framework for medical school
outcomes and does entrustment apply to students. Another argument is that pre-clerkship
learning is knowledge-focused, and workplace assessments such as EPAs do not fit. The
case for the use of EPAs during medical school is that schools need to incorporate
workplace learning and assessment earlier in the curricula to help students develop their
professional identity. Clinical curricula with early clinical experiences vertically
integrated and having increased clinical responsibilities over time help improve the
clinical abilities of graduates (Chen, van den Broek, & ten Cate, 2015). The literature
suggests that medical students should reach the level of indirect supervision (EPA level
3=without a supervisor's physical presence but quickly available) upon graduation from
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medical school. Medical schools feel that there must be a defined body of evidence to
support the entrustment decisions, and workplace-based evidence is essential.
Assessment tools are still lacking in this area. The pilot schools did feel the core EPAs
were an excellent framework. However, work is still needed on assessment development
and having space for authentic student work-place participation such as clinical
experiences while working on didactic portions of the curriculum in medical school
(Lomis et al., 2017). Pharmacy is having the same discussion about using the EPAs
during pharmacy school, but the same thoughts apply to the need to incorporate clinical
experiences earlier in the curricula as is required in the accreditation standards (ACPE,
2015).
Despite the widespread use of medical EPAs, there are some concerns about their
use. Criticisms of the medical EPAs include: not being real discrete, being singleencounter based medical tasks, and sounding more like objectives than tasks. Some feel
that the EPAs push professionalism, communicating with patients, and delivering quality
patient care to the background, and they do not do enough to interconnect the capabilities
to be a physician. There is also a fear that the EPA-based system has not increased
medical educators' capacity to make reliable ratings or valid judgments. EPAs still direct
too much attention to ordinary and technical skills. There are several recommendations to
address some of these issues. One proposal is to create a hybrid model that combines the
EPAs and competencies. Another suggestion is to develop a single set of descriptors
covering the full range from beginner to master long-term practitioner. EPAs are an area
of continued debate and research as the EPAs' usage is just starting in undergraduate
medical education (Krupat, 2018).
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EPA usage in pharmacy education is a newer concept, yet many of the same
discussions in medicine are occurring in pharmacy. The most significant debate in
pharmacy currently is the level of entrustment that students should be achieving and the
best methods of assessments for EPAs (VanLangen, 2019). Solutions to these debates
will be hard to determine until pharmacy has a core set of roles that all students need
preparing for upon graduation. Mapping of competencies and EPAs to these roles is one
way to help schools/colleges better define assessments and levels of entrustment to
ensure students are practice-ready upon graduation. The other thing that mapping to a
core set of roles would do would be to help identify gaps (if any) in the current pharmacy
competencies and EPAs.
Elements Missing From Pharmacy Education Outcomes and Assessments
Pharmacy has created competencies and EPAs like medicine (Haines et al., 2017;
Medina et al., 2013), but because there is no defined set of core roles that pharmacists
should be able to do, there is no way to ensure all the competencies and EPAs needed to
ensure student practice-readiness upon graduation as listed. The inability to know if the
current competency/EPA list is all-inclusive limits pharmacy's ability to begin the move
to full competency-based education, as seen in other health professions. One of the
biggest benefits of competency-based education is the ability to ensure all students have
the same baseline level of skills upon graduation due to the definition of consistent
competencies and assessment milestones that all students would need to meet before
graduation. Competency-based education allows students to achieve competencies at
their own pace as opposed to relying solely on the passage of time (i.e., just because you
move from one professional year to another because you passed all courses does not
mean you meet all competencies). However, pharmacy is far from moving to full
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competency-based education due to multiple factors. One factor is assigning experiential
rotations when current state laws dictate a maximum level of students per preceptor.
Schools may not have enough preceptors available with the move to full competencybased education, depending on how fast or slow students are moving through the
curriculum (Medina, 2017).
Another problem is how to handle faculty workload and assessments when the
number of students is not consistent moving through the curriculum and how to handle
lock-step curricula that require students to move from one course to another in a specific
order. Lastly, opponents of competency-based education fear that this move would mean
more emphasis on skills and less on the knowledge. This emphasis on skills could be a
problem in a content-heavy profession like pharmacy, thus moving pharmacists back to
the product-centered role as oppose to the patient-centered role (Medina, 2017). One way
to ensure pharmacy is developing competencies that would allow pharmacists to continue
to focus on patients instead of the product is to build competencies similar to other
healthcare professions.
Englander et al. (2013) conducted a review of the different competence domains
developed for any health care professional to extract a standard set of competencies for
use by all health professions to aid in interprofessional education. The ACGME list of six
domains and 36 competencies was the starting reference list for the comparison. After
reviewing other professions, the addition of two different domains occurred along with
12 additional competencies. Comparison of the list of 48 competencies to the 153
competency lists from across all medical education, including nursing, pharmacy,
chiropractic, optometry, public health, physician assistants, dentistry, and veterinary
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medicine, occurred. Englander et al. resulted in a final set of 8 domains of competency
that could serve as a template for any health profession’s development of a competency
list.
The eight competency domains include patient care, knowledge for practice, practicebased learning and improvement, interpersonal and communication skills,
professionalism, systems-based practice, interprofessional collaboration, and personal
and professional development. Comparing the pharmacy competencies to the Englander
list shows most of the competencies are within the CAPE 2013 outcomes just under
different competency headings (Englander et al., 2013). There are, however, some areas
missing in the pharmacy competencies, including transitions of care and providing role
modeling as well as specifics related to handling difficult conversations, uncertain
situations, conflict management, and stress management. The broad competency domain
of “systems-based practice” is not as well developed in the pharmacy competencies
either. The “systems-based practice” is one area that pharmacy needs to make more
explicit in the competencies and EPAs as there are only one competency and one broad
EPA dedicated to this area (Englander et al., 2013).
Pharmacy used a consensus process to develop the pharmacy EPAs and
conducted a face validity study, but the face validity study occurred with preceptors that
were mainly involved in patient care (Haines et al., 2018). However, to date, no one has
done studies looking at the EPAs' face validity using non-preceptors and nonpatient care
providers. The survey only asked about the currently written EPAs; it did not ask if they
thought any components of the pharmacist role were missing. Only one published study
conducted to date has looked at the use of the EPAs in practice, and this study found that
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the EPAs were not good at measuring leadership skills, developmental planning, and
practice management skills (Moon et al., 2018). The EPAs need reviewing to determine if
there is a need for additional EPAs in these areas as they are critical areas for the
pharmacist's role given many student pharmacists practice in community settings where
they will manage pharmacies and lead people. There have also been no studies to date
that have tried to define the roles that student pharmacists should prepare for upon
graduation. Without a standard set of roles, similar to medicine, how does pharmacy
know that the current competencies and EPAs created are complete and prepare students
for 21st-century practice and beyond?
Theory of Learning In a Supercomplex World
The theory of learning in a supercomplex world is one theory to use to transform
pharmacy education (Barnett, 2000a). This theory stems from the undergraduate higher
education literature and seeks to explain how learning changes based on how society
perceives the world: complex or supercomplex (Barnett, 2000a). A complex world is one
where handling of facts, data, evidence, tasks, and arguments occur within a framework
known by the person (Barnett, 2000a). The complexity arises when demands exceed the
resources needed to meet them, which leads to an overload of data. These situations can
lead to stress and challenges, but the circumstances are manageable with added resources
such as additional people or additional ways to manage data (Barnett, 2000b). In a
complex world, clearly and fundamentally identifiable problems occur even if a clear
solution is not immediately seen (Bengtsen, 2017). For example, in a complex healthcare
world, patients' disease states were treated without regard to a patient’s social or cultural
traits, so a healthcare professional only had to think within their professional knowledge
scope to diagnose and treat a patient (Leadbeatter & Peck, 2017).
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In contrast, in a supercomplex world, data overload is not manageable by merely
adding more resources, and problems are not as identifiable. This lack of manageability
and problem identification is because a supercomplex world leads to challenges in our
known frameworks due to knowledge and skills continually changing (Barnett, 2000a,
2000b). This conceptual overload leads to challengability, uncertainty, and
unpredictability (Barnett, 2000b). One needs to continually learn new knowledge and/or
adapt to evolving environments. For example, research telling practitioners what
influences different health conditions in patients continuously updates, and a practitioner
needs to be able to keep up with this new information and integrate it into their practice
(Leadbeatter & Peck, 2017). The ability to keep up with and incorporate further
knowledge into practice takes a different teaching and assessment type to prepare
students to learn in this type of ever-changing world.
It is important to remember that in a supercomplex world, the knowledge/skills
that one develops in school will become irrelevant over time and need to be transportable
from one situation to another, so one needs to create continuous learning skills (Barnett,
2000b; Bengtsen, 2017). To help students develop these skills, learners need to discover
how they learn, what to do when they encounter strange things, how to engage others,
control their learning, manage their personal growth, and listen. Educators must be
willing to stretch students out of their comfort zones (force students to face perspectives
different from their own), place students in situations of cognitive and experiential
complexity, and encourage students to engage each other in different points of view to
help them develop these necessary skills (Barnett, 2011; Bengtsen, 2017). Curricula also
need to take on three components: knowing, action/skills, and self-identity/attitude
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(Barnett, 2000a). These ideas are essential for creating pedagogies in healthcare
education that help a student become more self-aware and develop good professional
attitudes and the knowledge/skills needed for their profession (Bengtsen, 2017). A more
standardized definition of pharmacy roles upon graduation with competencies and
assessment EPAs aligned to them would help ensure that all students meet the same
minimal standards to be ready for supercomplex healthcare practice regardless of the
pharmacy program.
Study Purpose and Potential Implications to Practice and Research
Unlike medicine, pharmacy has not created a minimum set of roles that all
pharmacists should be competent in regardless of practice setting. This lack of roles
makes it hard to determine a set of competencies and EPA statements to ensure that all
students are ready for pharmacy practice as a generalist upon graduation. Currently,
schools/colleges of pharmacy use the current competency and EPA statements in various
ways depending on the pharmacy program's mission and goals. These different usages
mean that students are prepared differently for practice depending on where they
graduate. These differences also make it hard for schools/colleges to compare pedagogies
and methods of assessment. Answering the research questions for this study will provide
a minimal set of roles that students should be competent in upon graduation. This
research will also help to align the current competencies and EPAs along with levels of
entrustment that can be used by all schools/colleges of pharmacy.
This research will have an impact on pharmacy education and pharmacy practice in
several ways. Development of pharmacists’ roles for practice-readiness will help ensure
that all pharmacy school graduates possess the same minimal level of competence in
knowledge, skills, and attitudes upon graduation needed to function in both today’s
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healthcare environment and the future. Creating a standard set of roles and definitions of
these roles will help move the pharmacy profession forward as the profession continues
to expand its role on the healthcare team as the defined roles will help identify what the
profession can do. Pharmacy, however, will need to be careful setting up these roles as
they may intrude on other professional jurisdictions such as medicine and nursing.
Professional jurisdiction is the link between a profession and its work, which can be
attacked by other professions. Jurisdiction occurs when a profession takes control of a
problem. Most of the time, professions do not have full control of a problem but may split
control (i.e., law and accounting over tax practices in the US). One profession may also
be subordinate to the other and have a limited sphere of control over the problem (i.e.,
physician assistants and physicians). Other professions have advisory jurisdiction where a
profession offers advice or partial services to clients of other professions (i.e., pharmacy
and medicine). Still, others have limited jurisdiction where the profession cannot provide
full control but does have control over a piece of the problem (i.e., psychiatry in
medicine). Pharmacy is currently seeking to change its jurisdiction into more of a limited
jurisdiction model as opposed to an advisory model (Abbott, 1986). Driving this change
in jurisdiction is the change in healthcare discussed earlier. Pharmacy needs to be aware
of the jurisdictional lines that may need to be adjusted when the roles are created and
ensure there is buy-in for these roles, not just from within the profession but also outside.
To have these conversations, pharmacy needs to first decide on what roles it wants to
undertake.
Having minimal EPA levels that are consistently agreed upon by the profession
may also affect pharmacy education. It would allow schools/colleges of pharmacy to
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specialize by requiring higher EPA attainment levels before graduation or adding
additional specialty EPAs that are program-specific. The concept of having competencies
with minimum requirements of attainment for all programs that still allows schools to
specialize is not new. This concept is consistent with the concepts discussed in the degree
qualifications profile by the Lumina Foundation. This profile defines what degree
recipients should minimally be able to do at each degree level in non-professional schools
independent of the field of study. The profile allows proficiencies to be weighted and
shaped differently according to an institution or program’s mission and priorities (termed
spider webbing). The key is that each spider web contains all proficiencies, just maybe a
different degree of focus or emphasis in one area over another. The profile also allows
schools to add proficiencies as needed (Lumina Foundation, 2014). Creating a set of roles
for pharmacy students would work similarly in schools/colleges as the Degree Profile.
Schools/colleges could emphasize areas differently or add competencies/EPAs following
their mission/goals as long as the minimum roles' achievement still occurs.
Results from this study will also have an impact on pharmacy research. One area of
research is the types of assessments that will be useful to determine students have met the
appropriate level of EPAs as well as other assessments that may be required to ensure
that students are meeting the full definition of each role. Pharmacy will need to look for
ways to ensure that assessments are holistic and review students across the curriculum
and not just at one point in time. Arising will also be a need to develop pedagogies
appropriate to teach students how to achieve the competencies and EPAs associated with
each role. Lastly, more research may be needed on the current competencies/EPAs or the
way pharmacy assesses entrustment, especially if a consensus is achieved on pharmacists'
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roles but not on the competency/EPA mapping and/or the entrustment attainment levels.
The lack of agreement would signal the need for more research on the
competencies/EPAs and levels of entrustment.
Currently, pharmacy has developed a set of competencies and EPAs with the EPAs
being a new addition to pharmacy. Schools/colleges are currently working to find ways to
incorporate EPAs into their assessment plans. However, with this lack of role definition,
how the competencies and EPAs are incorporated, and the level of EPA attainment is
different across programs. This lack of standardization may lead to students being
prepared differently for practice depending on where they choose to attend school and
makes it hard to compare pedagogies and assessments across programs.
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CHAPTER 3: METHODS
The purpose of this project is to investigate the extent to which a consensus exists
among pharmacy professionals regarding core practice-ready roles for graduates that
align with pharmacy competencies and EPA statements, with levels of entrustment. A
multiphase mixed-methods experimental design with two phases (Creswell & Clark,
2011) is selected for the study methodology. A multiphase mixed-methods design uses a
series of sequentially aligned studies (data building from one study to another) that
require collecting a combination of quantitative and qualitative data. A multiphase mixed
methods design works well for the research questions in this study as the three questions
are all centered around the same broad objective: Exploring the development of graduate
core practice-ready roles aligned to competencies and EPAs with levels of entrustment.
Empirical findings have the potential to contribute to the development of school/college
pedagogies and assessments to ensure all students are practice-ready upon graduation.
This project will use an embedded mixed-method design for both phases. The
difference in the two phases will be which data type is dominant and supporting
(Creswell & Clark, 2011). The first phase will address Research Question One,
developing a set of core roles that define what student pharmacists should prepare to do
upon graduation. In Phase One, the qualitative data collection occurs via a nominal group
technique on the strengths and modifications needed on a core role proposal (discussed in
detail later) provided to the study participants. Quantitative data is supportive because the
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nominal group participants rate the importance of the strengths and modifications
discussed (Creswell & Clark, 2011). Phase Two will use the final core roles created in
Phase One to answer Research Questions Two (alignment of competencies and EPAs)
and Three (setting the level of entrustment) with simultaneous quantitative and
qualitative data collection occurring using a cross-sectional survey. In this phase, the
qualitative data (constructed-response questions) are supportive of the quantitative data
(selected-response questions; Creswell & Clark, 2011). For example, if one of the core
roles were Patient Care skills, panelists would be asked their level of agreement regarding
the competency “Provide-patient-centered care as the medication expert” (Medina et al.,
2013, p. 3-4) maps to this role. After completing Phases One and Two, the data to all
three research questions will tie to the broad objective of exploring the development of
graduate core practice-ready roles aligned to competencies and EPAs with levels of
entrustment.
There are multiple advantages to using a multiphase mixed-method design in this
study. First, the design offers the ability to address interconnected research questions that
require the collection of both qualitative and quantitative data to answer, such as the ones
proposed in this study. Research Question One will provide the roles for which the
pharmacy competencies and EPAs align in Research Questions Two and Three. Another
advantage is the ability to collect rich and comprehensive data since both phases will
collect quantitative and qualitative data. Using both data types allows for the collection of
participants' thoughts and feelings regarding the topics while still providing numeric
values that can be mathematically analyzed (Creswell & Clark, 2011). Another advantage
is the ability to analyze and report Phase One findings while completing Phase Two of
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the study due to the phases' autonomous nature and methodologies (Creswell & Clark,
2011). This project's studies loosely connect as the answers to the three research
questions are needed to fully explore the development of practice roles aligned to
competencies and EPAs with levels of entrustment to ensure that pharmacy graduates are
practice-ready.
Research Questions
This project will answer the following research questions:
1. What are the core professional roles that pharmacy programs feel should be
demonstrated by graduating student pharmacists?
2. According to pharmacy practitioners, what is the alignment of the current
pharmacy competencies and entrustable professional activities (EPAs) to the core
professional roles?
3. According to pharmacy practitioners, what level of entrustment should pharmacy
graduates be expected to achieve for each EPA?
General Methodology
This two-phase mixed methods study will use a different consensus development
technique for each phase (two in total; Delbecq et al., 1975). The use of consensus
development techniques is preferred for this study, given the research questions'
subjective nature. All three research questions require a combination of subjective
judgments from multiple people to form one agreed-upon answer (Delbecq et al., 1975).
The choice of two different consensus techniques for this study was due to the types of
data, group sizes, and anonymity needed for the various research questions. Phase One
(Research Question One) will use the nominal group technique (NGT), which allows for
the collection of qualitative data as the primary data type using quantitative data to
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support the final group decision. Phase Two (Research Questions Two and Three) will
use the Delphi technique, which allows for surveys to collect quantitative data with
qualitative data as explanations for why specific ratings were selected (Delbecq et al.,
1975). A more detailed discussion follows for each methodology used for the research
questions.
Research Question One
The first research question is: What are the core professional roles that pharmacy
programs feel should be demonstrated by graduating student pharmacists? Research
Question One will use the NGT for proposal review process developed by Delbecq et al.
(1975). This NGT method offers a framework for gathering stakeholder data on topics
that are complex and call for aggregation of individual judgments, such as the
development of a set of core roles that define what student pharmacists should prepare to
do upon graduation (Research Question One; Delbecq et al., 1975). The NGT proposal
review process allows a group of 6-7 experts to review a set of proposed core roles that
student pharmacists should prepare to do upon graduation (core role proposal) to provide
a group consensus on the strengths and modifications needed to improve the core roles
(Delbecq et al., 1975). With the complexity and amount of background literature for
review regarding the creation of the proposed core roles, it made sense to provide a group
of experts with a draft copy of the core roles derived from the existing pharmacy
competencies/EPAs and medical literature to stimulate the constructive formation of a
final set of core roles.
The NGT for proposal review process is conducted in four key stages and
typically occurs during a single scheduled meeting: silent generation, round-robin,
clarification, and voting (usually done by ranking or rating; Delbecq et al., 1975). The use
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of the NGT review process via an internet conference call with an outside facilitator
(someone not involved in the research project) will ensure all experts can provide input
into the core roles and ensures no one person dominates the conversation as each group
member provides input one at a time. This process will also allow experts to react to each
other’s ideas, leading to better quality and quantity of ideas, which is essential when
developing a set of core roles for pharmacy practice (Linstone & Turoff, 1975). The
group's ideas regarding the core pharmacy roles will be written down and voted on by the
participants per the NGT proposal review process rules. By the end of the conference,
call a set of core roles that define what student pharmacists should prepare to do upon
graduation will occur.
NGT has been used in multiple disciplines (e.g., social sciences) to conduct
exploratory research (i.e., to help develop questions for survey and interview field
research), allow citizen participation in decisions (i.e., collect information on the design
of new products or services), allow multidisciplinary experts to participate in decision
making (i.e., to provide solutions to complex problems), and to review proposals (i.e.,
new policies and procedures; Delbecq et al., 1975). The usage of this method also occurs
in pharmacy. It is most often used to generate evidence-based guidelines, inform practice
changes, and identify attributes to include when interviewing student pharmacists
(Johnson & Traynor, 2018; Kennie-Kaulbach et al., 2012; McMillan et al., 2016). The
NGT process is best for Phase One of this project as it will allow aggregation of
individual expert judgments on the development of a set of core roles that define what
student pharmacists should prepare to do upon graduation (Research Question One)

82

through the four phases of the process: silent generation, round-robin, clarification, and
voting (Delbecq et al., 1975).
A purposeful sampling of 6-7 pharmacy faculty and administrators that have
researched the areas of practice-readiness, pharmacy competencies, and EPAs will form
the expert panel of participants for the NGT process. The sample size for NGT is usually
between 2-14, with a maximum of seven being recommended (McMillan et al., 2016).
The use of purposeful sampling is due to the need to select faculty/administrators that
have done work in practice-readiness to ensure the panel had the necessary knowledge to
form the roles. Deans of four pharmacy programs, three large-research intensive fouryear pharmacy programs, and one smaller three-year teaching-intensive pharmacy
program will select the panelists. These programs will participate as they have faculty
who have done extensive research in pharmacy competencies and EPAs.
Silent generation. The purpose of silent generation, the first step in the NGT process,
is to provide adequate time for panelists to reflect on the core role proposal with no
interruptions (Delbecq et al., 1975). During this part of the process, panelists write down
strengths and potential modifications of the core role proposal without editing their
thoughts (stream of thought). Usually, the silent generation process occurs in the first part
of the live NGT meeting, but due to the complexity of the core role proposal to answer
Research Question One, a slight modification has occurred in this part of the process.
Rather than silent generation occurring at the start of the live meeting, panelists will
receive the proposal (core pharmacy roles and role definitions), an explanation of
proposal creation, the purpose of the proposal review, and worksheets on which to take
notes regarding the strengths and modifications needed on the proposed core roles and
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their definitions a day or two before the scheduled meeting. Before starting the NGT
proposal review process, I will write a proposed set of core roles and role definitions
based on published medical roles, literature review, and current pharmacy competencies
from Chapter 2 (Appendices A and B). The ability to complete the silent generation
process before the initial meeting will allow panelists in this study to more thoroughly
review the core roles/definitions and carefully think through strengths and modifications
given the proposal’s complexity as there would be less of a time constraint (Delbecq et
al., 1975).
Round-robin. The second stage of the NGT proposal review process is a two-part
round-robin and will be the first stage conducted during the live conference call. The
purpose of this 30-45-minute session is to record the strengths and modifications that
each panelist generated for the core role proposal during the silent generation step. For
this study, the round-robin will occur via video conference due to panelists' locations
throughout the country. In the NGT proposal review process, the round-robin occurs in
two parts: a review of the proposal strengths and then a discussion of proposed
modifications to strengthen the proposal (Delbecq et al., 1975). During the round-robin,
each panelist provides their thoughts about the strengths or proposal modifications one at
a time in an organized fashion. A MS Word document, visible to the panelists through the
video conferencing system, will be used to write down the proposed strengths and
modifications generated during the robin-round process (Delbecq et al., 1975).
In Part One, panelists will provide ideas related to the proposed core roles and
role definitions' strengths. There are several benefits to this approach, such as allowing
for equal participation of all members, depersonalizing the strengths (separating ideas
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from the person who provided them since the strengths are written down and shared as a
whole), and encouraging members to build off strengths already presented. Starting with
a discussion of the strengths of the core role proposal, it avoids the usual problem seen in
proposal reviews of focusing strictly on the proposal's negative aspects. Starting with the
strengths also helps determine if modifications provided later during the modification
discussion will lower the core role proposal's power. Identifying the strengths will also
help ensure core roles are not removed, which would weaken the final proposed set of
core roles. Panelists continue to give strengths one at a time until all panelists have
exhausted their ideas (seen when all members have “passed” when it is their turn). This
portion of the process is a free flow of ideas to ensure the generation of all proposal
strengths for the clarification and voting steps (Delbecq et al., 1975).
During Part Two, panelists will provide ideas related to modifications to improve
the proposed core roles and role definitions. The same benefits from the strengths apply
to the modifications, such as allowing for equal participation, depersonalizing the
modifications, and encouraging members to build off modifications already presented.
Panelists continue to give modifications one at a time until all panelists have exhausted
their ideas. This portion of the process is once again a free flow of ideas to ensure the
generation of all modifications of the core role proposal for the clarification and voting
steps (Delbecq et al., 1975). These modifications will occur to make changes in the final
set of core roles and their definitions. The purpose of the discussion is to point out
criticism of the core role proposal and provide solutions for the critiques (different roles,
different role definitions), thus making the proposal stronger. The NGT proposal review
process, as described starting with defining the strengths of the draft core roles and then
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moving on to changes, will help to ensure a collegial discussion when discussing the core
roles and role definitions. The round-robin step provides the data for the next step,
clarification.
Clarification. The clarification stage elicits clarity on each strength and modification.
During the clarification stage of the conference call (about 30 minutes), discussion of the
core role proposal’s strengths and modifications developed during the round-robin phase
occurs to clarify any statements, allow questions about any of the statements, and/or
provide (dis)agreements for any of the statements. During this section, panelists can
convey the logic behind any strength or modification added to the list, as well as reasons
they felt the item was essential to add. During this section, it will be necessary to ensure a
balanced amount of time spent reviewing each strength and modification to ensure that a
review of all strengths and modifications occurs (Delbecq et al., 1975). Once the
discussion of both the strength and modifications lists occurs, the group is ready for the
preliminary voting stage to determine which proposal strengths and modifications are the
most important to the panelists.
Voting. The purpose of the preliminary voting stage is to determine how strongly
each panelist feels about a strength or modification of the core role proposal from the
clarification phase using a numeric rating method. Aggregation of the individual
panelists’ numeric ratings occurs to determine a final single rating for a core role
proposal strength or core role proposal modification. For example, if there were three
panelists and they rated the role proposal strength of “covers all pharmacy roles” on a
scale of 0-100 as 50, 70, and 90, the final importance rating for this strength would be 70
(average of all three). Panelists will first rank all items on the core role proposal strength
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list from the clarification stage then the core role proposal modification list. This stage
will take place on the conference call immediately after the clarification phase and last
about 15 minutes (Delbecq et al., 1975).
For this study, a rating procedure will be used for voting since panelists will be
participating via video conference call. Panelists will first rate the items via a Microsoft
Form, on the core role proposal strength list from the clarification step via a scale of 0100, then on the role proposal modification list on the same scale. A rating of zero would
be assigned to items the panelist feels is the weakest of the strengths (e.g., the panelist
may feel that have six roles is not as strong of strength as the roles covering all areas of
practice) or the lowest priority modification, and 100 would be the item the panelist feels
is the most robust strength or the highest priority modification. I will average the
individual panelist’s ratings for each strength while the group works on rating the list of
modifications on a separate Microsoft Form. After panelists have completed their role
modification ratings, computation of an average rating score will occur for each
modification like the strengths. Once the preliminary voting finishes, there will be two
lists. One list will contain the average ratings for all the core role proposal strengths, and
one list will be the average ratings for all the potential modifications for the core roles.
After the preliminary voting finishes, the facilitator will have the panelists take
about 20 minutes to review the average ratings for the core role proposal strengths and
core role proposal modifications. The purpose of the discussion is to review any strengths
or modifications that receive ratings that are outliers (e.g., if the averages on five out of
the six strengths are 50-70 and the six strengths is a 10, discussion of this strength would
occur). The purpose of this discussion is to ensure that all panelists understand why the
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strength or modification discussed was added to the list and what it means before a final
vote occurs. The discussion is to ensure no misunderstandings of the strengths or
modifications that could influence the voting. This discussion is shorter than the initial
clarification section. It may not be needed if the ratings for the strengths and
modifications during the preliminary voting do not have any outliers. For this study, the
group will not only review the results of the voting but will also set the cut-off limit to
make modifications to the preliminary core role proposal (i.e., changes in the roles will
only occur for modifications with a rating of >60 points) before the final voting.
Once the preliminary strength and modification voting and a discussion occur, the
list of core role proposal strengths and core role proposal modifications will be once
again sent to the panelists via email for a final vote. The use of the same rating method
from the preliminary vote occurs where each panelist will once again rate their feelings
regarding the importance of each core role proposal strength and core role proposal
modification on a scale of 0-100 via Microsoft Forms (Delbecq et al., 1975). Once
complete, the final mean ratings for each core role proposal strength and each core role
proposal modification will occur with the group and take no more than 10 minutes. I will
use the final list of core role proposal strengths and core role proposal modifications to
create the final set of core roles that student pharmacists should prepare to do upon
graduation (Research Question One). This set of roles will form the basis for the survey
used in Phase Two (Research Questions Two and Three).
Research Questions Two and Three
Research Questions Two and Three are:
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•

According to pharmacy practitioners, what is the alignment of the current
pharmacy competencies and entrustable professional activities (EPAs) to
the core professional roles?;

•

According to pharmacy practitioners, what level of entrustment should
pharmacy graduates be expected to achieve for each EPA?

These two research questions will occur using the Delphi technique to collect quantitative
and qualitative data simultaneously (Delbecq et al., 1975). Like the NGT process, the
Delphi technique offers a framework for gathering stakeholder data on topics that call for
aggregation of individual judgments such as Research Questions Two and Three. One big
difference between the NGT process and the Delphi technique is that the Delphi allows
for the collection of data via multiple rounds of surveys instead of a live discussion. The
Rand Corporation developed the Delphi approach in 1953 during the Cold War to
forecast the impact of technology on warfare. Since then, the technique has expanded to
forecasting and policymaking and guideline development (Linstone & Turoff, 1975). The
Delphi technique has been used in pharmacy to forecast the future of hospital pharmacy
and to gain consensus on indicators for prescribing appropriateness, criteria for safety
features, clinically significant interactions, and different aspects of student education
(Johnson & Traynor, 2018; Kennie-Kaulbach et al., 2012; McMillan et al., 2016). The
Delphi approach's general method is a multistage self-completed survey (Delbecq et al.,
1975). The Delphi method is useful for this study as it a way to aggregate the judgments
of numerous (40-50) individuals to gather consensus around the mapping of
competencies and EPAs to the core roles (Research Question Two) and the assignment of
levels of EPA entrustment (Research Question Three; Delbecq et al., 1975).

89

Research Questions Two and Three seek to examine if there is a broad consensus
from different pharmacy practices on the competency/EPAs (Research Question Two)
mapped to the core roles developed in Research Question One and assign levels of
entrustment to each EPA (Research Question Three). A larger, more diverse group of
pharmacists (i.e., around 40-to 50 with multiple different types of pharmacy practice,
different times since graduation, various interactions with student pharmacists) is needed
for this consensus to ensure as many areas of pharmacy have a chance to review the
mappings and levels of entrustment. The anonymity provided by the Delphi survey
process is also crucial as it allows everyone to provide their opinion regarding the
mapping and levels of entrustment without feeling pressured to give a particular answer
as the surveys are conducted individually with no discussion among the participants
(Linstone & Turoff, 1975). The lack of pressure to provide a specific answer is essential,
given the lack of consensus currently related to levels of entrustment (VanLangen et al.,
2019). By the end of the Delphi process, an exploratory mapping of the current pharmacy
competencies and EPAs to the roles defined in Research Question One, along with a level
of entrustment for each EPA, will have occurred.
Within this study, a panel of 40-50 pharmacists from a variety of different
pharmacy disciplines, including, for example, community, institution, clinical, and
academia, will review the proposed mappings and levels of entrustment. The suggested
panelist size for a Delphi process is seven, but sizes can range from 4-3000 depending on
the project's needs. The size needs to be determined by the qualities required on the panel
more than size. (Linstone, 1978). A purposeful, non-randomized sample procedure will
occur to select participants in the Delphi panel to ensure consensus from as many
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pharmacy practice areas and years in practice (minimum of one year). Panelists from the
NGT group in Research Question One will provide a list of 5-10 people via a Microsoft
form. The form will collect the Delphi participant's name, pharmacy degree, practice site,
year of graduation from pharmacy school, and email. NGT participants need to ensure
that participants chosen come from a variety of different pharmacy disciplines (ensure at
least three disciplines are covered in the list) and from different years of experience (at
least one participant in each time-frame since graduation [1-5 years, 6-10, 11-15, >15]).
A non-randomized sample is best to use in this study as participants in the Delphi process
need to be from various pharmacy disciplines and years of experience to ensure
representation from as many areas of pharmacy practice in the sample as possible. There
is potential for bias and for not including all potential views given the study's nonrandom nature. Minimization of this bias occurs through the use of various
schools/colleges of pharmacy and different regions of the country to draw the sample.
This approach's general method is a multistage self-completed survey (ies; Delbecq et
al., 1975). Data previously gathered in Phase One will be used to develop the survey
instrument in this investigation. Specifically, I will map the current pharmacy
competencies/EPAs to the set of core roles created during the NGT process (Research
Question One) and assign a level of entrustment for each EPA. The mapped
competencies/EPAs and levels of entrustment will form the individual survey questions
for the Delphi process, where participants will rate their level of agreement with the
mapping as well as the level of entrustment on a 4-point Likert scale. Participants will
receive a constructed-response box for each question to explain if they disagreed with a
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mapping or level of entrustment. A more formal description of the survey questions
follows in the Round 1 discussion.
Surveys for all rounds will be sent out based on the Tailored Survey Design process
(Dillman, Smyth, & Christian., 2014). For each Delphi round in this study, sending an
initial email will occur with the instructions and the survey link. A reminder email will be
sent weekly for a total of three emails (each round will be open for a total of 3 weeks).
Emails will be sent before the start of the workday as studies have shown that people are
more likely to respond to surveys sent early in their workday before their day gets too
busy (Dillman et al., 2014).
Round 1. In round 1, the Delphi questionaries will comprise selected- and
constructed-response questions to gather data on stakeholders’ consensus on the
competency/EPA mappings and levels of entrustment. Each Delphi participant (panelist)
will rate their level of agreement with each competency and EPA role aligned to the roles
from Research Question One using a 4-point Likert scale from 1 (Strongly Disagree) to 4
(Strongly Agree). For example, if one of the roles were Patient Care skills, panelists
would be asked if they agree or disagree that the competency “Provide-patient-centered
care as the medication expert” (Medina et al., 2013, p. 3-4) and its associated EPAs map
to this role. Panelists will also be asked in a separate question to rate their agreement with
the level of entrustment before graduation they feel a student should achieve for the
specific mapped EPA using the same Likert scale. Entrustment is defined as the level one
can trust someone to complete a task (e.g., take a patient’s medication history). Level 1
entrustment suggests a student can observe but not complete a particular task. For
example, a student may observe the pharmacist do a patient's medication history, but the
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student is not yet ready to do the history themselves. Level 2 is execution with direct and
proactive supervision. For this level, the student will perform the medication history, but
the pharmacist is in the room and can provide advice or add in missing pieces to the
history if needed. Level 3 is performance with reactive supervision (quickly available).
At this level, the student will perform the medication history alone with the pharmacist in
the next room quickly available should help be needed. Level 4 is execution with
supervision from a distance or when asked for by the student. For this level, the student is
performing the medication history without a pharmacist in the nearby room or even
building. The student can be freely trusted to perform the history without any help unless
he/she asks for it. Level 5 is the ability to teach someone else the skill (ten Cate, 2013).
Panelists will be provided an open-ended comment box after each question to give
suggestions for rewording the competency/EPA, change in the alignment, or change in
entrustment level.
Results from the selected-response (Likert scale) questions will be aggregated into
two categories: Category 1 - Strongly Agree/Agree and Category 2 – Disagree/ Strongly
Disagree from each panelist’s response. Computation of the percent number of responses
for each category will then occur for each question. For example, if 50 participants
completed the survey with 30 indicating Strongly Agree and 10 indicating Agree for a
question, then the percent response for Category 1 (Strongly Agree/Agree) would be 80%.
For there to be consensus on the competency/EPA alignment or the level of entrustment
question, there must be a category score of 80% Strongly Agree/Agree for the question.
Data from the literature states that cut-offs for consensus can range from 51-80%
(Hasson, Keeney, & McKenna, 2000). A cut-off of ≥ 80% was chosen for this study to
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be conservative and in line with other pharmacy Delphi studies (Johnson & Traynor,
2018). Once a competency mapping, EPA mapping, or level of entrustment question has
reached an agreement level of 80%, it will not be included in the subsequent rounds.
A review of constructed-response comments occurs for any question that did not
achieve consensus (80% agreement) using structural coding via NiViVo software
(NiViVo qualitative data analysis software, 2019). In structural coding, a content-based
or conceptual phrase is assigned a segment of data based on the survey question being
asked to develop themes around the survey question. For example, in this study,
constructed-responses may be left regarding a change in the entrustment level assigned to
a particular EPA. A review of each comment will occur to determine the themes for why
the entrustment level should be changed (e.g., themes might include students will not be
able to practice this EPA enough in school to achieve more than a level 3) and what the
suggested levels are. The themes generated for both the mapping to the core roles and
EPA levels will be used to make changes in the survey questions for Round 2 (Saldaña,
2016). For example, suppose the comment themes suggest mapping a particular
competency or EPA to a different role. In that case, the Round 2 survey question will
indicate this new mapping and ask for the level of agreement. For example, if panelists
suggested the competency “Provide-patient-centered care as the medication expert”
(Medina et al., 2013, p. 3-4) needed mapping to another role besides Patient Care Skills
like maybe Medicine Exert, the Round 2 question would then ask for the level of
agreement on mapping to this new role. Panelists will receive the themes for the
comments that suggested the change in mapping, so they understand why the change
occurred.
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Round 2. In Round 2, panelists will receive a summary document and a new survey.
The summary document will be a quantitative summary for all survey questions and a
qualitative summary of questions that did not reach consensus for each competency/EPA
statement and level of entrustment. This summary will include the total percent Strongly
Agree/Agree and Disagree/Strongly Disagree of all panelists on the question and themes
developed from any open-ended comments provided (if the question did not reach
consensus). The new survey will gather data on the updated competency/EPA mappings
and any updated entrustment levels after review of the quantitative and qualitative data
from Round 1. The survey will contain new questions constructed based on changes
made to the questions from Round 1 that did not reach consensus. Removal of
competencies/EPAs and entrustment levels that achieved 80% agreement during Round 1
will occur for the Round 2 survey.
The new Round 2 survey questions will be constructed and analyzed in the same
manner as Round 1. The Delphi questionaries will comprise selected- and constructedresponse questions to gather data on stakeholders’ consensus on the updated
competency/EPA mappings and levels of entrustment that were created based on the data
from Round 1. Each panelist will rate their level of agreement with each new competency
and EPA role alignment or level of entrustment using the same 4-point Likert scale from
Round 1: 1 (Strongly Disagree) to 4 (Strongly Agree). Panelists will also have
constructed-response boxes to provide comments if needed. Results from the selectedresponse (Likert scale) questions will once again be aggregated into two categories:
Category 1 - Strongly Agree/Agree and Category 2 – Disagree/ Strongly Disagree for
each panelist’s response. Computation of each category's percent number will then occur
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for each question like in Round 1. For there to be consensus on the competency/EPA
alignment or the level of entrustment, there must be a category score of 80%
agree/strongly for the question. Once a competency mapping, EPA mapping, or level of
entrustment has reached an agreement level of 80%, it will not be included in the
subsequent rounds.
A review of constructed-response comments occurs again for any question that
did not achieve consensus (80% agreement) using structural coding via NiViVo software
(NiViVo qualitative data analysis software, 2019) just as in Round 1. Just as discussed
for Round 1, the themes generated for the mapping to the core roles and EPA levels will
be used to make changes in the survey questions for Round 3 (Saldaña, 2016). Panelists
will receive the themes for the comments that suggested the change in mapping, so they
understand why the change occurred.
Round 3. Round 3 will only need conducting if all competency/EPA alignments and
levels of entrustment have not met the 80% consensus level after Rounds 1 and 2. Round
3 will follow the same procedure from Round 2, where panelists will receive a summary
document and a new survey. The summary document will be a quantitative summary for
all survey questions and a qualitative summary of questions that did not reach consensus
for each competency/EPA statement and level of entrustment from Round 2. This
summary will include the total percent Strongly Agree/Agree and Disagree/Strongly
Disagree of all panelists on the question and themes developed from any open-ended
comments provided (if the question did not reach consensus). The new survey will gather
data on the updated competency/EPA mappings and any updated entrustment levels after
review of the quantitative and qualitative data from Round 2. The survey will contain
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new questions constructed based on changes made to the questions from Round 1 that did
not reach consensus. Removal of competencies/EPAs and entrustment levels that
achieved 80% agreement during Round 2 will occur for the Round 3 survey.
The new Round 3 survey questions will be constructed and analyzed in the same
manner as Round 1. The Delphi questionaries will comprise selected- and constructedresponse questions to gather data on stakeholders’ consensus on the updated
competency/EPA mappings and levels of entrustment created after Round 2. Each Delphi
participant (panelist) rate their level of agreement with each new competency and EPA
role alignment or level of entrustment using the same 4-point Likert scale from Round 1:
1 (Strongly Disagree) to 4 (Strongly Agree). Panelists will also have constructed-response
boxes to provide comments if needed. Results from the selected-response (Likert scale)
questions will once again be aggregated into two categories: Category 1 - Strongly
Agree/Agree and Category 2 – Disagree/ Strongly Disagree for each panelist’s response.
Computation of the percent number of responses for each category will then occur for
each question like the previous rounds. For there to be consensus on the competency/EPA
alignment or the level of entrustment, there must be a category score of 80%
agree/strongly for the question. Competency/EPA mappings or entrustment levels will
not be included in the final mapping document if they have not reached the 80% level of
agreement after Round 3. Completion of all Delphi rounds will answer Research
Questions Two and Three. Formulation of a final set of competencies and EPAs that
align with Research Question One's roles will occur along with a setting of a level of
entrustment for each EPA. Each panelist will receive the final structure of
roles/definitions, competency/EPA alignment, and entrustment levels.
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Once both Phases (One and Two) of this research project conclude, all three
research questions will have an answer:
1. What are the core professional roles that pharmacy programs feel should be
demonstrated by graduating student pharmacists?
2. According to pharmacy practitioners, what is the alignment of the current
pharmacy competencies and entrustable professional activities (EPAs) to the core
professional roles?
3. According to pharmacy practitioners, what level of entrustment should pharmacy
graduates be expected to achieve for each EPA?
The Phase One NGT process answers Research Question One by defining the core
professional roles that graduating student pharmacists should demonstrate upon
graduation. This process also defines these roles to allow for easier alignment of the
current pharmacy competencies and EPAs to these roles. The Phase Two Delphi process
answers Research Questions Two and Three, as this process provides a consensus
agreement of the alignment of the current pharmacy competencies and EPAs to the roles
from Phase One. This process then provides a consensus on the level of entrustment that
pharmacy graduates should expect to achieve for each EPA mapped to the roles.
Limitations
Despite the advantages of a multiphase mixed methods study, there are still
several limitations that need addressing. One limitation is the number of resources and
time required to complete these types of studies (Creswell & Clark, 2011). Resources will
not be an issue with this study as the study will be conducted via video conference call
for Phase One and via email and electronic survey for the second phase. Another
limitation is the lack of meaningful connection that can occur between the phases. For
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example, in some studies, it may not be clear how the data collected in Phase One is
being used for the next phase of the project (Creswell & Clark, 2011), which is not a
problem in this study as Phase Two requires the results from Phase One. Phase One
results will provide the roles, definitions, and alignments needed to complete the Delphi
process in Phase Two.
Disadvantages need considering for the consensus development techniques
chosen for Phase Two of this study. One downside of NGT is that it may be challenging
to organize the meeting at a time that suits everyone, which will be overcome via the
video conference call. This method has been used in the past for the consortium group
and works well. Another problem with any group meeting is the potential for one or more
participants to dominate the conversation or push their views, thus making some
participants feel uncomfortable expressing their thoughts (McMillan et al., 2016).
Mitigation of the problem of one person or group of people (people from one school over
the others) dominating the conversation occurs by choice of the NGT method of this
project over a focus group methodology. NGT protocol is set-up so that every member of
the group gets the opportunity to express their thoughts one at a time in an organized
order. The NGT process will allow everyone to express their strengths and modifications
of the proposal and control one person dominating the conversation. The mitigation of the
conversation domination will occur by requiring each person to respond to the discussion
question before the next person answers. Once everyone has responded to the question
once, the process starts again until no new generation of strengths and modifications
occurs. Also, the researchers chosen for this project by the Deans will be well-versed in
the literature related to this study's topic. They will not be inclined to defer to other’s
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opinions on the topic if they disagree. Another potential area of bias would be having the
researcher who developed the proposal lead the NGT process. Mitigation of researcher
bias is through the use of a facilitator who did not participate in the development of the
proposal but is well known in the field of pharmacy and assessment, so those on the NGT
panel will respect her ability to lead the discussion (Delbecq et al., 1975).
Some of the Delphi method's disadvantages include the time it takes to do the
process (it can take weeks or months) and is the potential for a low response rate to the
surveys (McMillan et al., 2016). The time it takes to do the Delphi method will be one
big negative to this process, but by combining the research questions into one Delphi
survey, it will help limit some of the timetable. The potential for a low response rate will
need monitoring and reminders sent to help improve the results. The last drawback is the
researcher's potential for bias who is reviewing and combining the results (McMillan et
al., 2016). Mitigation of the risk of bias will occur by providing both the original and the
changed mappings and levels of entrustment in each round of the Delphi process, thus
allowing Delphi participants to serve as reviewers.
Besides the limitations of the consensus processes chosen for this study, threats to
internal and external validity also need to be considered (Campbell & Stanley, 1963).
There are four threats to external validity to consider: (a) sample bias, (b) reactive effects
of testing, (c) reactive effects of arrangements, and (d) multiple treatment interference
(Campbell & Stanley, 1963). Reactive effects of testing and multiple treatment
interference will not be a problem in this study. Reactive effects of testing occur when the
giving of a pretest may affect the experimental testing results, and no pretest will happen
with this study. Multiple treatment interference occurs when numerous treatments occur
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in an experiment differently than in the real-world, thus making the results hard to
replicate. Multiple treatment interference will not be a problem in this study, as no
interventions occur. Reactive effects of arrangements refer to the inability to generalize to
non-experimental settings because the experimental setting is artificial. Reactive effects
of arrangements could potentially be a problem in this study since no actual testing of the
alignments and levels of entrustment will be happening; instead, results are from
practitioners’ thoughts about the appropriate alignments and entrustment levels
achievement. Future studies would need to be conducted in real-world educational
settings to determine if the entrustment levels are correct. There is less of an issue with
this validity threat as the consensus participants are active practitioners with various
practice experience. They should be capable of accurately determining what graduates
need to perform upon graduation. Sample bias is the last threat to external bias. Sample
bias occurs when there is a chance that the sample chosen for the study may not represent
the population of interest. Sample bias is a potential threat in this study, given only a
small number of pharmacists will participate in the consensus development process,
which may lead to a lack of diversity (i.e., race, age, rural/urban practice sites). One way
mitigation will occur is to use a non-randomized sample chosen by the NGT process
members to ensure that the sample selected is a diverse mix of pharmacy practice types
and levels of experience (Campbell & Stanley, 1963). The NGT process participants will
select participants with different races, different lengths in practice, from different areas
of the state (rural vs. urban), and at least one from the required ACPE practice sites that
all students need exposure to upon graduation (ACPE, 2015).
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Threats to internal validity also need to be considered. Internal validity threats
include (a) history, (b) maturation, (c) testing, (d) instrumentation, (e) statistical
regression, (f) selection, (g) mortality, (h) placebo, (i) contamination effect, (j)
Hawthrone effect, (k) experimenter bias, and (l) interaction effects (Campbell & Stanley,
1963). Many of these threats are not a problem in this study, as it is not an experimental
model with a treatment group. Statistical regression, selection, mortality, placebo,
contamination, Hawthorne effect, and interaction effects are not internal threats to this
study as the study does not place people into groups, nor is there an intervention or
treatment provided or compared between groups. Instrumentation will not be an issue as
the use of the same survey occurs throughout the study. While the survey stems may
change between the Delphi rounds based on the participants' open-ended comments, the
rating scale will remain the same. History, maturation, testing, and experimenter bias are
potential threats to internal validity that need consideration. History is when events occur
during the study that may impact the results, which could be an issue between the Delphi
rounds if participants were to change jobs or learn different information that may change
the way they think about the alignments and levels of entrustments in between the
rounds. Maturation could be a problem as processes with the participants (aging,
experience) could impact the outcomes. History and maturation will be mitigated by
keeping the time between the rounds to no more than 2-3 weeks. Another potential
internal threat is testing itself as results are affected when participants do multiple rounds
of “testing.” Testing will be mitigated by only using two to three rounds of the Delphi
process. The last threat to internal validity is experimenter bias, which occurs when the
experimenter’s expectations of the results may consciously or unconsciously affect the
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results. The experimenter’s expectations will be mitigated through the design of the NGT
process for Research Question One and then through providing both the original as well
as the changed mappings and levels of entrustment in each round of the Delphi process,
thus allowing Delphi participants to serve as reviewers to ensure researcher bias is
mitigated (Campbell & Stanley, 1963).
Summary/Statement of Significance
Pharmacy has implemented competency statements and EPA concepts from
medicine, but it has not established a consensus set of roles that define a practice-ready
pharmacist. The lack of clarity leads to schools/colleges of pharmacy defining this for
themselves. There is also some debate on the entrustment level that needs assigning to the
EPAs (VanLangen et al., 2019). Without this standardized set of roles with the EPAs
aligned to them and an agreed-upon level of attaining the EPA, it may mean that not all
students are leaving with the same minimal expectations potentially to practice. A
standard set of roles with competencies and EPAs aligned to them, as would be created
by answering the research questions in this study, would ensure that all schools/colleges
of pharmacy are providing students with the minimum level of training necessary to be a
practice-ready pharmacist upon graduation and be able to move into any pharmacy or
post-graduate training. These standard roles and aligned competencies and EPAs with
levels of entrustment will allow schools/colleges of pharmacy to collaborate on
researching the best practices for pedagogy and assessment.

103

CHAPTER 4: RESULTS
Introduction
A multiphase mixed-methods experimental design with two phases (Creswell &
Clark, 2011) was used for the study methodology. The multiphase mixed-methods model
used a series of sequentially aligned studies (data building from one study to another) that
required the collection of a combination of quantitative and qualitative data. A
multiphase mixed methods design worked well for the research questions in this study as
the three questions were all centered around the same broad objective: Exploring the
development of graduate core practice-ready roles aligned to competencies and EPAs
with levels of entrustment. Empirical findings have the potential to contribute to the
development of school/college pedagogies and assessments to ensure all students are
practice-ready upon graduation. The following research questions answered the broad
objective of this study:
1. What are the core professional roles pharmacy programs believe students should
be able to demonstrate competency in upon graduation?
2. What is the alignment of the current pharmacy competencies and entrustable
professional activities (EPAs) to the core professional roles?
3. What level of entrustment should pharmacy graduates be expected to achieve for
each EPA?
The two-phase mixed methods included using different consensus development
techniques for each phase (two in total; Delbecq et al., 1975). The use of consensus
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development techniques was preferred for this study, given the subjective nature of the
research questions asked. All three research questions required a combination of
subjective judgments from multiple people to form one agreed-upon answer (Delbecq et
al., 1975). The choice of two different consensus techniques for this study was due to the
types of data, group sizes, and anonymity needed for the various research questions.
Phase One (Research Question One) used the nominal group technique (NGT), which
allowed for the collection of qualitative data as the primary data type using quantitative
data to support the final group decision. Phase Two (Research Questions Two and Three)
used the Delphi technique, which allowed for surveys to collect quantitative data with
qualitative data as explanations for why specific ratings were selected (Delbecq et al.,
1975). This chapter discusses the results of the NGT and Delphi processes used to answer
each particular research question.
Research Question One
Research Question One answered the question: What are the core professional
roles pharmacy programs believe students should be able to demonstrate competency in
upon graduation? The NGT for proposal review census development technique was used
to answer this question. An initial set of proposed core roles (Appendix C) that student
pharmacists should prepare to do upon graduation (core role proposal) was provided to an
expert group to gather consensus on the strengths and modifications needed to improve
the core roles (Delbecq et al., 1975). With the complexity and amount of background
literature for review regarding the creation of the proposed core roles, it made sense to
provide the group with a draft copy of the core roles derived from the existing pharmacy
competencies/EPAs and medical literature to stimulate the constructive formation of a
final set of core roles.
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Five people from four different colleges/schools of pharmacy participated in the
NGT process plus a non-participating facilitator. The facilitator for the NGT process was
from a college/school of pharmacy not affiliated with the project and had experience
conducting focus groups. Purposeful sampling was used to select the NGT participants
due to the need to select faculty/administrators that had done work in practice-readiness
to ensure the panel had the necessary knowledge to discuss the roles. Deans of four
pharmacy programs, three large-research intensive four-year pharmacy programs and one
smaller three-year teaching-intensive pharmacy program selected the panelists. The
programs selected to provide participants had faculty who have done extensive research
in pharmacy competencies and EPAs. Each program provided at least one NGT
participant. Four of the NGT participants were from research-intensive, four-year
pharmacy programs, and one participant was from a three-year, teaching-intensive
program. All participants had earned Doctor of Pharmacy degrees. The participants'
average number of years of academic experience was 11.6 years (8.5 SD), with a range of
academic experience from 2 to 20 years. All participants had experience in the areas of
pharmacy school assessment, experiential education, or teacher development.
The NGT proposal review process took place via an internet conference call system.
The total call lasted a little under two hours. The first 10 minutes of the call was a general
overview of each part of the proposal review process. The review of the strengths of the
proposal occurred over four rounds lasting 30 minutes. A discussion on potential
modifications for the proposal occurred over seven rounds and lasted 45 minutes.
Preliminary voting for both rounds took about 10 minutes each and the final voting about
the same amount of time.
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The initial core role proposal that participants started with had a pharmacotherapeutic
expert as the central role. The central role defined a pharmacotherapeutic expert as one
who integrates all the core roles such as knowledge, appropriate patient care skills, and
professionalism to provide high-quality and safe patient-centered care. Being a
pharmacotherapeutics expert was considered the central role of a pharmacist and defined
the pharmacist's scope of practice. Seven core roles were then initially proposed to define
further a pharmacotherapeutic expert: knowledge, patient care skills, professional,
scholar, systems-based practice/manager, collaborator, and advocate/health promoter.
The full initial core role proposal is in Appendix C.
The strengths' round-robin and clarification stages of the NGT process identified
sixteen strengths of the initial core role proposal. A rating procedure was used for the
preliminary voting stage since panelists were participating via video conference call.
Panelists first rated the strengths via an on-line Microsoft Form on a scale of 0-100.
Panelists assigned a rating of zero to items they felt were extremely weak strengths, and
100 for items the panelist felt were the strongest strengths. Averaging of individual
panelist's ratings for each strength then occurred. Before voting, the group also set an
average rating cut-off to indicate strengths that needed further clarification before the
final voting. The cut-off selected was determined through a consensus voice vote of the
group. A cut-off of an average rating score of 60 or below identified items that needed
further clarification. Four of the five NGT participants voted on the strengths during the
preliminary voting stage.
During the round-robin and clarification phase, one strength identified was
participants "liked [that] added knowledge and patient care skills" were included in the
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roles. The average rating score on this role was 69, with a range of 45-80. Despite having
one rating below 45, all participants' average rating was above 60; thus, this strength did
not need further clarification before the final voting. Another strength identified was
"alignment with and overlap between this and other resources – CAPE and other
standards – helps with external validity." This strength had an average rating of 76, with a
range of 40-90. Again, despite having one rating below 60, the average participant rating
was above 60; thus, this strength did not need further clarification before the final voting.
Table 3 reports the full list of strengths generated during the initial NGT process, along
with the results of the initial vote.
Table 3
Initial Core Pharmacist's Role Proposal NGT Strength Results
Initial Strengths
Central tenet is about
being a
pharmacotherapy
expert (not just a drug
expert)

Participant 1 Participant 2 Participant 3 Participant 4

M

95

85

100

50

83

Liked added
knowledge and
patient care skills

70

80

80

45

69

Broad, good mix of
different topics/roles
that any pharmacy
graduate should be
able to perform upon
graduation

75

95

100

60

83

Clear interplay
between components
– all tie together

90

60

50

100

75

Alignment with and
overlap between this

85

90

90

40

76
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and other resources –
CAPE and other
standards – helps with
external validity
Evidence-based and
patient centered terms
were included

80

75

80

35

68

Scholarship – liked
blend/listing of
variety of different
ways that scholarship
could be included

60

60

10

55

46

Different components
such as advocate and
systems/based
manager – adds layer
of complexity to
being a pharmacist
was we are taking on
more in the healthcare
system

60

80

90

65

74

Personal wellness (of
pharmacist) was
highlighted

80

70

80

80

78

Most of the
components of the
PCPP were included
throughout

60

80

100

90

83

Advocate/Health
promoters – liked
ways different roles
were laid out and
were specific

80

60

80

10

58

Thread of patientcentered care
throughout all of the
areas

75

70

90

85

80
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Advocate/health
promoter – population
health was included
here

70

60

70

20

55

Collaborator –
included other
providers but also
included the patient

85

75

80

75

79

Professionalism –
included society as a
whole

90

50

70

70

70

Systemsbased/manager –
health care insurance
and health care
economics

80

85

40

30

59

Upon reviewing the full results after the initial round of voting on the proposal
strengths, four strengths were identified as having an average rating score of less than 60.
Outliers were discussed with the group to determine the rewording of the strengths, if
needed, before the final vote. The purpose of the clarification step was to ensure the
group members understood the intent of the statement before the final voting. Statements
either had words added or changed to ensure everyone understood the purpose of the
statement. Only the final strength, "Systems-based/manager – health care insurance and
health care economics," was reworded before the final vote. The strength was reworded
to "Systems-based/manager – health care insurance and health care economics were
specifically highlighted as these are often left out for pharmacists."
The final voting stage used the same rating procedure as the preliminary voting
stage. Panelists rated the strengths via an on-line Microsoft Form on a scale of 0-100.
Once again, panelists assigned a rating of zero to items they felt were the weakest of the
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strengths, and 100 to items they felt were strong strengths. Averaging of the individual
panelist's ratings for each strength then occurred. The group used the same average rating
cut-off as the preliminary voting stage of >60 to identify items that were strong enough
strengths to ensure they remained as part of the final core roles after modifications were
made. Once again, four of the five NGT participants rated the strengths during the final
voting stage.
The final vote found all strengths were above the cut-off score, meaning that all
the areas listed were strengths of the proposal. For example, one of the strengths was the
"central tenet is about being a pharmacotherapy expert (not just a drug expert)." This
strength had an average rating of 87 with a range of 50-100. This strength means the
participants felt it was essential to ensure the pharmacotherapy expert idea did not get
removed during the modification stage. Another strength was "Evidence-based and
patient-centered terms were included." The average rating for this strength was 84, with a
range of 75-95. Once again, because the average was greater than 60, the group felt it was
essential to ensure inclusion of the terms "evidence-based" and "patient-centered" in the
final version of the proposal. Once the modification round was completed, and changes
made in the proposal, it was essential to review this table of final strengths to ensure the
inclusion of all the concepts listed in the final proposal. If one of the strengths was
removed based on a modification, it was added back since the participants felt all of these
strengths were vital to include in the final proposal. Table 4 contains the final list of
strengths, along with the results of the final voting.
Table 4
Final Core Pharmacist's Role Proposal NGT Strength Results
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Final Strengths
Central tenet is
about being a
pharmacotherapy expert
(not just a drug
expert)

Part 1

Part 2

Part 3

Part 4

Part 5

M

100

95

90

50

100

87

Liked added
knowledge and
patient care
skills

90

70

80

80

50

74

Broad, good mix
of different
topics/roles that
any pharmacy
graduate should
be able to
perform upon
graduation

90

80

95

90

92

89

Clear interplay
between
components –
all tie together

80

90

60

90

60

76

Alignment with
and overlap
between this and
other resources
– CAPE and
other standards
– helps with
external validity

90

85

90

80

35

76

Evidence-based
and patient
centered terms
were included

80

80

75

90

95

84

Scholarship –
liked
blend/listing of
variety of
different ways

60

60

60

80

55

63
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that scholarship
could be
included
Different
components
such as advocate
and
systems/based
manager – adds
layer of
complexity to
being a
pharmacist was
we are taking on
more in the
healthcare
system
Personal
wellness (of
pharmacist) was
highlighted

70

60

90

90

65

75

90

80

70

70

70

76

Most of the
components of
the PCPP were
included
throughout

80

75

90

80

80

81

Advocate/Health
promoters –
liked ways
different roles
were laid out
and were
specific

80

80

60

80

20

64

Thread of
patient-centered
care throughout
all of the areas

80

75

80

80

75

78

80

70

70

80

30

66

Advocate/health
promoter –
population
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health was
included here
Collaborator –
included other
providers but
also included
the patient

80

85

80

90

85

84

Professionalism
– included
society as a
whole

70

90

60

75

90

77

Systemsbased/manager –
health care
insurance and
health care
economics were
specifically
highlighted as
these are often
left out for
pharmacist

60

80

90

90

40

72

The modifications round-robin and clarification stages of the NGT process identified
seventeen potential modifications for the initial core role proposal. The same rating
procedure as the strengths portion was used again for the modification preliminary voting
stage. Panelists first rated the modifications via an on-line Microsoft Form on a scale of
0-100. Panelists assigned a rating of zero to items they felt were unnecessary
modifications, and 100 for items they felt were vital modifications. An average of the
individual panelist's ratings for each modification then occurred. Before voting, the group
also set an average rating cut-off to identify modifications that needed further
clarification before the final voting. The cut-off selected was determined through a
consensus voice vote of the group. A cut-off of an average rating score of 60 or below
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indicated items that needed further clarification. All five NGT participants voted on the
modifications during the preliminary voting stage.
One potential modification was "Pharmacotherapeutics expert: Should include all the
other tenets – focus of the two bullets are clinical – systems-based practice/manager is
missing – double check all other tenets are covered there." The average rating for this
modification was 82, with a range of 40-100. Despite having one rating of <60, the
average was above the cut-off to potentially be included in the final list of modifications
to make on the proposal. Another potential modification was "Pharmacotherapeutics
expert – central tenet – seems to have a very heavy clinical tenet – is there another term
that can be used – maybe change to medication expert." The average rating for this
modification was 58, with a range of 20-80. As written, this modification was currently
below the cut-off of 60, meaning the modification would not be made in the final
proposal if the average rating remains this low after the final vote. The full list of
potential modifications generated during the initial NGT modification process with the
initial vote results is in Table 5.
Table 5
Initial Core Pharmacist's Role Proposal NGT Modification Results
Initial Modifications
Knowledge – bullet
1: psychological is
not usually part of the
pharmacist role so
what level of
knowledge would be
expected there
Pharmacotherapeutics
expert: Should
include all the other
tenets – focus of the

Part 1

Part 2

Part 3

Part 4

Part 5

M

75

30

80

30

70

57

100

100

70

40

100

82
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two bullets are
clinical – systemsbased
practice/manager is
missing – double
check all other tenets
are covered there
Drug information
seeking is missing
(using resources to
find and provide
information)

0

90

70

100

90

70

Pharmacotherapeutics
expert: is expert the
right word – consider
another word

80

30

40

50

60

52

Patient care skills –
first bullet: steps
through domains of
PCPP but
implementation is not
concretely there

100

100

60

90

90

88

Pharmacotherapeutics
expert: second bullet
– monitor/follow-up
is missing there

100

95

80

90

90

91

Patient care skills –
role of PCPP is there
but needs to be more
on the relationship
with the patient
(empathy, other
emotions)

90

30

50

75

70

63

Scholarship – likes
examples but makes
it seem that a
pharmacist needs to
all of these things –
needs to be more of
an example list

100

40

30

80

90

68

116

Scholarship – use of
data needs to be here
(health informatics)

0

90

70

50

80

58

Scholarship –
advancement of the
profession
(professional
advocacy); changing
future roles for
pharmacists

100

70

80

60

90

80

Systems-based
Practice – first bullet
– population
health/public health

50

80

60

80

80

70

Quality care
mentioned in several
places but quality
improvement is not
explicated stated

100

85

70

80

60

79

Collaborator – bullet
2 – "safe, high
quality, and effective
patient care" – comes
through in several
places – be consistent
in document

80

40

60

80

90

70

Should "evidencebased be included" –
bullet 1 on
collaborator maybe to
replace "high quality"

0

80

50

80

80

58

Collaborator – bullet
2 – "Must understand
role of others on the
team" – pharmacists
need to be able to
articulate their role
on the team

100

90

65

80

60

79
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Missing from CAPE:
Innovator seems to be
missing

100

80

70

80

80

82

Pharmacotherapeutics
expert – central tenet
– seems to have a
very heavy clinical
tenet – is there
another term that can
be used – maybe
change to medication
expert

80

70

70

50

20

58

After the preliminary round of voting for the modifications, a review of results
occurred to determine items that met the cut-off selected through a consensus voice vote
of the group to be outliers. A cut-off of an average rating score of 60 or below indicated
items that needed further clarification. There were five outliers identified to have an
average of <60. The group discussed the five outliers, and clarification of all five
statements occurred. The purpose of the clarification stage was to ensure the group
members understood the intent of the statement before the final voting. Statements either
had words added or changed to ensure everyone understood the purpose of the statement.
There were five outliers discussed with clarifications made. The first outlier discussed
was "Knowledge - bullet 1". Participants felt that psychological is not usually part of the
pharmacist role, so they were confused about what level of knowledge would be expected
for this bullet. Rewording of "Knowledge bullet 1" occurred to "psychological is not
usually part of the pharmacist role, so what level of knowledge would be expected there –
change is psychosocial." The second outlier discussed was "Pharmacotherapeutics
expert." The participants discussed whether expert was the right word and suggested
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considering another word. "Pharmacotherapeutics expert" was reworded to
"Pharmacotherapeutics expert: is expert the right word – consider "optimizer."
Another outlier discussed was under Scholarship. Participants discussed the need
to have the use of data mentioned here, specifically the use of the term health informatics.
Rewording of this bullet occurred to "Use/Analysis of outcomes data needs to be
included (health informatics/quality improvement)." Another outlier was under bullet one
in collaborator. Participants thought evidence-based should maybe replace the term high
quality. This bullet was reworded to "Should evidence-based be added to bullet one on
collaborator." The last outlier discussed was the central tenet of "Pharmacotherapeutics
expert." Participants felt this term had a very heavy clinical tenet, so they wondered if
another term was available. Rewording of the Pharmacotherapeutics expert statement
occurred to "Pharmacotherapeutics expert – central tenet – seems to have a very clinical
tenet – is there another term that can be used – maybe change to pharmacy expert."
The final voting stage used the same rating procedure as the modification
preliminary voting stage. Panelists rated the modifications once again via an on-line
Microsoft Form on a scale of 0-100. Panelists assigned a rating of zero to items they felt
were the weakest of the modifications, and 100 to items they felt were the strongest
modifications. An average of the individual panelist's ratings for each modification then
occurred. The group used the same average rating cut-off of >60 (as determined during
the preliminary voting stage) to identify modifications needed before finalizing the core
role proposal. Once again, all five NGT participants rated the modifications during the
final voting stage.
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The final vote found that sixteen out of the seventeen modifications were above
the cut-off of > 60. These results meant the panelist felt strongly these sixteen
modifications were necessary to clarify the proposed core roles’ central tenet, core role
definitions, and to ensure all core pharmacists' roles that pharmacists should be prepared
to do throughout their careers were in the proposal. For example, one modification was
"Drug information seeking is missing (using resources to find and provide information)."
The average rating for this modification was 76, with a range of 30-100. Despite having
one rating of below 60, the average was still above the cut-off for inclusion in the
modifications. The proposal was modified to ensure the inclusion of drug information in
describing one of the core roles. Another modification made before finalizing the core
roles was "Pharmacotherapeutics expert – central tenet – seems to have a very heavy
clinical tenet – is there another term that can be used – maybe change to pharmacy
expert." The average rating for this modification was 68, with a range of 0-100. Again,
even though there was a rating of <60, the overall average was high enough to make this
modification. Based on this modification, the name of the central tenet was changed.
Another modification that was voting on was "Pharmacotherapeutics expert: is expert the
right word – consider "optimizer." The average rating for this modification was 34, with a
range of 0-60. This modification did not meet the score of >60, meaning the inclusion of
this modification did not occur in the core role proposal. The final list of potential
modifications, along with the results of the final voting, is in Table 6.
Table 6
Final Core Pharmacist's Role Proposal NGT Modification Results
Final Modifications

Part 1

Part 2
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Part 3

Part 4

Part 5

M

Knowledge – bullet
1: psychological is
not usually part of the
pharmacist role so
what level of
knowledge would be
expected there change is
psychosocial

100

80

90

80

80

86

Pharmacotherapeutics
expert: Should
include all the other
tenets – focus of the
two bullet is clinical
– systems-based
practice/manager are
missing – double
check all other tenets
are covered there

100

70

100

90

50

82

Drug information
seeking is missing
(using resources to
find and provide
information)

100

70

90

90

30

76

Pharmacotherapeutics
expert: is expert the
right word – consider
"optimizer"

60

40

10

0

60

34

Patient care skills –
first bullet: steps
through domains of
PCPP but
implementation is not
concretely there

100

70

100

90

100

92

Pharmacotherapeutics
expert: second bullet
– monitor/follow-up
is missing there

100

80

95

90

100

93

Patient care skills –
role of PCPP is there

70

50

50

70

90

66
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but needs to be more
on the relationship
with the patient
(empathy, other
emotions)
Scholarship – likes
examples but makes
it seem that a
pharmacist needs to
all of these things –
needs to be more of
an example list

100

30

80

80

80

74

Use/Analysis of
outcomes data needs
to be included (health
informatics/quality
improvement)

90

70

90

80

80

82

Scholarship –
advancement of the
profession
(professional
advocacy); changing
future roles for
pharmacists

85

80

80

80

100

85

Systems-based
Practice – first bullet
– population
health/public health

80

60

80

80

30

66

Quality care
mentioned in several
places but quality
improvement is not
explicated stated

80

70

90

80

50

74

Collaborator – bullet
2 – "safe, high
quality, and effective
patient care" – comes
through in several
places – be consistent
in document

90

60

50

90

50

68
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Should "evidencebased" be added to
bullet 1 on
collaborator

80

50

80

80

30

64

Collaborator – bullet
2 – "Must understand
role of others on the
team" – pharmacists
need to be able to
articulate their role
on the team

80

65

90

80

100

83

Missing from CAPE:
Innovator seems to be
missing

80

70

80

80

100

82

Pharmacotherapeutics
expert – central tenet
– seems to have a
very heavy clinical
tenet – is there
another term that can
be used – maybe
change to pharmacy
expert

100

70

70

100

0

68

The final set of core roles after making the sixteen modifications and ensuring the
sixteen strengths were kept is in Appendix D. The final core role proposal answered
Research Question One: What are the core professional roles pharmacy programs believe
students should be able to demonstrate competency in upon graduation? Upon
completion of the NGT process, pharmacy expert became the central role of a
pharmacist. The NGT process then defined a set of core roles students should be able to
demonstrate competency in upon graduation to ensure they are ready for the central role
of pharmacy expert. These core roles included knowledge, patient care skills,
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professionalism, scholarship, systems-based practice, and collaborator. Further
description of each core role provided direction on what specific knowledge and skills are
needed to be considered competent in that particular role. The core roles developed
during the NGT process will be used to answer Research Questions Two and Three:
1. What is the alignment of the current pharmacy competencies and entrustable
professional activities (EPAs) to the core professional roles?
2. What level of entrustment should pharmacy graduates be expected to achieve for
each EPA?
In the second phase of this study, mapping the current pharmacy competencies and
EPAs to the core roles developed during the NGT process and assignment of entrustment
levels for the EPAs occurred. A modified Delphi process was used to determine
consensus on the mapping to the core roles and levels of EPA entrustment. The answer to
these two research questions will help determine gaps in the current pharmacy
competencies/EPAs based on the core roles.
Research Question Two
Research Question Two was: According to pharmacy practitioners, what is the
alignment of the current pharmacy competencies and entrustable professional activities
(EPAs) to the core professional roles? Usage of the Delphi technique to simultaneously
collect quantitative and qualitative data (Delbecq et al., 1975) answered Research
Question Two. Like the NGT process, the Delphi technique offered a framework for
gathering stakeholder data on topics that call for aggregation of individual judgments.
Therefore, Research Question Two addressed the extent to which there is broad
consensus from different pharmacy practices on the competency/EPAs (Research
Question Two) mapped to the core roles developed in Research Question One.
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In this research, the CAPE outcomes, along with the corresponding mapped
EPAs, were used as the pharmacy competencies/EPAs to map to the roles created during
Research Question One (ACPE, 2015; Pittegner et al., 2017). The initial mapping of the
competencies/EPAs to the core roles are in Appendix E. The mapping document created
the Delphi survey for round one. For example, participants were presented a role with a
competency and its EPAs underneath. Participants were then asked to report their level of
agreement with the alignment of that particular competency/EPA(s) as a group to the
pharmacy roles on a four-point Likert scale (1 = Strongly Disagree to 4= Strongly Agree).
Participants also could leave open-ended comments to explain their ratings. The
knowledge role had one competency with five EPAs mapped. The patient care skills role
had five competencies with 5-12 EPAs mapped depending on the competency.
Professionalism had four competencies mapped with 3-4 EPAs for each competency.
Scholarship had three competencies mapped with 2-6 EPAs under each competency.
Systems-based practice/manager had four competencies mapped, each with 2-9 EPAs.
Collaborator had four competencies mapped, each with 1-6 EPAs. Lastly, the
advocate/health promoter had four competencies, each with 4-8 EPAs. Overall,
participants were asked to review 25 different competency/EPA mappings during round
one for the seven different roles.
Delphi surveys typically use a 5-point Likert scale allowing participants to choose a
neutral response (McMillian et al., 2016). The choice of a 4-point Likert scale was to
force participants to agree or disagree, given the questions' nature. The use of a 4-point
Likert scale is also in-line with other Delphi studies done in pharmacy education
(Johnson & Traynor, 2018). Aggregation of the results from the selected-response (Likert
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scale) questions into two categories occurred: Category 1 - Strongly Agree/Agree and
Category 2 – Disagree/ Strongly Disagree from each panelist's response to determine
consensus achievement. Computation of the percent number of responses for each
category then occurred for each question. For example, if 50 participants completed the
survey with 30 indicating Strongly Agree and ten indicating Agree for a question, then the
percent response for Category 1 (Strongly Agree/Agree) would be 80%. For there to be
consensus on the competency/EPA alignment, there had to be a category score of ≥ 80%
Strongly Agree/Agree for the question. Data from the literature states that cut-offs for
consensus can range from 51-80% (Hasson et al., 2000). A cut-off of ≥ 80% was chosen
for this study to be conservative and in line with other pharmacy Delphi studies (Johnson
& Traynor, 2018). A review of constructed-response comments occurred for any question
that did not achieve consensus (<80% agreement) using structural coding via NiViVo
software (NiViVo qualitative data analysis software, 2019). Once a mapping reached
consensus (≥ 80% Strongly Agree/Agree), it was no longer included in subsequent round
surveys.
Panelists from the NGT group in Research Question One provided a list of people to
participate in the Delphi survey via online Microsoft form. The form collected the Delphi
participant's name, pharmacy degree, practice site, length of time in pharmacy practice,
and email. NGT participants ensured that participants chosen came from various
pharmacy disciplines and different years of experience. The initial Delphi participant list
was a total of 63 people [University of Arkansas = 14 (22.2%); Sullivan University = 19
(30.2%); University of North Carolina = 17 (27.0%); and University of Minnesota = 13
(20.6%)]. All but one participant had a PharmD degree. The other participant had a Ph.D.
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degree. Nine participants (14.3%) had >20 years of experience, 26 (41.3%) had 11-20
years of experience, 22 (34.9%) had 5-10 years of experience, and six (9.5%) had <5
years of experience. Twenty-three (36.5%) participants were male, and 40 (63.5%) were
female. The Delphi participants' demographics represent the make-up of the pharmacy
profession, which has more females than males. Forty-five (71.4%) practiced in urban
locations, 15 (23.8%) practiced in rural sites, and 3 (4.8%) practice in mixed sites.
Thirteen (20.6%) participants were acute care pharmacists, 18 (28.9%) were ambulatory
care pharmacists, six (9.5%) were hospital pharmacists, 11 (17.5%) were community
pharmacists, seven (11.1%) were in academia, three (4.8%) were in pharmacy
management, and five (7.9%) were in other types of pharmacy practice.
Round One. The first round Delphi survey had a total of 24 participants respond
(38% response rate). Six (25%) of the respondents had >20 years of experience, 10
(41.7%) had 11-20 years of experience, six (25%) had 5-10 years of experience, and two
(8.3%) had <5 years of experience. Seven (29.2%) respondents were male, 15 (62.5%)
were female, and two (8.3%) preferred not to answer. Seventeen (70.8%) had practice
sites in urban locations, and seven (29.2%) had rural practice sites. Seven (29.2%)
respondents were acute care pharmacists, eight (33.3%) were ambulatory care
pharmacists, four (16.7%) were community pharmacists, three (12.5%) were in academia,
and two (8.3%) were in other types of practice.
As defined in Research Question One, the knowledge role was: "Pharmacists must be
able to integrate knowledge of biomedical and psychosocial science principles of health
and disease, and clinical science to design appropriate treatment plans for their patients.
This knowledge includes understanding these principles across the life-span of the
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patient. Pharmacists understand that they serve a unique role in the healthcare team. They
are the "medication" experts and possess the most knowledge of how medications
contribute to the patient's care." There was one competency with five EPAs mapped to
the knowledge role. Consensus was achieved (≥80% Strongly Agree/Agree) for the
mapping to this role, so this role's inclusion did not occur in the round two survey. The
results are below in Table 7. The competency mapped under the knowledge role contains
all of the knowledge elements defined by this role, but the EPAs are not specific. While
participants felt the EPAs under this role were correct, the EPAs are general and leave the
specific knowledge to be learned to be determined by the pharmacy school/college.
Table 7
Competencies/EPAs Mapped to Knowledge Role
Competency

Learner: Develop, integrate,
and apply knowledge from the
foundational sciences (i.e.,
pharmaceutical,
social/behavioral/administrative,
and clinical sciences) to
evaluate the scientific literature,
explain drug action, solve
therapeutic problems, and
advance population health and
patient-centered care

EPAs

EPA: Analyze
information to
determine the
effects of
medication
therapy,
identify
medicationrelated
problems, and
prioritize
health-related
needs.
EPA: Establish
patient-centered
goals and create
a care plan for a
patient in
collaboration
with the
patient,
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Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
83.3%
12.5%
Yes

caregiver(s),
and other health
professionals
that are
evidence-based
and costeffective.
EPA:
Collaborate as a
member of an
IPE team.
EPA: Educate
patients and
professional
colleagues
regarding the
appropriate use
of medication.
EPA: Use
evidence-based
information to
advance patient
care.

The definition of patient care skills in Research Question One was: "Pharmacists
must be able to perform basic patient care skills such as communication, collection and
assessment of information to formulate and implement a treatment plan, and ability to
monitor if a treatment is successful or not. Pharmacists need to ensure they take a
patient's cultural, education level, and financial status into account when formulating a
treatment plan to ensure a patient's plan can be adherent. Pharmacists also understand that
part of patient care should include discussing the plan in a compassionate and empathetic
manner with not only the patient but also their support system as needed." There were
five competencies, each with various EPAs mapped to the Patient Care skills role.
Consensus was achieved (≥80% Strongly Agree/Agree) on four of the five
competencies/EPAs mapped to this role. The Educator competency was the one that did
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not achieve consensus, with only 79.2% of respondents strongly agreeing/agreeing with
this mapping. Comments from three respondents suggested that the EPAs related to
implementation, identifying patients at risk, and immunizations did not fit here. Two
respondents also suggested splitting Educator into a patient-focused competency and a
health care professional focused competency. These suggestions were used to set-up the
questions for the second-round survey. Overall, the competencies mapped under this role
help to define the role of patient care skills. Except for some EPAs mapped under the
Educator competency, the EPAs help define the actions needed to meet this role's
competencies. While the competencies and EPAs mapped to this role are the same as
ones mapped to later roles, in this case, they are specific to determine if a student was
competent in this role. The issue is because these same competencies and EPAs occur in
later roles, one would have a hard time determining which role was being assessed. There
are also some competencies missing. There are no competencies related to the cultural
and financial status of the patient. Table 8 shows the full results for this role.
Table 8
Competencies/EPAs Mapped to Patient Care Skills Role
Competency

EPAs

Patient-centered
care (Caregiver):
Provide patientcentered care as
the medication
expert (collect
and interpret
evidence,
prioritize,
formulate
assessments and

EPA: Collect information to
identify a patient's
medication-related problems
and health-related needs.
EPA: Analyze information to
determine the effects of
medication therapy, identify
medication-related problems,
and prioritize health-related
needs.
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Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
95.8%
0%
Yes

recommendations,
implement,
monitor and
adjust plans, and
document
activities).

EPA: Establish patientcentered goals and create a
care plan for a patient in
collaboration with the patient,
caregiver(s), and other health
professionals that are
evidence-based and costeffective.
EPA: Implement a care plan
in collaboration with the
patient, caregivers, and other
health professionals.
EPA: Follow-up and monitor
a care plan.
EPA: Maximize the
appropriate use of
medications in a population.
EPA: Ensure that patients
have been immunized against
vaccine-preventable diseases.

Health and
wellness
(Promoter):
Design
prevention,
intervention, and
educational
strategies for
individuals and
communities to
manage chronic
disease and
improve health
and wellness.

EPA: Collect information to
identify a patient's
medication-related problems
and health-related needs.
EPA: Identify patients at risk
for prevalent disease in a
population.
EPA: Minimize adverse drug
events and medications in a
population.
EPA: Maximize the
appropriate use of
medications in a population.
EPA: Ensure that patients
have been immunized against
vaccine-preventable diseases.

87.5%

8.3%

Yes

Problem Solving
(Problem Solver):
Identify
problems, explore
and prioritize
potential
strategies, and
design,

EPA: Collect information to
identify a patient's
medication-related problems
and health-related needs.
EPA: Analyze information to
determine the effects of
medication therapy, identify
medication-related problems,

87.5%

8.3%

Yes
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implement, and
evaluate a viable
solution.

and prioritize health-related
needs.
EPA: Implement a care plan
in collaboration with the
patient, caregivers, and other
health professionals.
EPA: Collaborate as a
member of an IPE team.
EPA: Oversee the pharmacy
operations for an assigned
shift.
EPA: Full-fill a medication
order.

Educator
(Educator):
Educate all
audiences by
determining the
most effective
and enduring
ways to impart
information and
assess
understanding.

EPA: Implement a care plan
in collaboration with the
patient, caregivers, and other
health professionals.
EPA: Identify patients at risk
for prevalent disease in a
population.
EPA: Minimize adverse drug
events and medications in a
population.
EPA: Maximize the
appropriate use of
medications in a population.
EPA: Ensure that patients
have been immunized against
vaccine-preventable diseases.
EPA: Educate patients and
professional colleagues
regarding the appropriate use
of medication.

79.2%

16.7%

No

Communication
(Communicator):
Effectively
communicate
verbally and
nonverbally when
interacting with
an individual,
group, or
organization.

EPA: Collect information to
identify a patient's
medication-related problems
and health-related needs.
EPA: Analyze information to
determine the effects of
medication therapy, identify
medication-related problems,
and prioritize health-related
needs.

83.3%

16.7%

Yes
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EPA: Follow-up and monitor
a care plan.
EPA: Collaborate as a
member of an IPE team.
EPA: Identify patients at risk
for prevalent disease in a
population.
EPA: Minimize adverse drug
events and medications in a
population.
EPA: Maximize the
appropriate use of
medications in a population.
EPA: Ensure that patients
have been immunized against
vaccine-preventable diseases.
EPA: Educate patients and
professional colleagues
regarding the appropriate use
of medication.
EPA: Use evidence-based
information to advance
patient care.
EPA: Oversee the pharmacy
operations for an assigned
shift.
EPA: Full-fill a medication
order.

As defined from Research Question One, the Professionalism role was: "Pharmacists
are committed to the health and well-being of their patients, society, and themselves.
Demonstration of this role occurs through ethical practice, high standards of personal
behavior, accountability to the profession and society, and maintenance of their own
personal health. Pharmacists serve essential roles in the healthcare team and society. As
such, professional identity is central. This tenet includes promotion of the public good,
adherence to high ethical and moral standards. It recognizes that to provide good quality
patient care, they must take care of themselves and others in their profession." There
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were four competencies, each with three EPAs mapped to the professionalism role.
Consensus was achieved (≥80% Strongly Agree/Agree) on all five competencies/EPAs
mapped to this role. The inclusion of this role did not occur in the second-round survey.
Table 9 shows the full results for this role. The competencies mapped to this role met
some of the items covered in this role's definition. Competencies are missing related to
ethics and maintenance of personal health. While participants did feel the EPAs mapped
to this role were appropriate, they again are not explicitly written for this role, so it is
hard to see how achieving them as written would mean you have achieved this role. For
example, “Overseeing the pharmacy operations for an assigned shift” is not clearly
defined for how it assesses the competency of self-awareness in the context of the
professionalism role. To help schools/colleges of pharmacy better address this EPA, the
EPA needs to be more explicit.
Table 9
Competencies/EPAs Mapped to Professionalism Role
Competency

EPAs

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree

Self-awareness (Selfaware): Examine and
reflect on personal
knowledge, skills,
abilities, beliefs,
biases, motivation,
and emotions that
could enhance or
limit personal and
professional growth.

EPA: Collaborate as a
member of an IPE team.
EPA: Oversee the
pharmacy operations for
an assigned shift.
EPA: Create a written plan
for continuous
professional development

91.7%

8.3%

Yes

Leadership (Leader):
Demonstrate
responsibility for

EPA: Collaborate as a
member of an IPE team.

87.5%

8.3%

Yes
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creating and
achieving shared
goals, regardless of
position.

EPA: Educate patients and
professional colleagues
regarding the appropriate
use of medication.
EPA: Oversee the
pharmacy operations for
an assigned shift.

Innovation and
Entrepreneurship
(Innovator): Engage
in innovative
activities by using
creative thinking to
envision better ways
of accomplishing
professional goals.

EPA: Collaborate as a
member of an IPE team.
EPA: Use evidence-based
information to advance
patient care.
EPA: Oversee the
pharmacy operations for
an assigned shift.

83.3%

16.7%

Yes

Professionalism
(Professional):
Exhibit behaviors
and values that are
consistent with the
trust given by the
profession by
patients, other
healthcare providers,
and society.

EPA: Collaborate as a
member of an IPE team.
EPA: Educate patients and
professional colleagues
regarding the appropriate
use of medication.
EPA: Oversee the
pharmacy operations for
an assigned shift.
EPA: Create a written plan
for continuous
professional development

91.7%

8.3%

Yes

As defined in Research Question One, the scholarship role was: "Pharmacists are
committed to excellence in their practice through life-long professional development, the
teaching of others, developing new innovative practices that advance the profession, and
use of evidence-based medicine. Pharmacists are committed to finding and promoting
drug and other health information that is evidence-based and up-to-date. Pharmacists
understand the importance of contributing to scholarship and evidence-based medical
literature." There were three competencies mapped to the scholarship role. One
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competency had six EPAs mapped to it, one had three, and one had two. Consensus was
achieved (≥80% Strongly Agree/Agree) on all three competencies/EPAs mapped to this
role. The inclusion of this role did not occur in the second-round survey. Table 10 shows
the full results for this role. For the most part, the competencies mapped to this role cover
all elements defined except for contributing to scholarship. There is no competency or
EPA that discusses contributing to scholarship, only the use of it. Like the other roles, the
competencies and EPAs mapped to this role are also not explicitly written for this role.
Some tend to be very general, leaving it up to the school/college to determine how they
would fit into this role.
Table 10
Competencies/EPAs Mapped to Scholarship Role
Competency

Educator
(Educator):
Educate all
audiences by
determining the
most effective
and enduring
ways to impart
information and
assess
understanding.

EPAs

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
EPA: Implement a care plan in 83.3%
16.7%
Yes
collaboration with the patient,
caregivers, and other health
professionals.
EPA: Identify patients at risk
for prevalent disease in a
population.
EPA: Minimize adverse drug
events and medications in a
population.
EPA: Maximize the
appropriate use of medications
in a population.
EPA: Ensure that patients
have been immunized against
vaccine-preventable diseases.
EPA: Educate patients and
professional colleagues
regarding the appropriate use
of medication.
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Communication
(Communicator):
Effectively
communicate
verbally and
nonverbally
when interacting
with an
individual,
group, or
organization.

EPA: Educate patients and
professional colleagues
regarding the appropriate use
of medication.
EPA: Use evidence-based
information to advance patient
care.

95.8%

4.2%

Yes

Innovation and
Entrepreneurship
(Innovator):
Engage in
innovative
activities by
using creative
thinking to
envision better
ways of
accomplishing
professional
goals.

EPA: Collaborate as a member
of an IPE team.
EPA: Use evidence-based
information to advance patient
care.
EPA: Oversee the pharmacy
operations for an assigned
shift.

83.3%

16.7%

Yes

The systems-based practice/manager role, as defined from Research Question One
was: "Pharmacists are committed to safety and quality in health care, professional
advocacy, health insurance, health care economics, health outcomes, quality
improvement, transitions of care, public health, and chronic care of patients. Pharmacists
understand that they work as part of a larger "system" of health care and that to provide
excellent, quality care, they need to be able to coordinate care within the systems, provide
treatment recommendations that work with the patients' insurance, and be an advocate for
optimal and quality patient care. Pharmacists also need to be an advocate for the
profession on professional roles/responsibilities and the ability to bill for services." There
were four competencies with a variety of EPAs mapped to the systems-based
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practice/manager role. Consensus was achieved (≥80% Strongly Agree/Agree) on three of
the four competencies/EPAs mapped to this role. Again, the Educator competency did not
reach consensus, with only 79.2% of respondents Strongly Agreeing/Agreeing to the
mapping to this role. Two respondents commented immunizations and identifying at-risk
patients did not fit under this role. These suggestions were taken into account when the
rewording of this mapping for the second-round survey. Table 11 shows the full results
for this role. The competencies and EPAs mapped to this role are again very general.
While they do fit under this role, they are not specific for the role, and some
competencies are missing. For example, the Manager's competency is written to fit the
broad healthcare system-based intent of this role. However, the EPAs underneath it is
written to be at the patient level and not at the system level. The EPAs would need to be
adjusted to assess competency for this role better. There are also competencies and EPAs
missing. There are no competencies or EPAs related to professional advocacy (not
advocating for the good of the patient but advocating for the good of the profession and
its place in healthcare), health outcomes, quality improvement, transitions of care, and
public health.
Table 11
Competencies/EPAs Mapped to Systems-based Practice/Manager Role
Competency

EPAs

Medication use
systems
management
(Manager): Manage
patient healthcare
needs using human,
financial,

EPA: Collect information
to identify a patient's
medication-related
problems and health-related
needs.
EPA: Establish patientcentered goals and create a
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Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
83.3%
16.7%
Yes

technological, and
physical resources
to optimize the
safety and efficacy
of medication use.

care plan for a patient in
collaboration with the
patient, caregiver(s), and
other health professionals
that are evidence-based and
cost-effective.
EPA: Implement a care
plan in collaboration with
the patient, caregivers, and
other health professionals.
EPA: Follow-up and
monitor a care plan.
EPA: Identify patients at
risk for prevalent disease in
a population.
EPA: Minimize adverse
drug events and
medications in a
population.
EPA: Maximize the
appropriate use of
medications in a
population.
EPA: Ensure that patients
have been immunized
against vaccine-preventable
diseases.
EPA: Oversee the
pharmacy operations for an
assigned shift.
EPA: Full-fill a medication
order.

Educator
(Educator): Educate
all audiences by
determining the
most effective and
enduring ways to
impart information
and assess
understanding.

EPA: Identify patients at
risk for prevalent disease in
a population.
EPA: Minimize adverse
drug events and
medications in a
population.
EPA: Maximize the
appropriate use of
medications in a
population.
EPA: Ensure that patients
have been immunized
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79.2%

16.7%

No

against vaccine-preventable
diseases.
EPA: Educate patients and
professional colleagues
regarding the appropriate
use of medication.
Communication
(Communicator):
Effectively
communicate
verbally and
nonverbally when
interacting with an
individual, group, or
organization.
Leadership
(Leader):
Demonstrate
responsibility for
creating and
achieving shared
goals, regardless of
position.

EPA: Oversee the
pharmacy operations for an
assigned shift.
EPA: Full-fill a medication
order.

91.7%

4.2%

Yes

91.7%

8.3%

Yes

EPA: Collaborate as a
member of an IPE team.
EPA: Educate patients and
professional colleagues
regarding the appropriate
use of medication.
EPA: Oversee the
pharmacy operations for an
assigned shift.

As defined in Research Question One, the collaborator role was: "Pharmacists work
with other healthcare professionals to provide safe, high-quality, evidence-based, and
patient-centered care. Pharmacists understand that being able to function effectively in an
interprofessional team is necessary to provide safe, high-quality, and patient-centered
care. Collaboration is also important with the patient and their support systems.
Collaboration requires trust, respect, and shared decision-making. It also requires the
sharing of knowledge, perspectives, responsibilities, and the willingness to learn from
others. To effectively collaborate, one must understand the roles of others on the team, be
able to articulate one's role on the team, be pursuing common goals, and be able to
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manage conflict effectively." There were four competencies with a variety of EPAs
mapped to the collaborator role. Consensus was achieved (≥80% Strongly Agree/Agree)
on all four competencies/EPAs mapped to this role. This role did not need to be included
in the second round Delphi survey. Table 12 shows the full results for this role. Overall
the competencies under this role fit; however, just as with the other roles, the
competencies/EPAs are general. The competencies and EPAs are not written to precisely
match this role, and many of the EPAs fit under more than one competency. For example,
if a student did not meet the EPA of “Collaborate as a member of an IPE team,” which
competency is meeting it for, Problem Solver, Collaborator, or Communicator. There is
also no competency or EPA related to conflict management.
Table 12
Competencies/EPAs Mapped to Collaborator Role
Competency

EPAs

Problem Solving
(Problem Solver):
Identify problems,
explore and
prioritize potential
strategies, and
design, implement,
and evaluate a viable
solution.

EPA: Collaborate as a
member of an IPE team.

Educator (Educator):
Educate all
audiences by
determining the most
effective and
enduring ways to
impart information
and assess
understanding.

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
87.5%
12.5%
Yes

91.7%
EPA: Implement a care
plan in collaboration with
the patient, caregivers, and
other health professionals.
EPA: Educate patients and
professional colleagues
regarding the appropriate
use of medication.
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4.2%

Yes

Interprofessional
collaboration
(Collaborator):
Actively participate
and engage as a
healthcare team
member by
demonstrating
mutual respect,
understanding, and
values to meet
patient care needs.

EPA: Follow-up and
monitor a care plan.
EPA: Collaborate as a
member of an IPE team.
EPA: Identify patients at
risk for prevalent disease
in a population.
EPA: Minimize adverse
drug events and
medications in a
population.
EPA: Maximize the
appropriate use of
medications in a
population.
EPA: Ensure that patients
have been immunized
against vaccinepreventable diseases.

91.7%

8.3%

Yes

Communication
(Communicator):
Effectively
communicate
verbally and
nonverbally when
interacting with an
individual, group, or
organization.

EPA: Collaborate as a
member of an IPE team.
EPA: Educate patients and
professional colleagues
regarding the appropriate
use of medication.

95.8%

4.2%

Yes

The advocate/health promoter role, as defined in Research Question One, was:
"Pharmacists are committed to using their expertise and influence to work with patient
populations to improve health and wellness in communities. They work to understand the
needs, speak on behalf of others, and seek to mobilize resources to effect change when
needed. Pharmacists understand that improving health is not limited to treating illness but
also includes disease prevention, health promotion, and health protection. They
understand their unique place in the healthcare team, and society allows them access to
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populations that others may not have. Pharmacists understand the need to work with
patients to help them navigate complex medical situations to get the care they may need."
There were four competencies with a variety of EPAs mapped to the advocate/health
promoter role. Consensus was achieved (≥80% Strongly Agree/Agree) on all four
competencies/EPAs mapped to this role. This role did not need to be included in the
second round Delphi survey. Table 13 shows the full results for this role. The
competencies mapped to this role are consistent with the intent of this role. However, just
like the previous roles, the competencies and EPAs are not specific for this role, leaving
it up to the schools/colleges of pharmacy to define the competency/EPAs' intent.
Table 13
Competencies/EPAs Mapped to Advocate/Health Promoter Role
Competency

EPAs

Populationbased care
(Provider):
Describe how
populationbased care
influences
patient-centered
care and
influences the
development of
practice
guidelines and
evidence-based
best practices.

EPA: Identify patients at risk
for prevalent disease in a
population.
EPA: Minimize adverse drug
events and medications in a
population.
EPA: Maximize the appropriate
use of medications in a
population.
EPA: Ensure that patients have
been immunized against
vaccine-preventable diseases.

Educator
(Educator):
Educate all
audiences by
determining the

EPA: Identify patients at risk
for prevalent disease in a
population.
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Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
91.7%
4.2%
Yes

87.5%

8.3%

Yes

most effective
and enduring
ways to impart
information and
assess
understanding.

EPA: Minimize adverse drug
events and medications in a
population.
EPA: Maximize the appropriate
use of medications in a
population.
EPA: Ensure that patients have
been immunized against
vaccine-preventable diseases.
EPA: Educate patients and
professional colleagues
regarding the appropriate use of
medication.

Patient
Advocacy
(Advocate):
Assure that
patients' best
interests are
represented.

EPA: Establish patient-centered
goals and create a care plan for
a patient in collaboration with
the patient, caregiver(s), and
other health professionals that
are evidence-based and costeffective.
EPA: Collaborate as a member
of an IPE team.
EPA: Minimize adverse drug
events and medications in a
population.
EPA: Maximize the appropriate
use of medications in a
population.
EPA: Ensure that patients have
been immunized against
vaccine-preventable diseases.
EPA: Educate patients and
professional colleagues
regarding the appropriate use of
medication.
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91.7%

8.3%

Yes

Cultural
sensitivity
(Includer):
Recognize
social
determinants of
health to
diminish
disparities and
inequities in
access to quality
care.

EPA: Collect information to
identify a patient's medicationrelated problems and healthrelated needs.
EPA: Establish patient-centered
goals and create a care plan for
a patient in collaboration with
the patient, caregiver(s), and
other health professionals that
are evidence-based and costeffective.
EPA: Identify patients at risk
for prevalent disease in a
population.
EPA: Minimize adverse drug
events and medications in a
population.
EPA: Maximize the appropriate
use of medications in a
population.
EPA: Ensure that patients have
been immunized against
vaccine-preventable diseases.
EPA: Educate patients and
professional colleagues
regarding the appropriate use of
medication.
EPA: Use evidence-based
information to advance patient
care.

91.7%

4.2%

Yes

After round one of the Delphi survey, two of the roles, patient care skills and
systems-based practice/manager, had competencies/EPAs that did not reach consensus (2
competencies/EPA mappings out of 25 [8%]). For round two of the Delphi survey,
participants were asked for consensus on updated mapping for these two roles. For
patient care skills, splitting of the educator competency into two competencies occurred.
One competency defined education for patients: "Educate patients and their caregivers by
determining the most effective and enduring ways to impart information and assess
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understanding." The other competency defined Healthcare professional education:
"Educate healthcare providers by determining the most effective and enduring ways to
impart information and assess understanding.". Both competencies had the same three
EPAs mapped to them related to minimizing adverse effects, maximizing the appropriate
use of medications, and providing education. For systems-based practice/manager,
removing the EPAs related to immunizations and identifying patients at risk occurred, but
rewording of the competency itself did not occur. These updated competency/EPA
mappings, along with the changes made to the survey upon review of the data for
Research Question Three, formed the round two Delphi survey. The same group of
participants as round one received the updated survey.
Round Two. The second round of the Delphi survey followed the same survey
procedure as round one, except questions were only asked on items that did not meet
consensus during round one (2 competencies/EPA mappings out of 25 [8%]). The same
participant group was used as round one. The second round Delphi survey had a total of
19 participants respond (30.2% response rate). Six (31.6%) of the respondents had >20
years of experience, five (9%) had 11-20 years of experience, seven (36.8%) had 5-10
years of experience, zero (80%) had <5 years of experience, and one preferred not to
answer (5.3%). Six (31.6%) respondents were male, 11 (58.0%) were female, and two
(10.5%) preferred not to answer. Fifteen (78.9%) had practice sites in urban locations,
three (15.8%) had rural practice sites, and one (5.3%) preferred not to answer. One
(5.3%) respondent was an acute care pharmacist, nine (47.4%%) were ambulatory care
pharmacists, two (10.5%%) were community pharmacists, two (10.5%) were in
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academia, two (10.5%) were hospital pharmacists, two (10.5%) were in management, and
one (5.2%) preferred not to answer.
Under the patient care skills role, the Educator competency did not meet consensus
during round one. Comments from respondents suggested that the EPAs related to
implementation, identifying patients at risk, and immunizations did not fit under this
competency for this role. Removal of these EPAs occurred from the question for this
round. Respondents also suggested splitting the Educator competency for this role into
two competencies, one related to healthcare professionals and one for patients. For round
two, the division of this competency into Patient Educator and Healthcare Professional
Educator occurred. Patient Educator's definition was "educating patients and their
caregivers by determining the most effective and enduring ways to impart information
and assess understanding." This competency then had three EPAs mapped to it. The
definition of Healthcare Professional Educator was "educating healthcare providers by
determining the most effective and enduring ways to impart information and assess
understanding." This competency also had three EPAs mapped to it. Consensus was
achieved (≥80% Strongly Agree/Agree) for all the mapping to this role, so this role's
inclusion in the round three survey did not occur. The results are below in Table 14. The
changes made based on the participants' feedback after round one did not address the
issues discussed related to this mapping after round one. The competencies and EPAs are
still very general and map to multiple roles. Even with splitting the Educator competency
into two parts, the patient educator's coverage occurs in multiple roles, and the EPAs
mapped are still not specific for this particular role. There was also no suggestion to add
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competencies related to the patient's cultural and financial status, which would be needed
to assess this role adequately.
Table 14
Updated Competencies/EPAs Mapped to Patient Care Skills Role
Competency

EPAs

Patient Educator
(Educator):
Educate patients
and their caregivers
by determining the
most effective and
enduring ways to
impart information
and assess
understanding.

EPA: Minimize adverse
drug events and medications
in a population.
EPA: Maximize the
appropriate use of
medications in a population.
EPA: Educate patients and
caregivers regarding the
appropriate use of
medication

Healthcare
professional
Educator
(Educator):
Educate healthcare
providers by
determining the
most effective and
enduring ways to
impart information
and assess
understanding.

EPA: Minimize adverse
drug events and medications
in a population.
EPA: Maximize the
appropriate use of
medications in a population.
EPA: Educate professional
colleagues regarding the
appropriate use of
medication.

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
100%
0%
Yes

94.7%

5.3%

Yes

Systems-based practice/manager had one competency not meet consensus during
round one. Respondents in round one did not feel immunizations and identifying at-risk
patients fit under this role. For the round two survey questions related to this competency,
removing the EPAs related to immunizations and identifying at-risk patients occurred.
Consensus was achieved (≥80% Strongly Agree/Agree) for the mapping to this role, so
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this role's inclusion did not occur in the round three survey. The results are below in
Table 15. These changes still did not address the issues discussed after round one related
to this role. The competencies and EPAs are still not written to match this role precisely
and many of the EPAs fit under more than one competency. There is also still no
competency or EPA related to conflict management.
Table 15
Updated Competencies/EPAs Mapped to Systems-based Practice/Manager Role
Competency

Educator (Educator):
Educate all audiences
by determining the
most effective and
enduring ways to
impart information
and assess
understanding.

EPAs
•

•

•

EPA: Minimize
adverse drug events
and medications in a
population.
EPA: Maximize the
appropriate use of
medications in a
population.
EPA: Educate
patients and
professional
colleagues regarding
the appropriate use of
medication.

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
94.7%
5.3%
Yes

After round two of the Delphi survey, all competencies and EPAs mapped to the core
roles developed in Research Question One met consensus. Since all competency and EPA
mapping met consensus, there was no need for a round three survey for Research
Question Two. Research Question Two asked the following: According to pharmacy
practitioners, what is the alignment of the current pharmacy competencies and entrustable
professional activities (EPAs) to the core professional roles? Appendix F shows the
alignment of the current pharmacy competencies and EPAs to the core professional roles
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developed in Research Question One. The average number of competencies under each
role was 4 (1-6), with the most in the patient care skills role. The average number of
EPAs mapped to each role was 17 (5-36), with patient care skills having the most EPAs.
The pharmacy roles developed in Research Question One are distinct and meant to stand
alone. However, the competencies and EPAs mapped to these roles are duplicative across
roles, as discussed previously. This duplication makes it hard for schools/colleges of
pharmacy to know for sure which role a student is competent in just by meeting the
competency/EPA as written.
The core role of knowledge had one competency, Learner, mapped to it along with
five EPAs. There were no missing competencies for this role. However, separation of the
mapped competency into more specific competencies related to the role would help
determine a student’s real areas of weakness. The patient care skills role had five
competencies mapped to it: Caregiver, Promoter, Problem Solver, Educator, and
Communicator. One pharmacy competency change occurred with the mapping to this
role. Delphi participants felt the Educator competency needed divided into patient
education and healthcare professional education for this role, given the importance of
education in patient care skills. The competencies had 3-12 EPAs mapped to them with
Communicator having the most. Two competencies are missing related to the cultural and
financial status of the patient for this role.
The professionalism role had four competencies mapped to it: Self-aware, Leader,
Innovator, and Professional. Each competency has 3-4 EPAs mapped to it with
Professional having the most. No competencies or EPAs were missing, but the
competencies and EPAs are very general. Scholarship has three competencies mapped to
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it: Educator, Communication, and Innovator. Each competency has 2-6 EPAs mapped to
it with Educator having the most. Competencies are missing for this role related to ethics
and maintenance of personal health. Systems-based practice/manager had four
competencies mapped: Manager, Educator, Communicator, and Leader. Each
competency had 3-10 EPAs mapped to them, with Manager having the most EPAs. The
systems-based practice/manager role had several competencies missing. There are no
competencies or EPAs related to professional advocacy (not advocating for the good of
the patient but advocating for the good of the profession and its place in healthcare),
health outcomes, quality improvement, transitions of care, and public health.
Collaborator had four competencies mapped: Problem Solver, Educator,
Collaborator, and Communicator. Each competency had 1-6 EPAs mapped to it, with
Collaborator having the most. The collaborator role was missing a competency and/or
EPA(s) related to conflict management. Lastly, advocate/health promoter had four
competencies mapped to it: Provider, Educator, Advocate, and Includer. Each
competency had 4-8 EPAs mapped to it, with Includer having the most. No competencies
were missing for this role.
Mapping of all current pharmacy competencies and EPAs to the core roles from
Research Question One occurred with no changes occurring in the wording of the EPAs
or the addition of any EPAs (with exception of splitting one EPA for one competency).
The lack of changes or additions to the already developed EPAs from AACP meant a
baseline level of entrustment that could form the first Delphi survey for Research
Question Three. The purpose of Research Question Three was to obtain a consensus on
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the level of entrustment that students should achieve by graduation for each of the EPAs
mapped to the pharmacy competencies.
Research Question Three
Research Question Three was: According to pharmacy practitioners, what level
of entrustment should pharmacy graduates be expected to achieve for each EPA? This
research question used the same Delphi technique as research question two to
simultaneously collect quantitative and qualitative data (Delbecq et al., 1975). Like the
NGT process, the Delphi technique offered a framework for gathering stakeholder data
on topics that call for aggregation of individual judgments such as Research Question
Three. Research Question Three sought to examine if there was a broad consensus from
different pharmacy practices on the entrustment level (Research Question Three)
assigned to the EPAs from the mapping for Research Question Two.
There were five levels of entrustment defined for this survey. Specifically, Level 1
entrustment suggests a student can observe but not complete a task (e.g., a student may
observe but not do a patient's medication history). Level 2 is execution with direct and
proactive supervision (e.g., student will perform the medication history with the
pharmacist in the room providing advice). Level 3 is performance with quickly available
(reactive) supervision (e.g., the student will perform the medication history alone with the
pharmacist in the next room should help be needed). Level 4 is execution with
supervision from a distance or when asked for by the student (e.g., a student can be freely
trusted to perform the history without any help). Level 5 is the ability to teach someone
else the skill (ten Cate, 2013).
Questions related to the levels of entrustment a student should achieve upon
graduation were devised for each of the AACP EPA statements. The level of entrustment
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chosen as the starting point for round one was a Level 3 (performance with quickly
available [reactive] supervision). This level of entrustment was chosen to be in-line with
the recommendations from the AACP Academic Affairs Standing Committee, who
developed the EPAs (Jarrett et al., 2018). For example, participants were presented with
an EPA with a level of entrustment: “Collect information to identify a patient’s
medication-related problems and health-related needs (Level 3).” Participants were then
asked to report their level of agreement with the alignment of that level of entrustment for
that EPA on a four-point Likert scale (1 = Strongly Disagree to 4= Strongly Agree)
similar to Research Question Two. For round one, participants were also given a fifth
option of choosing "depends on the role." The "depends on the role" would indicate that
respondents felt the level of entrustment would change depending on the EPA's role
mapping. Removal of this option occurred for rounds two and three.
Round One. Just as for Research Question Two, aggregation of the results from the
selected-response (Likert scale) questions into three categories occurred for Round One:
Category 1 - Strongly Agree/Agree, Category 2 – Disagree/ Strongly Disagree, and
Category 3 – “depends on the role” from each panelist's response to determine if
consensus was achieved. Rounds two and three only used Category 1 and Category 2 for
aggregation. Computation of the percent number of responses for each category then
occurred for each question. For example, if 50 participants completed the survey with 30
indicating Strongly Agree and ten indicating Agree for a question, then the percent
response for Category 1 (Strongly Agree/Agree) would be 80%. For there to be consensus
on the competency/EPA alignment, there had to be a category score of ≥ 80% Strongly
Agree/Agree for the question. A review of constructed-response comments occurred for
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any question that did not achieve consensus (≥ 80% agreement) using structural coding
via NiViVo software (NiViVo qualitative data analysis software, 2019). Once a mapping
reached consensus (≥ 80% Strongly Agree/Agree), it was no longer included in
subsequent round surveys.
The questions related to the EPA levels of entrustment were included in the same
round one survey as Research Question Two. Participants did not have to complete both
sections of the survey to have their data included. The first round Delphi survey for
Research Question Three had a total of 21 participants respond (33.3% response rate).
Five (23.8%) of the respondents had >20 years of experience, seven (33.3%) had 11-20
years of experience, seven (33.3%) had 5-10 years of experience, and two (9.5%) had <5
years of experience. Eight (38.1%) of respondents were male, and 13 (61.9%) were
female. Fifteen (71.4%) of respondents have practice sites in urban settings and six (28.6)
practice in rural settings. Five (23.8%) respondents were acute care pharmacists, eight
(38.1%) were ambulatory care pharmacists, four (19.0%) were community pharmacists,
two (9.5%) were in academia, and two (9.5%) were in other types of practice.
Of the fifteen EPAs, only four achieved consensus for students to meet a Level 3
(performance with quickly available [reactive] supervision) of entrustment upon
graduation after the first round Delphi survey. Respondents did not feel the four EPAs
that achieved consensus had a different level of entrustment depending on the role
mapping. For the remaining eleven EPAs, respondents felt the level of entrustment would
vary depending on the role mapping from Research Question Two (Appendix F).
Respondents also felt that students should meet higher levels of entrustment for two of
the EPAs upon graduation. These EPAs were "Collect information to identify a patient's
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medication-related problems and health-related needs" and "Educate patients and
professional colleagues regarding the appropriate use of medication." Respondents felt
that students should meet a Level 4 (execution with supervision from a distance or when
asked for by the student) for entrustment upon graduation for these EPAs. For six of the
EPAs, respondents felt the level of entrustment should be less than 3 upon graduation.
For these six EPAs, respondents felt students should only achieve a Level 2 (execution
with direct and proactive supervision) upon graduation. Table 16 shows the full results.
The other comment that was constant for all the EPAs is the respondents were not sure
where in the curriculum students were being assessed.
Table 16
EPAs with Level of Entrustment
EPAs

Collect information to identify a
patient's medication-related problems
and health-related needs. (Level 3)
Analyze information to determine the
effects of medication therapy, identify
medication-related problem, and
prioritize health-related needs.

Strongly Disagree/ Depends Consensus
Agree/
Strongly on Role Achieved
Agree
Disagree
72.7%
4.5
22.7%
No

70%

5%

25%

No

Establish patient-centered goals and
create a care plan for a patient in
collaboration with the patient,
caregiver(s), and other health
professionals that are evidence-based
and cost-effective. (Level 3)

71.4%

4.8%

23.8%

No

Implement a care plan in collaboration
with the patient, caregivers, and other
health professionals. (Level 3)

71.4%

14.3%

14.3%

No
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Follow-up and monitor a care plan.
(Level 3)

81.0%

4.8%

14.3%

Yes

Collaborate as a member of an IPE
team. (Level 3)

81.0%

0%

19.0%

Yes

Identify patients at risk for prevalent
disease in a population. (Level 3)

85.7%

0%

14.3%

Yes

Minimize adverse drug events and
medications in a population. (Level 3)

71.4%

4.8%

23.8%

No

Maximize the appropriate use of
medications in a population. (Level 3)

76.2%

9.5%

14.3%

No

Ensure that patients have been
immunized against vaccinepreventable diseases. (Level 3)

95.2%

0%

4.8%

Yes

Educate patients and professional
colleagues regarding the appropriate
use of medication. (Level 3)

76.2%

0%

23.8%

No

Use evidence-based information to
advance patient care. (Level 3)

76.2%

0%

23.8%

No

Oversee the pharmacy operations for
an assigned shift. (Level 3)

38.1%

33.3%

28.6%

No

Full-fill a medication order. (Level 3)

71.4%

9.5%

19.0%

No

Create a written plan for continuous
professional development. (Level 3)

76.2%

9.5%

14.3%

No

Based on the first round of the Delphi survey for Research Question Three,
respondents were unsure where in the curriculum students were being assessed and felt
that most of the EPAs' level of entrustment depended on the role mapping. For the second
round Delphi survey, directions to the respondents were made more explicit that
entrustment levels are being assigned based on students at graduation (in their final
rotation). The survey for round two asked respondents whether they agree with the EPAs'
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levels of entrustment based on their role mapping. Levels of entrustment were also
adjusted up or down based on participants’ comments. The combination of this updated
survey and changes from Research Question Two was sent to the same group of
participants as the round one survey.
Round Two. The second round of the Delphi survey followed the same survey
procedure as round one, except questions were only asked on items that did not meet
consensus during round one (11/15 [73.3%] did not meet consensus). The same
participant group was used as round one as well. The second round Delphi survey had a
total of 18 participants respond (28.6% response rate). Six (33.3%%) of the respondents
had >20 years of experience, five (27.8%) had 11-20 years of experience, seven (38.9%)
had 5-10 years of experience, and zero (80%) had <5 years of experience. Six (33.3%%)
respondents were male, 11 (61.1%) were female, and one (5.6%) preferred not to answer.
Fifteen (83.3%) had practice sites in urban locations, and three (16.7%) had rural practice
sites. One (5.6%) respondent was an acute care pharmacist, nine (50%) were ambulatory
care pharmacists, two (11.1%) were community pharmacists, two (11.1%) were in
academia, two (11.1%) were hospital pharmacists, and two (11.1%) were in management.
Usage of the same five levels of entrustment occurred for this survey as in Round
One. Level 1 entrustment suggests a student can observe but not complete a task (e.g., a
student may observe but not do a medication history on a patient). Level 2 is execution
with direct and proactive supervision (e.g., student will perform the medication history
with the pharmacist in the room providing advice). Level 3 is performance with quickly
available (reactive) supervision (e.g., the student will perform the medication history
alone with the pharmacist in the next room should help be needed). Level 4 is execution
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with supervision from a distance or when asked for by the student (e.g., a student can be
freely trusted to perform the history without any help). Level 5 is the ability to teach
someone else the skill (ten Cate, 2013).
Per the results from round one, EPA mapping to the core roles with levels of
entrustment provided by the participants’ comments occurred. The knowledge role had
five EPAs mapped to it all with Level 3 entrustment (performance with quickly available
[reactive] supervision). Consensus was achieved (>80% Strongly Agree/Agree) for the
mapping to this role, so the inclusion of these EPAs was not needed in the round three
survey. The results are below in Table 17. Participants felt that students should have the
knowledge related to each of the EPA statements and should be trusted to discuss this
knowledge with minor involvement of the preceptor. The only issue is that the EPAs
listed under this role do not cover all the knowledge components required to be
competent in this role adequately.
Table 17
EPAs with Level of Entrustment for the Knowledge Role
EPAs

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
EPA: Analyze information to determine the effects 88.9%
11.1%
Yes
of medication therapy, identify medication-related
problems, and prioritize health-related needs.
(Level 3)
EPA: Establish patient-centered goals and create a
care plan for a patient in collaboration with the
patient, caregiver(s), and other health
professionals that are evidence-based and costeffective. (Level 3)
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94.4%

5.6%

Yes

EPA: Educate patients and professional colleagues
regarding the appropriate use of medication.
(Level 3)

88.9%

11.1%

Yes

EPA: Use evidence-based information to advance
patient care. (Level 3)

94.4%

5.6%

Yes

The patient care skills role has ten EPAs mapped to it. Nine of the ten EPAs achieved
consensus (≥80% Strongly Agree/Agree) after round two. The inclusion of these nine
EPAs did not occur in the round three Delphi survey. One EPA, “Implement a care plan
in collaboration with the patient, caregivers, and other healthcare professionals,” did not
achieve consensus at an entrustment level 2 (execution with direct and proactive
supervision). Delphi participants felt this EPA should be at least a Level 3 (performance
with quickly available [reactive] supervision) at graduation. Table 18 contains the survey
results for this role. Participants felt that four of the EPAs related to analyzing
information from patients, establishing patient-centered goals, full-filling medication
orders, and using evidence-based information students should achieve a Level 3
(performance with quickly available [reactive] supervision) at graduation. Participants
felt that the ability to collect information from patients should be at a Level 4 (execution
with supervision from a distance or asked for by the student). Lastly, three of the EPAs
related to maximizing medication use in a population, minimizing adverse drug events,
and overseeing pharmacy operations, participants felt students should achieve a Level 2
(execution with direct and proactive supervision) upon graduation. Overall the EPAs
mapped to this role match well with the competencies mapped and the role itself, except
for Educator, which had EPAs which were not role-specific. The problem is that the
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EPAs are not specific for only this role, so how is a school/college to know if the student
is achieving this role when meeting the EPA or another role?
Table 18
EPAs with Level of Entrustment for the Patient Care Skills Role
EPAs
EPA: Collect information to identify a patient’s
medication-related problems and health-related
needs. (Level 4)

Strongly
Agree/
Agree
94.4%

Disagree/ Consensus
Strongly Achieved
Disagree
5.6%
Yes

EPA: Analyze information to determine the
effects of medication therapy, identify
medication-related problems, and prioritize
health-related needs. (Level 3)

88.9%

11.1%

Yes

EPA: Establish patient-centered goals and create a
care plan for a patient in collaboration with the
patient, caregiver(s), and other health
professionals that are evidence-based and costeffective. (Level 3)

94.4%

5.6%

Yes

EPA: Implement a care plan in collaboration with
the patient, caregivers, and other health
professionals. (Level 2)

66.7%

33.3%

No

EPA: Maximize the appropriate use of
medications in a population. (Level 2)

94.4%

5.6%

Yes

EPA: Minimize adverse drug events and
medications in a population. (Level 2)

94.4%

5.6%

Yes

EPA: Oversee the pharmacy operations for an
assigned shift. (Level 2)

100%

0%

Yes

EPA: Full-fill a medication order. (Level 3)

88.9%

11.1%

Yes

EPA: Educate patients and professional
colleagues regarding the appropriate use of
medication. (Level 4)

88.2%

11.8%

Yes
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Use evidence-based information to advance
patient care. (Level 3)

88.9%

11.1%

Yes

The professionalism role has four EPAs mapped to it with levels of entrustment
ranging from 2-4. All ten EPAs achieved consensus (≥80% Strongly Agree/Agree) after
round two. The inclusion of these EPAs did not occur in round three of the Delphi
survey. Table 19 contains the survey results for this role. Participants felt that students
should achieve an entrustment level of 2 upon graduation (execution with direct and
proactive supervision) for the EPA related to overseeing pharmacy operations. Students
should achieve an entrustment level of 3 (performance with quickly available [reactive]
supervision) for items related to developing plans for professional development and using
evidence-based medicine. Lastly, students should achieve an entrustment level of 4
(execution with supervision from a distance or when asked by the student) to educate
patients and colleagues. The EPAs mapped to this role are not specific for the definitions
and competencies mapped for this role. The lack of specificity means that
schools/colleges will need to further define these for themselves to know if students are
achieving this role.
Table 19
EPAs with Level of Entrustment for the Professionalism Role
EPAs

EPA: Oversee the pharmacy operations for an
assigned shift. (Level 2)
EPA: Create a written plan for continuous
professional development (Level 3)
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Strongly
Agree/
Agree
100%

100%

Disagree/ Consensus
Strongly Achieved
Disagree
0%
Yes

0%

Yes

EPA: Educate patients and professional
colleagues regarding the appropriate use of
medication. (Level 4)

83.3%

16.7%

Yes

EPA: Use evidence-based information to advance
patient care. (Level 3)

88.9%

11.1%

Yes

The scholarship role had six EPAs mapped to it with levels of entrustment ranging
from 2-4. Four of the EPAs achieved consensus (≥80% Strongly Agree/Agree) after
round two with entrustment levels from 2-4. The inclusion of these EPAs did not occur in
round three of the Delphi survey. The two EPAs that met consensus were related to
minimizing adverse drug events and maximizing medication use in the population.
Participants felt that students should achieve an entrustment level of 2 (execution with
direct and proactive supervision ) upon graduation. Two of the EPAs did not achieve
consensus. The EPA “Implement a care plan in collaboration with the patient, caregivers,
and other health professionals” did not achieve consensus at a Level 2 (execution with
direct and proactive supervision). Participants felt this EPA should be at least a Level 3
(performance with quickly available [reactive] supervision). The EPA “Educate patients
and professional colleagues regarding the appropriate use of medication” did not achieve
consensus at a Level 4 (execution with supervision from a distance or when asked for by
the student). Participants felt this EPA should be a Level 3 [performance with quickly
available (reactive) supervision], a different level of attainment than in other roles. Some
participants mentioned that maybe this EPA should not be under this role. The EPA was
left, however, because it reached consensus under Research Question 2. The inclusion of
these two EPAs occurred in the round three Delphi Survey. Table 20 contains the survey
results. Just as discussed in previous roles, while these EPAs do somewhat fit this role,
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they are not explicitly written for this role, making it hard to know which role the student
is achieving.
Table 20
EPAs with Level of Entrustment for the Scholarship Role
EPAs

EPA: Implement a care plan in collaboration with
the patient, caregivers, and other health
professionals. (Level 2)

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
61.1%
38.9%
No

EPA: Minimize adverse drug events and
medications in a population. (Level 2)

83.3%

16.7%

Yes

EPA: Maximize the appropriate use of
medications in a population. (Level 2)

83.3%

16.7%

Yes

EPA: Educate patients and professional colleagues
regarding the appropriate use of medication.
(Level 4)
EPA: Use evidence-based information to advance
patient care. (Level 3)

77.8%

22.2%

No

88.9%

11.1%

Yes

EPA: Oversee the pharmacy operations for an
assigned shift. (Level 2)

88.9%

11.1%

Yes

The systems-based/practice manager role had eight EPAs mapped to it with
entrustment levels ranging from 2-4. All ten EPAs achieved consensus (≥80% Strongly
Agree/Agree) after round two. The inclusion of these EPAs did not occur in round three
of the Delphi survey. Table 21 contains the survey results for this role. Participants felt
that students should achieve an entrustment level 2 (execution with direct and proactive
supervision ) for EPAs to minimize adverse drug events, maximize the appropriate use of
medications, and oversee pharmacy operations. Students should achieve an entrustment
level 3 (performance with quickly available [reactive] supervision) for items related to
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establishing patient-centered goals and care plans, implementing care plans, and fullfilling medication orders. Lastly, students should achieve an entrustment level of 4
(execution with supervision from a distance or when asked by the student) for EPAs
related to collecting patient information and educating patients and colleagues. These
EPAs' entrustment levels are the same as those seen for previous roles for these EPAs.
While these EPAs do fit under this role, they are written more at the patient level than at
the broader systems-level leaving it to the school/college to define attainment for
themselves. There are also no EPAs related to professional advocacy (not advocating for
the good of the patient but advocating for the good of the profession and its place in
healthcare), health outcomes, quality improvement, transitions of care, and public health.
Table 21
EPAs with Level of Entrustment for the Systems-based/Practice Manager Role
EPAs
EPA: Collect information to identify a patient’s
medication-related problems and health-related
needs. (Level 4)

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
94.4%
5.6%
Yes

EPA: Establish patient-centered goals and create a
care plan for a patient in collaboration with the
patient, caregiver(s), and other health
professionals that are evidence-based and costeffective. (Level 3)

88.9%

11.1%

Yes

EPA: Implement a care plan in collaboration with
the patient, caregivers, and other health
professionals. (Level 3)

88.9%

11.1%

Yes

EPA: Minimize adverse drug events and
medications in a population. (Level 2)

94.4%

5.6%

Yes

EPA: Maximize the appropriate use of
medications in a population. (Level 2)

94.4%

5.6%

Yes
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EPA: Oversee the pharmacy operations for an
assigned shift. (Level 2)

100%

0%

Yes

EPA: Full-fill a medication order. (Level 3)

83.3%

16.7%

Yes

EPA: Educate patients and professional colleagues
regarding the appropriate use of medication.
(Level 4)

88.9%

11.1%

Yes

The collaborator role had four EPAs mapped to it with levels of entrustment ranging
from 2-4. Three of the EPA achieved consensus (≥80% Strongly Agree/Agree) after
round two with entrustment levels from 2-4. The inclusion of these EPAs did not occur in
round three of the Delphi survey. Participants felt that students should achieve
entrustment levels of 2 (execution with direct and proactive supervision) for EPAs related
to minimizing adverse drug events and maximizing the appropriate use of medications.
Students should achieve an entrustment level of 4 (execution with supervision from a
distance or when asked for by the student) for the EPA related to educating patients.
These entrustment levels are the same as other roles to which these EPAs are mapped.
One of the EPAs did not achieve consensus: “Implement a care plan in collaboration with
the patient, caregivers, and other health professionals” at a Level of 2 (execution with
direct and proactive supervision). Participants felt this EPA should be at least a Level 3
(performance with quickly available [reactive] supervision). The inclusion of this EPA
did occur in the round three Delphi Survey. Table 22 contains the survey results and
comments for this role. Like the other roles, the EPAs mapped to this role do fit, but they
are not role-specific, leaving it up to schools/colleges of pharmacy to further define.
There is also no EPA related to conflict management.
Table 22
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EPAs with Level of Entrustment for the Collaborator Role
EPAs

EPA: Implement a care plan in collaboration with
the patient, caregivers, and other health
professionals. (Level 2)

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
72.2%
27.8%
No

EPA: Educate patients and professional colleagues
regarding the appropriate use of medication.
(Level 4)

83.3%

16.7%

Yes

EPA: Minimize adverse drug events and
medications in a population. (Level 2)

94.4%

5.6%

Yes

EPA: Maximize the appropriate use of
medications in a population. (Level 2)

94.4%

5.6%

Yes

The advocate/health promoter role has six EPAs mapped to it with entrustment levels
ranging from 2-4. All six EPAs achieved consensus (≥80% Strongly agree/Agree) after
round two. The inclusion of these EPAs did not occur in round three of the Delphi
survey. Table 23 contains the survey results for this role. Participants felt that students
should achieve an entrustment level of 2 (execution with direct and proactive
supervision) for EPAs to minimize adverse drug events and maximize appropriate
medication use. Students should achieve an entrustment Level 3 (performance with
quickly available [reactive] supervision) for EPAs to establish patient-centered goals and
use evidence-based medicine. Lastly, students should achieve an entrustment Level 4
(execution with supervision from a distance or when asked by the student) for EPAs
related to educating patients/colleagues and collecting patient information. These levels
of entrustment are the same as recommended for previous roles to which these EPAs
were mapped. Once again, these EPAs do fit under this role, but they are not rolespecific, leaving schools/colleges to define the EPA further.
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Table 23
EPAs with Level of Entrustment for the Advocate/Health Promotor Role
EPAs

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
94.4%
5.6%
Yes

EPA: Minimize adverse drug events and
medications in a population. (Level 2)
EPA: Maximize the appropriate use of
medications in a population. (Level 2)

94.4%

5.6%

Yes

EPA: Educate patients and professional
colleagues regarding the appropriate use of
medication. (Level 4)

88.9%

11.1%

Yes

EPA: Establish patient-centered goals and create
a care plan for a patient in collaboration with the
patient, caregiver(s), and other health
professionals that are evidence-based and costeffective. (Level 3)

88.9%

11.1%

Yes

EPA: Collect information to identify a patient’s
medication-related problems and health-related
needs. (Level 4)

83.3%

16.7%

Yes

EPA: Use evidence-based information to advance
patient care. (Level 3)

88.9%

11.1%

Yes

After round two, there were still four EPAs that had not met consensus for their
level of entrustment for the roles they were mapped to in Research Question Two. These
EPAs fell in patient care skills, scholarship, and collaborator role. The EPA not meeting
consensus in the patient care skills role was increased to an entrustment level of 3
(performance with quickly available [reactive] supervision). The two EPAs under the
scholarship role were also increased to an entrustment level of 3 as was the one EPA
under collaborator. The updated survey was sent to the same participants as rounds one
and two.
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Round Three. The third round of the Delphi survey followed the same survey
procedure as round one and two, except questions were only asked on items that did not
meet consensus during round two (4/117 [3.4%] EPA mappings to the roles). The same
participant group was used as round one as well. The second round Delphi survey had a
total of 13 participants respond (20.6% response rate). Five (38.5%) of the respondents
had >20 years of experience, two (15.4%) had 11-20 years of experience, four (30.8%)
had 5-10 years of experience, and two (15.4%) had <5 years of experience. Three
(23.1%) respondents were male, Nine (69.2%) were female, and one (7.7%) preferred not
to answer. Nine (69.2%) had practice sites in urban locations and four (30.8%) had rural
practice sites. One (7.7%) respondent was an academic pharmacist, six (46.2%) were
ambulatory care pharmacists, two (15.4%) were community pharmacists, and four
(30.8%) were hospital pharmacists.
Usage of the same five levels of entrustment occurred for this survey as in rounds
one and two. Level 1 entrustment suggests a student can observe but not complete a task
(e.g., a student may observe but not do a medication history on a patient). Level 2 is
execution with direct and proactive supervision (e.g., student will perform the medication
history with the pharmacist in the room providing advice). Level 3 is performance with
quickly available (reactive) supervision (e.g., the student will perform the medication
history alone with the pharmacist in the next room should help be needed). Level 4 is
execution with supervision from a distance or when asked for by the student (e.g., a
student can be freely trusted to perform the history without any help). Level 5 is the
ability to teach someone else the skill (ten Cate, 2013).
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Three roles, patient care skills, scholarship, and collaborator, had EPAs mapped
to them that did not reach consensus regarding their level of entrustment during round
two. After round three, the one EPA under patient care skills related to implementing a
care plan and both EPAs under scholarship related to implementing a care plan and
educating patients/colleagues met consensus (≥80% Strongly Agree/Agree). However, the
EPA under collaborator did not meet consensus. The EPA that did not meet consensus
under collaborator was “Implement a care plan in collaboration with the patient,
caregivers, and other health professionals.” Delphi participants felt assigning a level was
difficult for this EPA as collaborating with other health care professionals requires time
to build relationships, which is sometimes hard given the short time students are on
rotation. Also, the ability to do this EPA is dependent on the complexity of the patient
care plans. Table 24 shows the full results from the third round.
Table 24
EPAs with Level of Entrustment for Patient Care Skills, Scholarship, and Collaborator
EPAs

Strongly Disagree/ Consensus
Agree/
Strongly Achieved
Agree
Disagree
Patient Care Skills
EPA: Implement a care plan in collaboration with
92.3%
7.7%
Yes
the patient, caregivers, and other health
professionals. (Level 3)
Scholarship
EPA: Implement a care plan in collaboration with
84.6%
15.4%
Yes
the patient, caregivers, and other health
professionals. (Level 3)
EPA: Educate patients and professional
colleagues regarding the appropriate use of
medication. (Level 3)
Collaborator
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84.6%

15.4%

Yes

EPA: Implement a care plan in collaboration with
the patient, caregivers, and other health
professionals. (Level 3)

76.9%

23.1%

No

The final overall competency and EPA with levels of entrustment mapping
(Appendix F) answers Research Question 3: What level of entrustment should pharmacy
graduates be expected to achieve for each EPA? All but five of the EPA statements were
determined to have levels of entrustment at Level 3. “Collect information to identify a
patient’s medication-related problems and health-related needs” was given a Level 4
(execution with supervision from a distance or when asked for by the student )
entrustment regardless of the role and competency mapping. “Maximize the appropriate
use of medication in a population and “Minimize adverse drug events and medications in
a population” were a Level 2 (execution with direct and proactive supervision)
entrustment regardless of the role and competency mapping. “Oversee the pharmacy
operation for an assigned shift” also had a Level 2 entrustment regardless of the role and
competency mapping.
The EPA, “Educate patients and professional colleagues regarding the appropriate
use of medication,” was given different entrustment levels depending on the role
mapping. The level of entrustment given was consistent within the role and did not
depend on the competency it was mapped too. For the roles of knowledge and
scholarship, the EPA had a Level 3 [performance with quickly available (reactive)
supervision] entrustment. Whereas for patient care skills, professionalism, systems-based
practice/manager, collaborator, and advocate/health promoter, a Level 4 entrustment was
given.
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Only one EPA did not meet consensus for its entrustment level upon completion
of the third Delphi round. This EPA was “Implement a care plan in collaboration with the
patient, caregivers, and other health professionals, under the Collaborator role. This EPA,
however, did meet consensus for a Level 3 [performance with quickly available (reactive)
supervision] entrustment in other roles. This EPA will remain under the collaborator role
in the mapping but will not be assigned a level of entrustment since there was no
consensus on a level.
Upon the conclusion of this study, all three research questions were answered.
The final core role proposal in Appendix D answers Research Question One: What are
the core professional roles pharmacy programs believe students should be able to
demonstrate competency in upon graduation? Pharmacy expert became the central role
of a pharmacist with several core roles defining it. The core roles included knowledge,
patient care skills, professionalism, scholarship, systems-based practice, and collaborator.
The core roles were then used to answer research questions two and three:
1. What is the alignment of the current pharmacy competencies and entrustable
professional activities (EPAs) to the core professional roles?
2. What level of entrustment should pharmacy graduates be expected to achieve for
each EPA?
The alignment of the current pharmacy competencies and EPAs with their levels of
entrustments developed during the Delphi process for Research Questions Two and Three
is in Appendix F. Consensus occurred on all competency and EPA mappings. Consensus
occurred on all but one of the EPA levels of entrustment under the collaborator role.
Overall, the entrustment levels were consistent for all EPAs regardless of the role and
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competency mapping except for the EPA related to education. The EPAs related to
educating patients and colleagues did have a level of entrustment that varied depending
on the role mapping. Once under a role, however, the EPA had the same level of
entrustment regardless of the role's competency mapping. More research is needed to
verify this pilot study's results and determine why the EPA related to implementation did
not reach consensus.
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CHAPTER 5: DISCUSSION
In 2013, pharmacy programs developed and subsequently implemented pharmacy
competencies (CAPE outcomes) and EPAs to mirror medicine to help define and assess
the knowledge, skills, and attitudes needed by students upon graduation (Medina et al.,
2013; Pittenger et al., 2017). While the CAPE outcomes are required to be used by
schools/colleges for accreditation, EPAs are not. EPAs also do not have an accreditation
required defined level of entrustment, which allows pharmacy programs to set this for
themselves. Consequently, this inconsistency means that students may be prepared
differently for practice depending on where they graduate and may lead to graduates not
being as prepared for safe and effective practice as seen in other professions (Frank et al.,
2017; Josiah Macy Jr. Foundation, 2017). Having a defined set of pharmacy roles with
competency and EPA mapping along with a set level of entrustment based on progression
through a professional’s career may be one way to help ensure minimal preparation for
all graduates. The purpose of this project was to investigate the extent to which a
consensus exists, if any, among pharmacy professionals regarding core practice-ready
roles for graduates that then align to current pharmacy competencies and EPA statements,
with levels of entrustment. In particular, the study addressed three research questions
centered around the development of graduate core practice-ready roles aligned to
competencies and EPAs with levels of entrustment using a two-phase embedded mixedmethod design.
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This chapter discusses the implications of the results of this study with prior research
presented in Chapter 2. The discussion will include analyzing how the core roles
developed during this project compare with the current pharmacy competencies. It will
also review the literature on current validity and definition of entrustment levels for the
EPAs, evolving pharmacy practice, employer expectations, and other healthcare
professions to determine any gaps in the new roles, competencies, and/or EPAs. Next, a
discussion on how the roles and competency/EPA mapping can contribute to the
development of school/college pedagogies and assessment to ensure all students are
practice-ready upon graduation occurs. Lastly, study limitations, as well as future
research and practice implications, are discussed.
The current pharmacy competencies and EPAs are perceived as mapping to the
core roles within this study, with some missing competencies. These missing
competencies include transitions of care, role modeling, handling difficult conversations,
handling difficult situations, conflict management, stress management, and areas related
to patient privacy, sensitivity to patients, and ethics. This mapping also reveals that many
of the pharmacy competencies map to multiple core roles and are not specific for the role.
The lack of specificity regarding the competencies and EPAs makes assessing whether a
student is competent for a particular role more difficult for schools/colleges of pharmacy.
If a student masters the competency and EPAs related to Problem Solver, for example,
are they competent for the role of patient care skills, collaborator, or both? Work is
needed to review the current competencies and EPAs to ensure they are specific for the
core role to which they are mapped.
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In regards to the EPAs, the results from this study mirror the EPA face validity
results seen in Haines et al. (2018) but are different than results seen in VanLangen et al.
(2019) and Pittenger et al. (2019). Haines et al. reported greater than 75% agreement that
the current 15 pharmacy EPA statements describe activities pertinent to pharmacy
practice, which was echoed by the participants in the Delphi portion of this project. The
difference between this study and the Haines et al. face validity study is Haines et al. just
looked at the EPAs themselves, not how they mapped to the current pharmacy
competencies. VanLangen et al. and Pittenger et al. both found different results regarding
the usefulness of the EPAs in pharmacy practice. VanLangen et al. and Pittenger et al.
found that the EPA related to identifying risk for prevalent diseases in a population was
not an essential skill for students to have upon graduation. In contrast, this study found
that all EPAs were essential and mapped to at least one competency. However, the EPA
assessed did depend on the core role the competency mapped too. The results from this
study add to the pharmacy literature by asking practitioners if they felt the current EPAs
mapped correctly to the pharmacy competencies based on the roles the competency was
mapped too. Correct mapping of the EPAs to the pharmacy competencies is vital to
ensure the EPAs are adequately assessing whether students are ready to perform the core
roles that define a pharmacist’s scope of practice. The next steps will be to conduct a
more extensive face validity study that includes all stakeholders to ensure the core roles
and mappings developed in this study are correct.
Despite participants initially feeling the level of entrustment would depend on the
role to which the EPA mapped, after this project, all but one of the EPAs had the same
level of entrustment regardless of the role and competency mapping. There was one EPA
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that participants felt did have a different level of entrustment based on the role to which it
mapped. “Educate patients and professional colleagues regarding the appropriate use of
medication,” was given a different level of entrustment depending on the role mapping.
The level of entrustment given was consistent within the role and did not depend on the
competency it was mapped too. For the roles of knowledge and scholarship, the EPA had
a Level 3 entrustment, which is in line with the AACP recommendation (Jarrett et al.,
2018). Whereas for patient care skills, professionalism, systems-based practice/manager,
collaborator, and advocate/health promoter, a Level 4 entrustment was given. Only one
EPA did not meet consensus for its entrustment level upon completion of the third Delphi
round. This EPA was “Implement a care plan in collaboration with the patient,
caregivers, and other health professionals, under the Collaborator role. This EPA,
however, did meet consensus for a Level 3 entrustment in other role mappings. These
differences in the level of entrustment depending on the role mapping for certain EPAs
needs researching further. Is there truly a different level of entrustment required for the
EPA at the role, is the EPA maybe not worded correctly, or is pharmacy not defining
levels of entrustment in a manner that works for pharmacy education since there is no
residency requirement like medicine?
Data from this study are similar to the medical literature data regarding student
EPA entrustment attainment upon graduation. The medical literature suggests that
medical students should reach the level of indirect supervision (EPA level 3=without a
supervisor’s physical presence but quickly available) upon graduation from medical
school (Lomis et al., 2017). This level of entrustment makes sense, given that medical
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students are required to complete residency training before starting their careers. Data
from the pharmacy literature is a little more conflicting.
Pharmacy faculty and students cannot agree on the level of entrustment necessary
upon graduation. VanLangen et al. (2019) found that faulty agreed that 67% (10 out of
the 15) of the EPAs had a level three entrustment upon graduation, which is similar in
number to the results from this study [60% (nine out of 15)]. On the other hand, students
felt they were a level 4 entrustment for all EPAs except collaborating on interprofessional
teams and ensuring appropriate vaccinations for which they felt they were a Level 5 upon
graduation. This study found the Delphi participants feel that students should achieve a
lower level of entrustment attainment than students feel they can obtain upon graduation.
Interestingly, students studied in Pittenger et al. (2019) did not feel as prepared
for overseeing pharmacy operations despite saying they felt they were a Level 4
entrustment. This unpreparedness feeling would match the Delphi participants’ thoughts
on students only achieving a Level 2 entrustment upon graduation. Comparing the results
of this study to the pharmacy literature indicates the need for more research in the area of
EPAs for pharmacy education. As discussed previously, is there truly a different level of
entrustment required for the EPA at the role mapped? The EPA may not be worded
correctly for that role, or is pharmacy not defining entrustment levels in a manner that
works for pharmacy education since there is no residency requirement like medicine?
These are the next questions that need answering.
Before reworking the current pharmacy competencies/EPAs to match the newly
developed core roles, the literature on evolving pharmacy practice and employer
expectations need reviewing to ensure these new roles cover all areas needed for
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graduates to be practice-ready. Schools/colleges of pharmacy need to ensure they teach
the knowledge and skills requested by employers to ensure students are employable upon
graduation. Based on a review of the current literature, pharmacy employers are looking
for graduates that have not only the CAPE outcomes but also have additional skills
related to relationship building, adaptability, conflict resolution, time management, and
curiosity (Alston et al., 2017; American College of Clinical Pharmacy, 2014; Augustine
et al., 2018; Chanakit et al., 2015; Greinter & Knebel, 2003; Hester et al., 2014; KennieKaulbach et al., 2012; McLaughlin et al., 2017; O’Sullivan et al., 2017; Saseen et al.,
2017; Thompson et al., 2012; Vlasses et al., 2013). These missing skills requested by
employers create a disconnect between what employers want and what they are getting.
The core roles developed during this study encompass these additional skills that
employers want students to have before graduation. Coverage of relationship-building
occurs in patient care skills, collaborator, and advocate/health promoter. Coverage of
adaptability, conflict resolution, and innovation occurs in the system-based
practice/manager role. Curiosity coverage is under scholarship. The problem is that the
current competencies and EPAs mapped to these core roles do not address these specific
areas. The lack of specificity would mean that schools/colleges of pharmacy would not be
designing pedagogies and assessments to address these areas, which employers consider
necessary to hire someone upon graduation. Not only do the core roles contain the skills
requested by employers, but they also contain the skills needed for students to be
practice-ready for the current healthcare trends that are driving the transformation of the
US healthcare system. These trends include changes in (a) technology (e.g., telehealth,
telemedicine), (b) healthcare insurance (move to high deductible plans), (c) workforce,
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(d) drug supply chains, and, lastly, (e) regulatory (Affordable Health Care Act;
Vogenberg & Santilli, 2018).
All the core roles developed during this study will help to prepare students for the
healthcare trends of telehealth, telemedicine, and consumer wearables (Vogenberg &
Santilli, 2018). Knowledge around the interpretation of healthcare data using technology
is essential to allow pharmacists to take a more active role in patient treatment in the
community setting leading to new and innovative pharmacy practice models (Vogenberg
& Santilli, 2018). To develop these new innovative practice models, pharmacists will
need to be continually learning and developing new skills through evidence-based
medicine, which is in the scholarship role. The change in the drug delivery models also
makes it challenging to ensure everyone has access to all the patient’s accurate medical
records as patients are now receiving care and medications through multiple places
(Vogenberg & Santilli, 2018). Pharmacists need to be part of the teams that look for ways
to increase access to medical records needed to treat patients across transitions of care
such as the hospital to community and community to the hospital while still maintaining a
patient’s healthcare confidentiality (Vogenberg & Santilli, 2018). Patient care skills such
as communication, collection and assessment of information, and the ability to monitor
therapy along with the roles of collaborator and advocate/health promoter will be needed
to help pharmacists develop cost-effective treatment plans using these new areas of
technology (Vogenberg & Santilli, 2018). The core role definitions design is to ensure
students would be prepared to design treatment plans and use technology. However, the
competencies and EPAs that schools/colleges of pharmacy use to design pedagogies and
assessments around these roles are not specific enough to ensure the same baseline
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knowledge is provided to all students regardless of the school/college attended. Also,
specific competencies related to contributing to scholarship and the evidence-based
medicine literature are lacking. These missing competencies are a crucial oversight. The
best way to ensure pharmacy can continue to increase its role on the healthcare team is to
have people who are willing to publish and discuss the innovative practice models they
are using to take care of patients.
The core roles of knowledge and systems-based practice/manager help to prepare
students for the trend of healthcare insurance moving to high deductibles. The knowledge
role trains students to integrate the knowledge of biomedical and psychosocial science
related to health and disease and clinical science to design patient treatment plans that are
cost-effective (Vogenberg & Santilli, 2018). The system-based practice/manager role
helps prepare pharmacists to work with both state and national stakeholders to provide
pharmacists with ways to bill for patient care services. Billing will be necessary as
pharmacy tries to develop innovative practices that take advantage of telehealth and
telemedicine opportunities. This role also helps to prepare pharmacists that can work in
the broader healthcare landscape to help physicians and other healthcare practitioners
choose cost-effective treatments in broader healthcare system settings (Vogenberg &
Santilli, 2018). The problem is that the competencies and EPAs listed under these roles
occur under other roles, so how would a school/college know if a student was competent
in this role categorically instead of one of the other roles. Care needs taking to ensure the
competencies and EPAs listed under each of the roles are specific for that role to ensure
schools/colleges understand what pedagogies and assessments are needed to ensure
students are practice-ready for these healthcare trends.
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Patient care skills such as communicating with multiple different entities
(patients, caregivers, providers, and insurance companies) will be necessary as the
workforce continues to contain a mix of younger and older workers, different races, and
different cultures (Pew Research Center, 2016). Changes in the Affordable Care Act
affect ways patient access care and how healthcare workers are getting paid for providing
care. The changes in healthcare provider payments open the door for pharmacists to
provide care to patients in the community setting, given their accessibility and potential
to begin to bill for these services (Vogenberg & Santilli, 2018). Pharmacists will also
need to watch for regulatory changes that will affect pharmacy (Vogenberg & Santilli,
2018) and will also need to participate in advocating for regulatory changes that will
allow pharmacists to bill for services outside of just dispensing a product. Also, similar to
some of the other roles, the EPAs listed here are not specific for this role, so if
schools/colleges are only using the EPAs listed to assess students, one would not know if
a student was competent in this role.
Pharmacists also need to be involved in the changes being made in drug supply
chains (Vogenberg & Santilli, 2018) to ensure the safe and ethical delivery of
medications occurs with the move to more delivery of medications straight to patient’s
homes. While the competencies and EPAs mapped to the professionalism role would help
ensure students are prepared for the professional aspects of practice, competencies and
EPAs related to ethics and patient confidentiality are not explicitly stated. Many
schools/colleges of pharmacy teach and assess these areas, but they do not occur as standalone competencies and EPAs. This lack of standalone competencies/EPAs could mean
that schools/colleges of pharmacy are not intentional about ensuring these concepts are
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covered in curricula and assessments as they would be if the competencies/EPAs were
listed.
The core roles developed in this study cover the knowledge and skills needed to
ensure students are ready for the healthcare trends occurring in the US healthcare system.
However, as discussed, the competencies and EPAs used by schools/colleges of
pharmacy to develop pedagogies and assessments related to these roles are not specific
enough to ensure teaching and assessment of all aspects of the roles. This lack of
specificity would mean that students may be prepared differently for practice depending
on the school/college attended. For the core roles developed in this study to be useful
updated competencies and EPAs would need to be developed. Before updating the
competencies and EPAs, the healthcare literature needs to be reviewed as the last
component to ensure all healthcare education areas occur in the core roles.
Englander et al. (2013) conducted a review to extract a standard set of competencies
for all health professions to aid in interprofessional education. The eight competency
domains include patient care, knowledge for practice, practice-based learning and
improvement, interpersonal and communication skills, professionalism, systems-based
practice, interprofessional collaboration, and personal and professional development.
During this study, the core roles developed include five out of the eight of these
competency domains: patient care, knowledge, professionalism, systems-based practice,
and collaboration. The Englander et al. domains of practice-based learning and
improvement fall under the professionalism role in the pharmacy core roles as does
personal and professional development. The weaving of communication skills occurs
throughout the core roles as opposed to being a standalone competency domain.
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Comparing the pharmacy competencies in this study to the Englander list shows most
of the Englander competencies map just under different core roles (Englander et al.,
2013). However, there are some competencies still missing. One area is patient care, with
competencies missing in transitions of care, patient privacy, and sensitivity to patients.
Another area with missing competencies is attitudes such as providing role modeling,
handling difficult conversations, handling difficult situations, conflict management, stress
management, ethics, professional advocacy (not advocating for the good of the patient
but advocating for the good of the profession and its place in healthcare), and personal
health. The last area missing is systems-based care and includes missing competencies in
health outcomes, quality improvement, and public health. Many of these are areas that
many schools/colleges of pharmacy would say they cover within their curricula.
However, explicit coverage does not occur in the competencies and EPAs despite being
considered as part of the core roles needed for pharmacy students to be practice-ready
upon graduation and being mentioned by employers as being necessary for practice. It
will be essential to review the competencies Englander et al. (2013) created for inclusion
in any competencies/EPA updates that would need to be done based on the core roles
developed in this study. Having specific competencies in these areas would ensure that all
students are practice-ready in all areas upon graduation regardless of the school/college to
which they attend.
Another critical literature review is the dimensions of professional competence:
cognitive, technical, integrative, relational, and affective/moral constructs. The newly
developed pharmacy core roles cover all the professional competency dimensions. The
cognitive dimension includes the core knowledge and skills needed to problem-solve
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(knowledge and patient-care skills roles). The technical dimension consists of those skills
that are hands-on and required for a specific type of pharmacy practice (patient-care skills
roles). Integration includes the ability to link basic and clinical knowledge to other
disciplines and manage uncertainty within the defined clinical setting and place in the
pharmacist’s career (the central tenet of pharmacy expert and collaborator, systems-based
practice/manager, and scholarship roles). The relationship domain includes the
communication skills, teamwork, and conflict-management skills needed to form
relationships within the healthcare domain as well as the patient and their families
(patient-care skills and collaborator roles). The affective/moral domain includes
emotional intelligence and ethics, consisting of the pharmacists’ ability to observe their
emotional intelligence, curiosity, and willingness to acknowledge and correct errors
(professionalism roles). These domains all work together to produce a pharmacist capable
of functioning in the ever-changing healthcare world to manage ambiguous problems,
tolerate uncertainty, and make decisions with sometimes limited knowledge (Epstein &
Hundert, 2002).
The last set of healthcare literature to review for comparison is the medical
literature. This review is vital as pharmacy works very closely with medicine. It will be
essential to ensure the core roles are defined clearly for pharmacy to avoid jurisdiction
issues as these newly defined roles move pharmacy from just an advisory jurisdiction
with physicians into more of a limited jurisdiction model (Abbott, 1986). The roles begin
to assert that pharmacists can handle patients' medication therapy outside of just advising
physicians but with a move into a more independent model. The move to an independent
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model will require conversations to ensure that everyone feels comfortable and that a
definition of the practice scope is evident.
The jurisdictional issues arise as one looks at a pharmacy expert's roles and see
how closely they align with those of a physician. Pharmacy’s scope of practice is a
pharmacy expert. A pharmacy expert is one that “integrates knowledge, uses appropriate
patient care skills, and is professional to provide safe, high-quality, evidence-based, and
patient-centered” within a pharmacist’s limits of expertise. The pharmacy expert
definition is very similar to the CanMEDs’ definition of a medical expert, which defines
the physician scope of practice: “physicians integrate all of the roles, applying medical
knowledge, clinical skills, and professional values in their provision of high-quality and
safe patient-centered care” (Frank et al., 2015, p. 3). As conversations regarding
jurisdiction start, one needs to keep in mind that a pharmacist’s area of expertise lies with
the medication therapy management and public health areas related to medications and
their use for the prevention and treatment of disease (Frenck et al., 2010; Isasi & Krofah,
2015). Now that a set of core roles as been proposed for pharmacy, the conversations
around jurisdiction can begin with a universal language.
The development of core roles with mapping has helped to demonstrate some of
the gaps in the current pharmacy competencies and EPAs that schools/colleges of
pharmacy use to develop pedagogies and assessments. These gaps may be leading to
students not be as prepared for practice as needed. Since the development of a core set of
pharmacy roles has occurred, schools/colleges of pharmacy could use the medical model
of competency and EPA development to ensure all areas of the roles are taught and
assessed in schools/colleges of pharmacy.
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The core medical roles played an essential part in the development of the
medicine competency statements used to drive pedagogy and assessment for medical
education. A person achieving all the competencies for a given role is said to be
“competent” in that area. For example, CanMeds defines five critical competencies for
the medical expert role. One of these competencies is “practice medicine within their
defined scope of practice and expertise” (Frank et al., 2014, p. 10). The creation of
assessments occurs from the enabling competencies that are under each of the five
broader competencies. For example, under the competency just mentioned, there are six
enabling competencies with one being “Integrate the CanMEDS Intrinsic Roles into their
practice of medicine” (Frank et al., 2014, p. 10). With the development of a set of core
roles, pharmacy can now work through a similar process. Mapping of competencies that
cover all areas of the core roles would help to ensure that all students are prepared the
same upon graduation regardless of the school/college of pharmacy from which they
graduate. It would also allow the development of assessments to share among
schools/colleges of pharmacy.
Assessment planning is a critical step to determine if students are practice-ready.
Medical school is ahead of pharmacy in the development of competencies and assessment
of competence. Medicine has defined levels of competency depending on where a student
is in their career. The competency levels in medical school are medical school
fundamentals and early clinical activity. Competency levels for residency are transitions
to discipline, foundations of the discipline, and core of the discipline. Lastly, competency
levels for learning in practice are transitions to practice and continuing professional
development (Frank et al., 2014). While pharmacy has created competencies and EPAs, it
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has not defined entrustment levels based on students' progress through their career, nor
does pharmacy agree on the level of entrustment upon graduation.
For performance activities like entrustable professional activities to be useful, one
needs to map the EPA's competencies and set the entrustment level required for each
stage of training (Modi et al., 2015). Medicine has created such a mapping with their
roles mapped to competencies to EPAs with defined entrustment levels for a particular
time in a student’s learning career (medical school, residency). While pharmacy has
created the competencies and EPAs, there is no set level of entrustment that all
schools/colleges are using, nor is there a set entrustment level depending on a student’s
stage of their career. The work done in this project continues to add to the literature
showing there is work that pharmacy needs to do in the area of entrustment as one of the
EPAs did not reach consensus. Also, some of the EPA levels of entrustment varied
depending on the role to which it was mapped. The development of a set of core roles
with mapping to the current pharmacy competencies and EPAs is the first step in
pharmacy developing an education model similar to medicine.
Study Limitations
Several limitations need discussing with this study. One limitation was the
inability to find a time that worked best for all potential NGT groups to meet. The initial
invited group contained six members, with only five members being able to participate.
Even with this limitation, the NGT group was still a mix of four different pharmacy
programs and different opinions related to pharmacists' roles. The small size of the NGT
group, while planned, is another potential limitation of this study. While a small group
was suitable for this pilot study, a broad consensus development process would need
doing before these roles could be considered for implementation across the country.
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Another potential limitation of NGT studies is the potential for one or more participants
to dominate the conversation or push their views. This domination of conversation could
have potentially been a big issue in this study, given the large pharmacy programs
involved and the research interests of the participants. Everyone listened to the facilitator
and answered one at a time during each round. Everyone provided thoughtful answers for
both strengths and limitations and participated equally. There were no feelings of
domination or pushing one set of views. Thus, the limitation of the potential domination
of conversation in this study was avoided.
Some of the Delphi method's disadvantages include the time it takes to do the
process and the potential for a low response rate to the surveys (McMillan et al., 2016).
The time it takes to do the Delphi method was one big negative to the use of this process,
but combining the research questions into one Delphi survey helped limit some of the
timetable. This project's timetable did get pushed back due to a pandemic situation that
caused the surveys to go out later than was initially intended. Once the surveys started,
though, the process flowed through the timeline as initially scheduled. The potential for a
low response rate was also a limitation. The response rate for the surveys was around 3040%, which is relatively low. The responses, though, are representative of the pharmacy
practice population. The samples chosen came from four diverse areas of the country
(Arkansas, Kentucky, North Carolina, and Minnesota). Participants were also from varied
backgrounds that are representative of the broad areas of current pharmacy practice. This
study's number of responses should not be a problem as this study is a pilot study, and
larger Delphi groups would be needed before this data could be widely used.
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Besides the limitations of the consensus processes chosen for this study, threats to
internal and external validity also needed to be considered (Campbell & Stanley, 1963).
Sample bias and reactive effects of arrangements are threats to external validity that were
potential factors in this study (Campbell & Stanley, 1963). Reactive effects of
arrangements refer to the inability to generalize to non-experimental settings because the
experimental setting is artificial. Reactive effects of arrangements could have been
potentially a problem in this study since no actual testing of the alignments and levels of
entrustment happened; instead, results are from practitioners’ thoughts about the
appropriate alignments and levels of entrustment achievement. Future studies will need to
be conducted in real-world educational settings to determine if the entrustment levels are
correct. The threat of reactive effects of arrangements is less of a validity threat as the
consensus participants were active practitioners with various practice experience. They
were capable of accurately determining what graduates need to perform upon graduation.
Sample bias is the last threat to external validity. Sample bias occurs when there is a
chance that the sample chosen for the study may not represent the population of interest.
Sample bias was a potential threat in this study, given only a small number of
pharmacists participated in the consensus development process, which may have led to a
lack of diversity (i.e., race, age, rural/urban practice sites). Mitigation of sample bias
occurred by using a non-randomized sample chosen by the NGT process members to
ensure that the sample selected is a diverse mix of pharmacy practice types and levels of
experience (Campbell & Stanley, 1963).
Threats to internal validity also need to be considered. Internal validity threats
that had be considered included (a) history, (b) maturation, (c) testing, (d)
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instrumentation, and (e) experimenter bias (Campbell & Stanley, 1963). History is when
events occur during the study that may impact the results, which could be an issue
between the Delphi rounds if participants were to change jobs or learn different
information that may change the way they think about the alignments and levels of
entrustments in between the rounds. Maturation could be a problem as processes with the
participants (aging, experience) could impact the outcomes. Mitigation of history and
maturation occurred by keeping the time between the rounds to no more than 2-3 weeks.
Another potential internal threat is testing itself as results are affected when participants
do multiple rounds of “testing.” Testing was mitigated by only using two to three rounds
of the Delphi process. The last threat to internal validity is experimenter bias, which
occurs when the experimenter’s expectations of the results may consciously or
unconsciously affect the results. The experimenter’s thoughts regarding what the core
roles should be along with the mapping and EPA levels could come through in the way
the results are presented. The experimenter’s potential to influence the results were
mitigated through the design of the NGT process for Research Question One and then
through providing both the original as well as the changed mappings and levels of
entrustment in each round of the Delphi process, thus allowing Delphi participants to
serve as reviewers to ensure researcher bias was mitigated (Campbell & Stanley, 1963).
Future Research/Practice Implications
Results from this study will have an impact on pharmacy, pharmacy education,
and pharmacy research methodologies in multiple ways. For pharmacy education, the
development of the pharmacy roles is the first step to ensuring students are minimally
prepared for all potential pharmacy practice areas both now and in the future. As
education begins to train pharmacists in these new roles, professional jurisdiction
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discussions will need to occur to ensure everyone understands what pharmacists are
prepared to undertake and that these roles can help further advance the practice of other
professions instead of limiting their practice (Abbott, 1986).
The development of core roles with the alignment of pharmacy competencies and
EPAs will provide a roadmap for minimum competency (Lumina Foundation, 2014). The
developed core roles also help describe what the pharmacy profession can do for other
identities both inside and outside healthcare. The core roles will help propel the
profession forward as they work to increase pharmacy’s professional identity and move
to more cognitive practice instead of just dispensing of a product. While the core roles
and competency/EPA mapping will be useful for schools/colleges of pharmacy, more
research and consensus building will be needed before they are ready for incorporation
into the accreditation standards. This is especially true for the levels of entrustment given
that one of the EPAs did not reach consensus on a level. Another future research area will
be what role do the pre-program requirements for pharmacy school play in students'
development for these future pharmacy roles? Should pharmacy consider requiring a
degree before entry to allow students to start developing some of the necessary
competencies before entry into a pharmacy program?
Lastly, this study further demonstrates how mixed-methods study techniques can
be used in pharmacy educational research. The nominal group technique conducted via
video conferencing and the Delphi technique conducted via electronic survey can be
beneficial methods in gathering a broader consensus on the development of pharmacy
roles and other areas needing consensus. These are research methods that are currently
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gaining use in the pharmacy literature but could be used more often for research studies
that need to gather data that generates ideas or develops guidelines.
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Appendix A
Pharmacy CAPE Outcomes
The 15 CAPE outcomes, with one-word descriptors, center around four large domains
(Medina et al., 2013). The four broad domains include Foundational Knowledge
(knowledge), Essentials for Practice and Care (skills), Approach to Practice and Care
(skills), and Personal and Professional Development (attitudes; Medina et al., 2013). The
CAPE design was to represent all areas of pharmacy and guide the curricular and
assessment efforts of schools/colleges of pharmacy. The 15 CAPE outcomes include
(Medina et al., 2013, p. 3-8):
Domain 1: Foundational Knowledge
•

1.1 Learner: Develop, integrate, and apply knowledge from the foundational
sciences (i.e., pharmaceutical, social/behavioral/administrative, and clinical
sciences) to evaluate the scientific literature, explain drug action, solve
therapeutic problems, and advance population health and patient-centered care

Domain 2: Essentials for Practice and Care
•

2.1 Patient-centered care (Caregiver): Provide patient-centered care as the
medication expert (collect and interpret evidence, prioritize, formulate
assessments and recommendations, implement, monitor and adjust plans, and
document activities).
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•

2.2 Medication use systems management (Manager): Manage patient healthcare
needs using human, financial, technological, and physical resources to optimize
the safety and efficacy of medication use.

•

2.3 Health and wellness (Promoter): Design prevention, intervention, and
educational strategies for individuals and communities to manage chronic disease
and improve health and wellness.

•

2.4 Population-based care (Provider): Describe how population-based care
influences patient-centered care and influences the development of practice
guidelines and evidence-based best practices.

Domain 3: Approach to Practice and Care
•

3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize
potential strategies, and design, implement, and evaluate a viable solution.

•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.

•

3.3 Patient Advocacy (Advocate): Assure that patients’ best interests are
represented.

•

3.4 Interprofessional collaboration (Collaborator): Actively participate and engage
as a healthcare team member by demonstrating mutual respect, understanding,
and values to meet patient care needs.

•

3.5 Cultural sensitivity (Includer): Recognize social determinants of health to
diminish disparities and inequities in access to quality care.

•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
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Domain 4: Personnel and Professional Development
•

4.1 Self-awareness (Self-aware): Examine and reflect on personal knowledge,
skills, abilities, beliefs, biases, motivation, and emotions that could enhance or
limit personal and professional growth.

•

4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving
shared goals, regardless of position.

•

4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities
by using creative thinking to envision better ways of accomplishing professional
goals.

•

4.4 Professionalism (Professional): Exhibit behaviors and values that are
consistent with the trust given by the profession by patients, other healthcare
providers, and society.
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Appendix B
Pharmacy Entrustable Professional Activities (EPAs)
EPA creation for pharmacy started in 2015-16 with the Academic Affairs
Standing Committee of AACP. The president charged this committee to identify EPAs
for pharmacy graduates as they transition from completion of their advanced pharmacy
practice experiences into professional practice and other postgraduate opportunities. This
work continued with the 2016-17 Academic Affairs committee, which compiled
comments and input from stakeholders regarding the draft EPAs and completing the final
edits. The fifteen EPAs created by the Academic Affairs Committee are as follows
(Haines et al., 2017, p. 3-4):
Patient Care Provider Domain
•

Collect information to identify a patient’s medication-related problems and
health-related needs.

•

Analyze information to determine the effects of medication therapy, identify
medication-related problems, and prioritize health-related needs.

•

Establish patient-centered goals and create a care plan for a patient in
collaboration with the patient, caregiver(s), and other health professionals that
are evidence-based and cost-effective.

•

Implement a care plan in collaboration with the patient, caregivers, and other
health professionals.

•

Follow-up and monitor a care plan.
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IPE Team Member Domain
•

Collaborate as a member of an IPE team.

Population Health Promoter Domain
•

Identify patients at risk for prevalent disease in a population.

•

Minimize adverse drug events and medications in a population.

•

Maximize the appropriate use of medications in a population.

•

Ensure that patients have been immunized against vaccine-preventable
diseases.

Information Master Domain
•

Educate patients and professional colleagues regarding the appropriate use of
medication.

•

Use evidence-based information to advance patient care.

Practice Manager Domain
•

Oversee the pharmacy operations for an assigned shift.

•

Full-fill a medication order.

Self-Developer Domain
•

Create a written plan for continuous professional development
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Appendix C
Initial Core Pharmacist's Role Proposal
Figure C.1: Model of Initial Core Pharmacist's Role
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Figure C.1. Graphical depiction of the initial core pharmacist's role. Adapted from
"ACGME common program Requirements [Web page]," by Accreditation Council for
Graduate Medical Education., 2017, Retrieved from
https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRs_2017-0701.pdf; "CanMeds 2015 Physician Competency Framework", by J. R. Frank et al., 2015,
Ottawa: Royal College of Physicians and Surgeons of Canada; "Generic professional
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capabilities framework," by General Medical Council, 2017, Retrieved from www.gmcuk.org.
Central Role: Pharmacotherapeutics Expert
•

Pharmacotherapeutics experts integrate all the tenets such as knowledge, using
appropriate patient care skills, and being professional to provide high-quality and
safe patient-centered care. Being a pharmacotherapeutics expert is the central role
of a pharmacist and defines the pharmacist's scope of practice.

•

A pharmacotherapeutics expert will draw upon their knowledge, skills, and
attitudes to collect and interpret information, make clinical decisions, and make
therapeutics interventions. This is done within their scope of practice and with the
understanding of the limits of their expertise. Decision-making is informed by
evidence-based medicine and considers the patient and their caregivers'
preferences and the appropriate use of available resources. Their practice is up-todate, ethical, and conducted in collaboration with other members of the healthcare
team as well as the patient and their caregivers.

Core Roles Needed to Become The "Expert":
•

Knowledge
o Pharmacists must integrate knowledge of biomedical, psychological, and
social science principles of health and disease, and clinical science to
design appropriate treatment plans for their patients. This knowledge
includes understanding these principles across the life-span of the patient.
o Pharmacists understand that they serve a unique role in the healthcare
team. They are the "medication" experts and possess the most knowledge
of how medications contribute to the patient's care.
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•

Patient Care Skills
o Pharmacists must be able to perform basic patient care skills such as
communication, collection, and assessment of information to formulate a
treatment plan and ability to monitor if a treatment is successful or not.
o Pharmacists need to ensure they take a patient's cultural, education level,
and financial status into account when formulating a treatment plan to
ensure a patient's plan can be adherent. Pharmacists also understand that
part of patient care should include discussing the plan with the patient and
their support system as needed.

•

Professionalism
o Pharmacists are committed to the health and well-being of their patients,
society, and themselves. This is demonstrated through ethical practice,
high standards of personal behavior, accountability to the profession and
society, and maintenance of their health.
o Pharmacists serve essential roles in the healthcare team and society, as
such, professional identity is central. This tenet includes promotion of the
public good, adherence to high ethical and moral standards. It recognizes
that to provide good quality patient care, they must take care of
themselves and others in their profession.

•

Scholarship
o Pharmacists are committed to excellence in their practice through life-long
professional development, the teaching of others, the use of evidencebased medicine, and contributing to scholarship.
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•

Systems-based Practice/Manager
o Pharmacists are committed to safety and quality in health care,
professional advocacy, health insurance, health care economics, transitions
of care, and chronic care of patients.
o Pharmacists understand that they work as part of a more extensive
"system" of health care and that to provide good, quality care, they need to
be able to coordinate care within the systems, provide treatment
recommendations that work with the patient's insurance, and be an
advocate for optimal and quality patient care. Pharmacists also need to be
an advocate for the profession on professional roles/responsibilities and
the ability to bill for services

•

Collaborator
o Pharmacists work with other healthcare professionals to provide safe,
high-quality, and patient-centered care.
o Pharmacists understand that being able to function effectively in an
interprofessional team is necessary to provide safe, high-quality, and
effective patient care. Collaboration is also important with the patient and
their support systems. Collaboration requires trust, respect, and shared
decision-making. It also requires the sharing of knowledge, perspectives,
responsibilities, and the willingness to learn from others. To collaborate
effectively, one must understand others' roles on the team, be pursuing
common goals, and manage conflict effectively.

•

Advocate/Health Promoter
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o Pharmacists are committed to using their expertise and influence to work
with patient populations to improve communities' health and wellness.
They work to understand the needs, speak on behalf of others, and seek to
mobilize resources to effect change when needed.
o Pharmacists understand that improving health is not limited to treating
illness but also includes disease prevention, health promotion, and health
protection. They understand their unique place in the healthcare team, and
society allows them access to populations that others may not have.
Pharmacists understand the need to work with patients to navigate
complex medical situations to get the care they may need.
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Appendix D
Final Core Pharmacist's Role Proposal
Figure D.1. Model of Final Core Pharmacist's Roles
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Figure D.1. Graphical depiction of the initial core pharmacist's role. Adapted from
"ACGME common program Requirements [Web page]," by Accreditation Council for
Graduate Medical Education., 2017, Retrieved from
https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRs_2017-0701.pdf; "CanMeds 2015 Physician Competency Framework", by J. R. Frank et al., 2015,
Ottawa: Royal College of Physicians and Surgeons of Canada; "Generic professional
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capabilities framework," by General Medical Council, 2017, Retrieved from www.gmcuk.org.
Central Role: Pharmacy Expert
•

Pharmacy experts integrate all the tenets such as knowledge, using appropriate
patient care skills, and being professional to provide safe, high-quality, evidencebased, and patient-centered care. Being a pharmacy expert is the pharmacist's
central role and defines the pharmacist's scope of practice.

•

A pharmacy expert will draw upon their knowledge, skills, and attitudes to collect
and interpret information, make clinical decisions, make therapeutics
interventions, and monitor the results of therapeutic interventions. This is done
within their scope of practice and with the understanding of the limits of their
expertise. A pharmacy expert also understands they work as part of a more
extensive "system" of healthcare to coordinate and advocate optimal and quality
patient care to improve health by treating illnesses, disease prevention, health
promotion, and health protection. Decision-making is informed by evidence-based
medicine and considers the patient and their caregivers' preferences and the
appropriate use of available resources. Their practice is up-to-date, innovative,
ethical, and is conducted in collaboration with other members of the healthcare
team as well as the patient and their caregivers.

Core Roles Needed To Become The "Expert":
•

Knowledge
o Pharmacists must integrate knowledge of biomedical and psychosocial
science principles of health and disease, and clinical science to design
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appropriate treatment plans for their patients. This knowledge includes
understanding these principles across the life-span of the patient.
o Pharmacists understand that they serve a unique role in the healthcare
team. They are the "medication" experts and possess the most knowledge
of how medications contribute to the patient's care.
•

Patient Care Skills
o Pharmacists must be able to perform basic patient care skills such as
communication, collection and assessment of information to formulate and
implement a treatment plan, and the ability to monitor if a treatment is
successful or not.
o Pharmacists need to ensure they take a patient's cultural, education level,
and financial status into account when formulating a treatment plan to
ensure a patient's plan can be adherent. Pharmacists also understand that
part of patient care should include discussing the plan in a compassionate
and empathetic manner with the patient and their support system as
needed.

•

Professionalism
o Pharmacists are committed to the health and well-being of their patients,
society, and themselves. This is demonstrated through ethical practice,
high standards of personal behavior, accountability to the profession and
society, and maintenance of their health.
o Pharmacists serve essential roles in the healthcare team and society, as
such, professional identity is central. This tenet includes promotion of the
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public good, adherence to high ethical and moral standards. It recognizes
that to provide good quality patient care, they must take care of
themselves and others in their profession.
•

Scholarship
o Pharmacists are committed to excellence in their practice through life-long
professional development, the teaching of others, developing new
innovative practices that advance the profession, and the use of evidencebased medicine. Pharmacists are committed to finding and promoting
drugs and other health information that is evidence-based and up-to-date.
o Pharmacists understand the importance of contributing to scholarship and
evidence-based medical literature.

•

Systems-based Practice/Manager
o Pharmacists are committed to safety and quality in health care,
professional advocacy, health insurance, health care economics, health
outcomes, quality improvement, transitions of care, public health, and
patients' chronic care.
o Pharmacists understand that they work as part of a more extensive
"system" of health care and that to provide good, quality care, they need to
be able to coordinate care within the systems, provide treatment
recommendations that work with the patients' insurance, and be an
advocate for optimal and quality patient care. Pharmacists also need to
advocate for the profession on professional roles/responsibilities and the
ability to bill for services.
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•

Collaborator
o Pharmacists work with other healthcare professionals to provide safe,
high-quality, evidence-based, and patient-centered care.
o Pharmacists understand that being able to function effectively in an
interprofessional team is necessary to provide safe, high-quality, and
patient-centered care. Collaboration is also important with the patient and
their support systems. Collaboration requires trust, respect, and shared
decision-making. It also requires the sharing of knowledge, perspectives,
responsibilities, and the willingness to learn from others. To collaborate
effectively, one must understand the roles of others on the team, articulate
one's role on the team, be pursuing common goals, and manage conflict
effectively.

•

Advocate/Health Promoter
o Pharmacists are committed to using their expertise and influence to work
with patient populations to improve communities' health and wellness.
They work to understand the needs, speak on behalf of others, and seek to
mobilize resources to effect change when needed.
o Pharmacists understand that improving health is not limited to treating
illness but also includes disease prevention, health promotion, and health
protection. They understand their unique place in the healthcare team, and
society allows them access to populations that others may not have.
Pharmacists understand the need to work with patients to navigate
complex medical situations to get the care they may need.
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Appendix E
Initial Roles/Competencies/EPA Mapping
Role: Knowledge
Pharmacists must integrate knowledge of biomedical and psychosocial science
principles of health and disease, and clinical science to design appropriate treatment plans
for their patients. This knowledge includes understanding these principles across the lifespan of the patient. Pharmacists understand that they serve a unique role in the healthcare
team. They are the "medication" experts and possess the most knowledge of how
medications contribute to the patient's care.
•

1.1 Learner: Develop, integrate, and apply knowledge from the foundational
sciences (i.e., pharmaceutical, social/behavioral/administrative, and clinical
sciences) to evaluate the scientific literature, explain drug action, solve
therapeutic problems, and advance population health and patient-centered care
o EPA: Analyze information to determine the effects of medication therapy,
identify medication-related problems, and prioritize health-related needs.
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective.
o EPA: Collaborate as a member of an IPE team.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
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o EPA: Use evidence-based information to advance patient care.
Role: Patient Care Skills
Pharmacists must be able to perform basic patient care skills such as
communication, collection and assessment of information to formulate and implement a
treatment plan, and the ability to monitor if a treatment is successful or not. Pharmacists
need to ensure they take a patient's cultural, education level, and financial status into
account when formulating a treatment plan to ensure a patient's plan can be adherent.
Pharmacists also understand that part of patient care should include discussing the plan in
a compassionate and empathetic manner with the patient and their support system as
needed.
•

2.1 Patient-centered care (Caregiver): Provide patient-centered care as the
medication expert (collect and interpret evidence, prioritize, formulate
assessments and recommendations, implement, monitor and adjust plans, and
document activities).
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs.
o EPA: Analyze information to determine the effects of medication therapy,
identify medication-related problems, and prioritize health-related needs.
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective.
o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals.
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o EPA: Follow-up and monitor a care plan.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
•

2.3 Health and wellness (Promoter): Design prevention, intervention, and
educational strategies for individuals and communities to manage chronic disease
and improve health and wellness.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.

•

3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize
potential strategies, and design, implement, and evaluate a viable solution.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs.
o EPA: Analyze information to determine the effects of medication therapy,
identify medication-related problems, and prioritize health-related needs.
o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals.
o EPA: Collaborate as a member of an IPE team.
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o EPA: Oversee the pharmacy operations for an assigned shift.
o EPA: Full-fill a medication order.
•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.

•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs.
o EPA: Analyze information to determine the effects of medication therapy,
identify medication-related problems, and prioritize health-related needs.
o EPA: Follow-up and monitor a care plan.
o EPA: Collaborate as a member of an IPE team.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
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o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
o EPA: Use evidence-based information to advance patient care.
o EPA: Oversee the pharmacy operations for an assigned shift.
o EPA: Full-fill a medication order.
Role: Professionalism
Pharmacists are committed to the health and well-being of their patients, society,
and themselves. This is demonstrated through ethical practice, high standards of personal
behavior, accountability to the profession and society, and maintenance of their health.
Pharmacists serve essential roles in the healthcare team and society, as such, professional
identity is central. This tenet includes promotion of the public good, adherence to high
ethical and moral standards. It recognizes that to provide good quality patient care, they
must take care of themselves and others in their profession.
•

4.1 Self-awareness (Self-aware): Examine and reflect on personal knowledge,
skills, abilities, beliefs, biases, motivation, and emotions that could enhance or
limit personal and professional growth.
o EPA: Collaborate as a member of an IPE team.
o EPA: Oversee the pharmacy operations for an assigned shift.
o EPA: Create a written plan for continuous professional development
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•

4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving
shared goals, regardless of position.
o EPA: Collaborate as a member of an IPE team.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
o EPA: Oversee the pharmacy operations for an assigned shift.

•

4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities
by using creative thinking to envision better ways of accomplishing professional
goals.
o EPA: Collaborate as a member of an IPE team.
o EPA: Use evidence-based information to advance patient care.
o EPA: Oversee the pharmacy operations for an assigned shift.

•

4.4 Professionalism (Professional): Exhibit behaviors and values that are
consistent with the trust given by the profession by patients, other healthcare
providers, and society.
o EPA: Collaborate as a member of an IPE team.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
o EPA: Oversee the pharmacy operations for an assigned shift.
o EPA: Create a written plan for continuous professional development

Role: Scholarship
Pharmacists are committed to excellence in their practice through life-long
professional development, the teaching of others, developing new innovative practices
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that advance the profession, and the use of evidence-based medicine. Pharmacists are
committed to finding and promoting drugs and other health information that is evidencebased and up-to-date. Pharmacists understand the importance of contributing to
scholarship and evidence-based medical literature.
•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.

•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
o EPA: Use evidence-based information to advance patient care.

•

4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities
by using creative thinking to envision better ways of accomplishing professional
goals.
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o EPA: Collaborate as a member of an IPE team.
o EPA: Use evidence-based information to advance patient care.
o EPA: Oversee the pharmacy operations for an assigned shift.
Roles: Systems-based Practice/Manager
Pharmacists are committed to safety and quality in health care, professional
advocacy, health insurance, health care economics, health outcomes, quality
improvement, transitions of care, public health, and patients' chronic care. Pharmacists
understand that they work as part of a more extensive "system" of health care and that to
provide good, quality care, they need to be able to coordinate care within the systems,
provide treatment recommendations that work with the patients' insurance, and be an
advocate for optimal and quality patient care. Pharmacists also need to advocate for the
profession on professional roles/responsibilities and the ability to bill for services.
•

2.2 Medication use systems management (Manager): Manage patient healthcare
needs using human, financial, technological, and physical resources to optimize
the safety and efficacy of medication use.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs.
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective.
o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals.
o EPA: Follow-up and monitor a care plan.
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o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
o EPA: Oversee the pharmacy operations for an assigned shift.
o EPA: Full-fill a medication order.
•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.

•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
o EPA: Oversee the pharmacy operations for an assigned shift.
o EPA: Full-fill a medication order.

•

4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving
shared goals, regardless of position.
o EPA: Collaborate as a member of an IPE team.
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o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
o EPA: Oversee the pharmacy operations for an assigned shift.
Role: Collaborator
Pharmacists work with other healthcare professionals to provide safe, highquality, evidence-based, and patient-centered care. Pharmacists understand that being
able to function effectively in an interprofessional team is necessary to provide safe,
high-quality, and patient-centered care. Collaboration is also important with the patient
and their support systems. Collaboration requires trust, respect, and shared decisionmaking. It also requires the sharing of knowledge, perspectives, responsibilities, and the
willingness to learn from others. To collaborate effectively, one must understand the roles
of others on the team, articulate one's role on the team, be pursuing common goals, and
manage conflict effectively.
•

3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize
potential strategies, and design, implement, and evaluate a viable solution.
o EPA: Collaborate as a member of an IPE team.

•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
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•

3.4 Interprofessional collaboration (Collaborator): Actively participate and engage
as a healthcare team member by demonstrating mutual respect, understanding,
and values to meet patient care needs.
o EPA: Follow-up and monitor a care plan.
o EPA: Collaborate as a member of an IPE team.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.

•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
o EPA: Collaborate as a member of an IPE team.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.

Role: Advocate/Health Promoter
Pharmacists are committed to using their expertise and influence to work with
patient populations to improve communities' health and wellness. They work to
understand the needs, speak on behalf of others, and seek to mobilize resources to effect
change when needed. Pharmacists understand that improving health is not limited to
treating illness but also includes disease prevention, health promotion, and health
protection. They understand their unique place in the healthcare team, and society allows
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them access to populations that others may not have. Pharmacists understand the need to
work with patients to navigate complex medical situations to get the care they may need.
•

2.4 Population-based care (Provider): Describe how population-based care
influences patient-centered care and influences the development of practice
guidelines and evidence-based best practices.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.

•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.

•

3.3 Patient Advocacy (Advocate): Assure that patients’ best interests are
represented.
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o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective.
o EPA: Collaborate as a member of an IPE team.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
•

3.5 Cultural sensitivity (Includer): Recognize social determinants of health to
diminish disparities and inequities in access to quality care.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs.
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective.
o EPA: Identify patients at risk for prevalent disease in a population.
o EPA: Minimize adverse drug events and medications in a population.
o EPA: Maximize the appropriate use of medications in a population.
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases.
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o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication.
o EPA: Use evidence-based information to advance patient care.
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Appendix F
Mapping of Competencies and EPAs With Levels of Entrustment to Core Roles
Role: Knowledge
Pharmacists must integrate knowledge of biomedical and psychosocial science
principles of health and disease, and clinical science to design appropriate treatment plans
for their patients. This knowledge includes understanding these principles across the lifespan of the patient. Pharmacists understand that they serve a unique role in the healthcare
team. They are the “medication” experts and possess the most knowledge of how
medications contribute to the patient's care.
•

1.1 Learner: Develop, integrate, and apply knowledge from the foundational
sciences (i.e., pharmaceutical, social/behavioral/administrative, and clinical
sciences) to evaluate the scientific literature, explain drug action, solve
therapeutic problems, and advance population health and patient-centered care
o EPA: Analyze information to determine the effects of medication therapy,
identify medication-related problems, and prioritize health-related needs.
(Level 3)
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective. (Level 3)
o EPA: Collaborate as a member of an IPE team. (Level 3)
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o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 3)
o EPA: Use evidence-based information to advance patient care. (Level 3)
Role: Patient Care Skills
Pharmacists must be able to perform basic patient care skills such as
communication, collection and assessment of information to formulate and implement a
treatment plan, and ability to monitor if a treatment is successful or not. Pharmacists need
to ensure they take a patient’s cultural, education level, and financial status into account
when formulating a treatment plan to ensure a patient's plan can be adherent. Pharmacists
also understand that part of patient care should include discussing the plan in a
compassionate and empathetic manner with the patient and their support system as
needed.
•

2.1 Patient-centered care (Caregiver): Provide patient-centered care as the
medication expert (collect and interpret evidence, prioritize, formulate
assessments and recommendations, implement, monitor and adjust plans, and
document activities).
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs. (Level 4)
o EPA: Analyze information to determine the effects of medication therapy,
identify medication-related problems, and prioritize health-related needs.
(Level 3)
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective. (Level 3)
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o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals. (Level 3)
o EPA: Follow-up and monitor a care plan. (Level 3)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)
•

2.3 Health and wellness (Promoter): Design prevention, intervention, and
educational strategies for individuals and communities to manage chronic disease
and improve health and wellness.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs. (Level 4)
o EPA: Identify patients at risk for prevalent disease in a population. (Level
3)
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)

•

3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize
potential strategies, and design, implement, and evaluate a viable solution.
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o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs. (Level 4)
o EPA: Analyze information to determine the effects of medication therapy,
identify medication-related problems, and prioritize health-related needs.
(Level 3)
o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals. (Level 3)
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)
o EPA: Full-fill a medication order. (Level 3)
•

3.2a Patient Educator (Patient Educator): Educate patients and their caregivers by
determining the most effective and enduring ways to impart information and
assess understanding.
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)

•

3.2b Healthcare Professional Educator (Healthcare Professional Educator):
Educate healthcare providers by determining the most effective and enduring
ways to impart information and assess understanding.
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o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs. (Level 4)
o EPA: Analyze information to determine the effects of medication therapy,
identify medication-related problems, and prioritize health-related needs.
(Level 3)
o EPA: Follow-up and monitor a care plan. (Level 3)
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Identify patients at risk for prevalent disease in a population. (Level
3)
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)
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o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
o EPA: Use evidence-based information to advance patient care. (Level 3)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)
o EPA: Full-fill a medication order. (Level 3)
Role: Professionalism
Pharmacists are committed to the health and well-being of their patients, society,
and themselves. This is demonstrated through ethical practice, high standards of personal
behavior, accountability to the profession and society, and maintenance of their own
personal health. Pharmacists serve essential roles in the healthcare team and society, as
such, professional identity is central. This tenet includes promotion of the public good,
adherence to high ethical and moral standards. It recognizes that to provide good quality
patient care, they must take care of themselves and others in their profession.
•

4.1 Self-awareness (Self-aware): Examine and reflect on personal knowledge,
skills, abilities, beliefs, biases, motivation, and emotions that could enhance or
limit personal and professional growth.
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)
o EPA: Create a written plan for continuous professional development.
(Level 3)

•

4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving
shared goals, regardless of position.
o EPA: Collaborate as a member of an IPE team. (Level 3)
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o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)
•

4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities
by using creative thinking to envision better ways of accomplishing professional
goals.
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Use evidence-based information to advance patient care. (Level 3)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)

•

4.4 Professionalism (Professional): Exhibit behaviors and values that are
consistent with the trust given by the profession by patients, other healthcare
providers, and society.
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)
o EPA: Create a written plan for continuous professional development.
(Level 3)

Role: Scholarship
Pharmacists are committed to excellence in their practice through life-long
professional development, teaching others, developing new innovative practices that
advance the profession, and using evidence-based medicine. Pharmacists are committed
to finding and promoting drug and other health information that is evidence-based and
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up-to-date. Pharmacists understand the importance of contributing to scholarship and
evidence-based medical literature.
•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals. (Level 3)
o EPA: Identify patients at risk for prevalent disease in a population. (Level
3)
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 3)

•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 3)
o EPA: Use evidence-based information to advance patient care. (Level 3)
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•

4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities
by using creative thinking to envision better ways of accomplishing professional
goals.
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Use evidence-based information to advance patient care. (Level 3)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)

Role: Systems-based Practice/Manager
Pharmacists are committed to safety and quality in health care, professional
advocacy, health insurance, health care economics, health outcomes, quality
improvement, transitions of care, public health, and patients' chronic care. Pharmacists
understand that they work as part of a more extensive “system” of health care and that to
provide good, quality care, they need to be able to coordinate care within the systems,
provide treatment recommendations that work with the patients' insurance, and be an
advocate for optimal and quality patient care. Pharmacists also need to advocate for the
profession on professional roles/responsibilities and the ability to bill for services.
•

2.2 Medication use systems management (Manager): Manage patient healthcare
needs using human, financial, technological, and physical resources to optimize
the safety and efficacy of medication use.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs. (Level 4)
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective. (Level 3)
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o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals. (Level 3)
o EPA: Follow-up and monitor a care plan. (Level 3)
o EPA: Identify patients at risk for prevalent disease in a population. (Level
3)
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)
o EPA: Full-fill a medication order. (Level 3)
•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)

•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
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o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)
o EPA: Full-fill a medication order. (Level 3)
•

4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving
shared goals, regardless of position.
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2)

Role: Collaborator
Pharmacists work with other healthcare professionals to provide safe, highquality, evidence-based, and patient-centered care. Pharmacists understand that being
able to function effectively in an interprofessional team is necessary to provide safe,
high-quality, and patient-centered care. Collaboration is also important with the patient
and their support systems. Collaboration requires trust, respect, and shared decisionmaking. It also requires the sharing of knowledge, perspectives, responsibilities, and the
willingness to learn from others. To collaborate effectively, one must understand the roles
of others on the team, articulate one’s role on the team, be pursuing common goals, and
manage conflict effectively.
•

3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize
potential strategies, and design, implement, and evaluate a viable solution.
o EPA: Collaborate as a member of an IPE team. (Level 3)

•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
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o EPA: Implement a care plan in collaboration with the patient, caregivers,
and other health professionals. (No level – no consensus)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
•

3.4 Interprofessional collaboration (Collaborator): Actively participate and engage
as a healthcare team member by demonstrating mutual respect, understanding,
and values to meet patient care needs.
o EPA: Follow-up and monitor a care plan. (Level 3)
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Identify patients at risk for prevalent disease in a population. (Level
3)
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
3)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)

•

3.6 Communication (Communicator): Effectively communicate verbally and
nonverbally when interacting with an individual, group, or organization.
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)

Role: Advocate/Health Promoter
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Pharmacists are committed to using their expertise and influence to work with
patient populations to improve communities' health and wellness. They work to
understand the needs, speak on behalf of others, and seek to mobilize resources to effect
change when needed. Pharmacists understand that improving health is not limited to
treating illness but also includes disease prevention, health promotion, and health
protection. They understand their unique place in the healthcare team, and society allows
them access to populations that others may not have. Pharmacists understand the need to
work with patients to navigate complex medical situations to get the care they may need.
•

2.4 Population-based care (Provider): Describe how population-based care
influences patient-centered care and influences the development of practice
guidelines and evidence-based best practices.
o EPA: Identify patients at risk for prevalent disease in a population. (Level
3)
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)

•

3.2 Educator (Educator): Educate all audiences by determining the most effective
and enduring ways to impart information and assess understanding.
o EPA: Identify patients at risk for prevalent disease in a population. (Level
3)
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o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
•

3.3 Patient Advocacy (Advocate): Assure that patients’ best interests are
represented.
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective. (Level 3)
o EPA: Collaborate as a member of an IPE team. (Level 3)
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
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•

3.5 Cultural sensitivity (Includer): Recognize social determinants of health to
diminish disparities and inequities in access to quality care.
o EPA: Collect information to identify a patient’s medication-related
problems and health-related needs. (Level 4)
o EPA: Establish patient-centered goals and create a care plan for a patient
in collaboration with the patient, caregiver(s), and other health
professionals that are evidence-based and cost-effective. (Level 3)
o EPA: Identify patients at risk for prevalent disease in a population. (Level
3)
o EPA: Minimize adverse drug events and medications in a population.
(Level 2)
o EPA: Maximize the appropriate use of medications in a population. (Level
2)
o EPA: Ensure that patients have been immunized against vaccinepreventable diseases. (Level 3)
o EPA: Educate patients and professional colleagues regarding the
appropriate use of medication. (Level 4)
o EPA: Use evidence-based information to advance patient care. (Level 3)
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Oct 2001

The Cooper Clayton Method to Stop Smoking
Kentucky Cancer Program. Lexington, Kentucky

Aug 2001

Pharmacy-Based Immunization Program
University of Kentucky. Lexington, Kentucky

Apr 1999

Basic Life Support
Louisville, Kentucky

2003-2012

Dale Carnegie Training Course

May 2008

Advanced Cardiac Life Support
Lexington, Kentucky

2000-2002

Scholarship of Teaching and Learning Program
University of Kentucky. Lexington, Kentucky

2000-2002

Basic Life Support
Lexington, Kentucky

1996-2002
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ROFESSIONAL EXPERIENCE
Professor

Sullivan University College of
Pharmacy and Health Sciences
Louisville, KY

2013-present

Assistant Dean of
Academic Affairs and
Assessment

Sullivan University College of
Pharmacy and Health Sciences
Louisville, KY

2010-present

Assistant Dean of
Academic Affairs

Sullivan University College of
Pharmacy
Louisville, KY

2008-2010

Chair

Clinical and Administrative Sciences
Department
Sullivan University College of
Pharmacy
Louisville, KY

2007-2008

Associate Professor

Sullivan University College of
Pharmacy
Louisville, KY

2007-2013

Associate Professor

Ferris State University
Grand Rapids, MI

2006-2007

Assistant Professor

Ferris State University
Grand Rapids, MI

2002-2006

Staff Pharmacist

University of Kentucky Clinic
Lexington, Kentucky

2001-2002

Staff Pharmacist

University of Kentucky Chandler
Medical Center
Lexington, Kentucky

2000-2002

Pharmacy Intern

The Kroger Company
Louisville, Kentucky

1994-2000
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TEACHING
Sullivan University College of Pharmacy and Health Sciences
Lectures
VARK, Mindset, & Grit
Results Overview
PharmD Program
Outcomes
How To Provide Good
Evaluations and Do Self
Evaluations
Getting Ready for the
NAPLEX
Presentation I

Course
PHR 5009: Development of the
Student Pharmacist
PHR 5009: Development of the
Student Pharmacist
PHR 6606 Professional Seminar
Course

Academic Year
2020-present

PHR 6606 Professional Seminar
Course
PHR 5204: Communication and
Collaborative Solutions
PHR 5204: Communication and
Collaborative Solutions (moved to
PHR 6606 Professional Seminar
Course in 2016-2017)
PHR 6814: Learn to Teach

2019-present

PHR 6814: Learn to Teach

2009-2019

PHR 6814: Learn to Teach

2009-2019

PHR 6814: Learn to Teach

2009-2019

Presentation Delivery

PHR 6814: Learn to Teach

2009-2019

Peer Assessment; SelfAssessment
Active Learning
Techniques
Professionalism

PHR 6814: Learn to Teach

2013-2019

PHR 6814: Learn to Teach

2013-2019

PHR 5000: Introduction to
Pharmacy
PCAS 519: Public Health Issues

2010-2015

PCAS 523/531: Research Design
and Literature Evaluation I and II
PCAS 606: Clinical Laboratory

2008-2009

Presentation II

Overview of Careers in
Academia; Teaching
Organizational Structure
Writing Learning
Objectives and Review of
Bloom’s Taxonomy
Teaching to Target
Learning Styles
Generational Differences

Overview of Public Health
True Experiments
Chapter 1: Definition and
Concepts
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2019-present
2019-present

2008-present
2008-present

2013-2019

2012-2014

2011-2015

Chapter 3: Drug
Interference with Test
Results
Chapter 9: Pulmonary
Function Test
Chapter 17: Rheumatic
Diseases
IBS/IBD
How to Write a
Publishable Research
Paper
Cerebrovascular Disease
Glaucoma
Urinary Incontinence
Precepted students for
student research project
True Experiments

PCAS 606: Clinical Laboratory

2011-2015

PCAS 606: Clinical Laboratory

2011-2013

PCAS 606: Clinical Laboratory

2011-2012

PCAS 609: Pharmacotherapeutics I
PCAS 617: Pharmaceutical Debates
on Recent Issues Affecting the
Profession
PCAS 622: Pharmacotherapeutics II
PCAS 633: Pharmacotherapeutics
IV
PCAS 633: Pharmacotherapeutics
IV
PCAS 700: Research Project

2010-2012
2009-2011

PCAS 523/531: Research Design
and Literature Evaluation I and II

2008-2009

Course Coordination
PHR 6606: Professional Seminar
PHR 5009: Development of Student Pharmacist
PHR 5204: Communications and Collaborative Solutions
PHR 6814: Learn to Teach (Elective)
PCAS 519: Public Health Issues
PCAS 604: Landmark Trials I (elective)
PCAS 522: CAM/Self-Care
PCAS 536: Applied Therapeutics Lab I
PCAS 612: Pharmacotherapeutics I
PCAS 523/531: Research Design and Literature Evaluation I
and II

2009-2010
2009-2010
2009-2010
2010-2013

Academic Year
2019-present
2016-present
2019-2020
2010-2019
2012-2014
2011-2012
2009-2010
2009-2010
2009-2010
2008-2009

Sullivan University College of Pharmacy and Health Sciences Master’s in Physician
Assistant
Lectures
Poster Creation

Course
PA 540: Principles of PA Practice
IV
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Academic Year
2017-2019

Grand Valley State University
Lectures
Neuropharmacology
Neurology Pharmacology

Course
PT 643: Clinical Medicine III
PAS 630: Clinical Rotations:
Pharmacology for GVSU
Physician Assistant Studies
Program

Academic Year
2006-2007
2003-2004

Course
CTA 510: Clinical Pharmacology
in Drug Development
CTA 510: Clinical Pharmacology
in Drug Development
CTA 510: Clinical Pharmacology
in Drug Development

Academic Year
2003-2004

Western Michigan University
Lectures
Pulmonary Pharmacology
Inflammation and Immune
Modulation
Anti-inflammatory Drugs

2003-2004
2003-2004

Ferris State University
Lectures
Course
Introduction/Ethics/Professionalism/ PHPR 514: Clinical
Evaluation
Communication
Presentation Style
PHPR 514: Clinical
Communication
Know Your Audience/Active
PHPR 514: Clinical
Learning
Communication
Medication Histories
PHPR 514: Clinical
Communication
Health Professional Communication PHPR 514: Clinical
Communication
GERD/ Peptic Ulcer Disease/ Stress PHPR 523/524:
Ulcers
Pharmacotherapy
Drug-Induced GI Disease
PHPR 523/524:
Pharmacotherapy
Supportive Care for the Cancer
PHPR 523/524:
Patient
Pharmacotherapy
Eye Products
PHPR 521/522:
Pharmacotherapy
Stroke
PHPR 521/522:
Pharmacotherapy
Student Patient Presentations
PHPR 501: Integrated Lab
Cardiovascular Lab
PHPR 501: Integrated Lab
Introduction to Basic Pharmacist
PHAD 310: The Profession
Communication Skills
of Pharmacy
253

Academic Year
2004-2008
2004-2008
2004-2008
2003-2008
2004-2005
2002-2004
2002-2003
2002-2003
2002-2004
2002-2004
2002-2004
2003-2004
2003-2004

Course Coordination
PHPR 602: Adult Ambulatory Care Medicine Clerkship
PHPR 514: Clinical Communication

Academic Year
2002-2008
2004-2008

University of Kentucky
Lectures
Small Group Facilitator:
Dyslipidemia and
Hypertension
Small Group Facilitator:
Surgical Prophylaxis/
Parenterals/ Diabetes
Small Group Facilitator:
Thyroid and Substance Abuse
Small Group Facilitator: Otitis
Media and UTIs
Critical Care Clinical
Pharmacology Group
Facilitator
Congestive Heart Failure
Ocular Infections and
Glaucoma
Hormone Replacement
Therapy
Menopause
Smoking Cessation
Top 200 Drug Review
Ophthalmic Conditions

Course
PHR 949: Contemporary
Aspects of Pharmacy Practice IV

Academic Year
2001-2002

PHR 939: Contemporary
Aspects of Pharmacy Practice III

2001-2002

PHR 929: Contemporary
Aspects of Pharmacy Practice II
PHR 919: Contemporary
Aspects of Pharmacy Practice I
MD 842: Advanced Clinical
Pharmacology and
Anesthesiology
PHR 895: Ambulatory Care
Elective
PHR 961: Integrated
Therapeutics II
PHR 961: Integrated
Therapeutics II
PHR 961: Integrated
Therapeutics II
PHR 923: Nutrition and Health
Promotion
PHR 939: Contemporary
Aspects of Pharmacy Practice III
PHR 916: Non-Prescription
Products and Supplies I

2000-2002
2000-2002
2000-2002

2000-2001
2001-2002
2001-2002
2000-2001
2001-2002
2001-2002
2001-2002

PRESENTATIONS
National
“Interprofessional Curriculum for the Care of Older Adults (ICCOA) to
APPE Students. American Association of Colleges of Pharmacy Schools
Poster. (Author)
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Jul 2020

“Nailed it! Doctor of Pharmacy Students’ Self-Awareness of
Performance on Objective Structured Clinical Examinations (OSCE).
American Pharmacists Association Virtual Poster Session. (Author)

Mar 2020

“Addressing Student Performance Concerns Through Effective
Remediation Programs.” American Association of Colleges of Pharmacy
Student Services Sig. Webinar. (Presenter)

Mar 2020

“Co-Curriculum Assessment Modalities Across Accredited Pharmacy
Program.” American Association of Colleges of Pharmacy Assessment
Sig. Webinar. (Moderator)

Nov 2019

“Practicing Understanding: Strategies to Orient Non-Practiced Faculty to Jul 2019
the Pharmacy Profession and Professional Education”. American
Association of Colleges of Pharmacy Annual Meeting. Platform
Presentation. (Presenter)
“Text Anxiety’s Effect on Performance: Managing the Power of the
Mind”. American Association of Colleges of Pharmacy Annual
Meeting. Platform Presentation. (Presenter)

Jul 2019

“Bridging the Great Divide: Characterizing Activities to Orient NonPractice Faculty to the Pharmacy Profession”. American Association of
Colleges of Pharmacy Annual Meeting. Poster Presentation. (Author)

Jul 2019

“Bridging the Gap Between Didactic and Experiential
Learning”. American Association of Colleges of Pharmacy Annual
Meeting. Poster Presentation. (Author)

Jul 2019

“Influence of Program Type, Curricular Delivery, and Demographics on
Test Anxiety”. American Association of Colleges of Pharmacy Annual
Meeting. Poster Presentation. (Author)

Jul 2019

“A Qualitative Study of Evaluating Pharmacy Faculty Perceptions on
Empathy in Education”. American Association of Colleges of Pharmacy
Annual Meeting. Poster Presentation. (Author)

Jul 2019

“How to support struggling students through effective remediation
plans”. American Association of Colleges of Pharmacy Webinar.
(Author)

Mar 2019

“Assessing Reliability and Validity of Advanced Pharmacy Practice
Experience (APPE) Evaluations from One College of Pharmacy in the
United States.” American Society of Health-Systems Pharmacist Annual
Meeting. Poster Presentation. (Author)

Dec 2018
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“ExamSoft Use as a Curricular Assessment and Learning Analytics
Tool.” American Association of Colleges of Pharmacy Annual Meeting.
Poster Presentation. (Author)

Jul 2018

“Student Perceptions of the PCOA – A Multi-institutional Sample”.
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. (Author)

Jul 2018

“PCOA Opportunities and Challenges: Two Sides of the Same Coin.”
American Association of Colleges of Pharmacy Annual Meeting.
Platform Presentation. (Presenter)

Jul 2018

“Fostering a Culture of Collaboration Using the Four Frames Model.”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. (Author)

Jul 2018

“Pharmacy Expert Panel Webinar.” ExamSoft Webinar. (Author)

Apr 2018

“Predicting NAPLEX Success Utilizing Performance on Skills-based
Assessment in the Patient Care Laboratory Setting.” American College
of Clinical Pharmacy Meeting. Poster Presentation. (Author)

Oct 2017

“Using ExamSoft Data for Faculty Development.” ExamSoft Webinar.
(Author)

Aug 2017

“Standard 4.1 and a Professional Development and Advising Plan for
Student Achievement of Educational Outcomes.” Association of
Colleges of Pharmacy Annual Meeting. Poster presentation. Nashville,
TN. (Author)

Jul 2017

“Chicken or the egg? Exploring the link between assessment resources
and culture of assessment.” Association for the Assessment of Learning
in Higher Education Annual Meeting. Louisville, KY. (Author)

Jun 2017

“Use of ExamSoft data to prepare for and ease the accreditation process.”
ExamSoft Webinar. (Author)

Apr 2017

“Understanding the structure, resources, and culture towards assessment
in US schools of pharmacy.” Assessment Institute in Indianapolis
Meeting. Platform presentation. Indianapolis, IN. (Author)

Oct 2016

“Predictors of NAPLEX Performance in an Accelerated Program.”
American Association of Colleges of Pharmacy Annual Meeting. Poster
presentation. Anaheim, CA. (Primary Author)

Jul 2016
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“Creating an Arms Race? Examining School Costs and Motivations for
Providing NAPLEX and PCOA Preparation. American Association of
Colleges of Pharmacy Annual Meeting. Poster presentation. Anaheim,
CA. (Author)

Jul 2016

“Continuum of Student Development: A 3 Tiered Approach in a 3 Year
Program.” American Association of Colleges of Pharmacy Annual
Meeting. Poster presentation. Anaheim, CA. (Primary Author)

Jul 2016

“Mini-Session: Preparation for NAPLEX and PCOA Exams: results of a Jul 2016
National Study. American Association of Colleges of Pharmacy Annual
Meeting. Platform presentation. Anaheim, CA. (Author)
“Special Session: More Than Just Numbers: Providing AutonomySupportive Feedback to large Student Populations. American
Association of Colleges of Pharmacy Annual Meeting. Platform
presentation. Anaheim, CA. (Author)

Jul 2016

“Creation of Longitudinal Report Cards Using Assessment Data.”
ExamSoft Annual Meeting. Platform presentation. Dallas, TX. (CoAuthor)

Jun 2016

“Successful Didactic Course Remediation in an Accelerated Program.”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. National Harbor, MD. (Co-Author)

Jul 2015

“Impact of a Landmark Trials Elective on Pharmacy Curriculum
Outcomes Assessment (PCOA) Student Scores.” American Association
of Colleges of Pharmacy Annual Meeting. Poster Presentation. National
Harbor, MD. (Co-Author)

Jul 2015

“Evaluation of student and faculty perceptions on implementation of
electronic assessments in an accelerated Doctor of Pharmacy Program.”
American Pharmacist Association. Poster Presentation. San Diego, CA.
(Co-Author)

Mar 2015

“A Curriculum Committee Toolkit for Addressing the 2013 CAPE
Outcomes.” American Association of College of Pharmacy Webinar.
Platform Presentation. Web. (Author)

Mar 2015

“Preparing Students for an Accelerated Pharm D Program At Sullivan
University.” American Association of Colleges of Pharmacy Annual
Meeting. Poster Presentation. Grapevine, TX. (Co-Author)

Jul 2014
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“Success Rate of Exam Remediation in a 3-Year Accelerated Program.”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. Kissimmee, FL. (Primary Author)

Jul 2012

“Use of NAPLEX to Validate SUCOP Benchmarking of Student
Jul 2012
Outcome Achievement.” American Association of Colleges of Pharmacy
Annual Meeting. Poster Presentation. Kissimmee, FL. (Primary
Author)
“A Prospective Evaluation of Group Presentation and Peer Review in a
Critical Care Elective Course.” American Association of Colleges of
Pharmacy Annual Meeting. Poster Presentation. San Antonio, TX. (CoAuthor)

Jul 2011

“Survey results for exam remediation at US Colleges of Pharmacy.”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. San Antonio, TX. (Primary Author)

Jul 2011

“Do HSRT exam results predict how well students will do in pharmacy
Therapeutic courses?” American Association of Colleges of Pharmacy
Annual Meeting. Poster Presentation. San Antonio, TX. (Primary
Author)

Jul 2011

“Course action plan impact on course outcomes.” American Association
of Colleges of Pharmacy Annual Meeting. Poster Presentation. San
Antonio, TX. (Co-Author)

Jul 2011

“Correlation of student self-assessment of program outcomes with course
grade averages.” American Association of Colleges of Pharmacy Annual
Meeting. Poster Presentation. San Antonio, TX. (Primary Author)

Jul 2011

“Comparison of HSRT results between students with degrees prior to
pharmacy school versus only pre-requisites.” American Association of
Colleges of Pharmacy Annual Meeting. Poster Presentation. San
Antonio, TX. (Primary Author)

Jul 2011

“End of the Year Capstone Exam Descriptions”. American Association
of Colleges of Pharmacy Annual Meeting. Poster Presentation. San
Antonio, TX. (Primary Author)

Jul 2011

“Longitudinal Didactic Review Examinations During Advance Pharmacy
Practice Experiences (APPE)”. American Association of Colleges of
Pharmacy Annual Meeting. Poster Presentation. San Antonio, TX.
(Primary Author)

Jul 2011
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“Experience with an Exam Remediation Procedure in a 3-Year
Accelerated Program.” American Association of Colleges of Pharmacy
Annual Meeting. Poster Presentation. Seattle, WA (Primary Author)

Jul 2010

“Tracking Performance of Sullivan University College of Pharmacy
Students Using Pharmacy Curricular Outcomes Assessment (PCOA).”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. Seattle, WA. (Co-Author)

Jul 2010

“Quantitative Measurement of Student Attainment of Sullivan University
College of Pharmacy Program-level ABOs.” American Association of
Colleges of Pharmacy Annual Meeting. Poster Presentation. Seattle,
WA. (Co-Author)

Jul 2010

“A Pilot Study to Evaluate Professionalism in a Pharmacy Curriculum.”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. Boston, MA. (Co-Author)

Jul 2009

“Does Examination Remediation Impact on Course Retention?”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. Boston, MA. (Co-Author)

Jul 2009

“Sullivan University College of Pharmacy Bridge Program: IPPE to
APPE.” American Association of Colleges of Pharmacy Annual
Meeting. Poster Presentation. Boston, MA. (Primary author)

Jul 2009

“Sullivan University College of Pharmacy NAPLEX and MPJE
Preparation.” American Association of Colleges of Pharmacy Annual
Meeting. Poster Presentation. Boston, MA. (Primary author)

Jul 2009

“Faculty Satisfaction With the Student Self-Assessment of Program
Outcomes Achievement System (RXOutcome) Process.” American
Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. Boston, MA. (Primary author)

Jul 2009

“Student Self-Assessment of Program Outcomes Achievement.”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. Boston, MA. (Co-Author)

Jul 2009

“An Innovative Approach to the Development, Delivery, and Assessment
of Informatics Course for a Newly Established Doctor of Pharmacy
Program.” American Association of Colleges of Pharmacy Annual
Meeting. Poster Presentation. Chicago, Chicago, IL. (Co-Author)

Jul 2008

259

“Curricular Comparison of a New 3 Year Doctor of Pharmacy Degree
Program vs Established Degree Programs.” American Association of
Colleges of Pharmacy Annual Meeting. Poster Presentation. Chicago, IL.
(Co-Author)

Jul 2008

“Public Health Opportunities at a New Doctor of Pharmacy Program.”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. Chicago, IL. (Primary author)

Jul 2008

“Proton Pump Inhibitor Use by Hospital Inpatients as a Risk For
Nosocomial Infection by Clostridum difficile.” American College of
Physicians Meeting. Platform Presentation. Philadelphia, Pennsylvania.
(Co-Author)

Apr 2006

“Mentoring Junior Faculty.” American Association of College of
Pharmacy Annual Meeting. Poster Presentation. Cincinnati, Ohio.
(Primary author)

J
ul 2005

“Type 2 Diabetes in Children and Adolescents: Who’s To Blame?” Live
on-line Pharmacy CE. Continuing Education for Pharmacists
presentation. ContinuingEducation.com. ACPE Continuing Education
approved. (written by Joan Rider, presented by me as an encore
presentation)

Dec 2003

“Non-adherence With Multiple Sclerosis Therapies.” American College
of Clinical Pharmacy Meeting. Poster Presentation. Savannah, Georgia.
(Primary author)

Apr 2002

“Topiramate Use In Essential Tremors.” American Society of HealthSystem Pharmacists Midyear Clinical Meeting. Poster Presentation. New
Orleans, Louisiana. (Primary author)

Dec 2001

“Idiopathic Paresthesia Reaction to Rofecoxib.” American Society of
Health-System Pharmacists Annual Meeting. Poster Presentation. Los
Angeles, California. (Primary author)

Jun 2001

“Pharmacist Intervention in the Management of Type 2 Diabetes: Does It
Improve Glycosylated Hemoglobin and Blood Pressure Control?”
American Association of Colleges of Pharmacy Annual Meeting. Poster
Presentation. San Diego, California. (Primary author)

Jul 2000

“Why I Participated in the Novo-Nordisk Diabetes Project Grant
Program.” American Association of Colleges of Pharmacy Annual
Meeting. Platform Presentation. San Diego, California. (Sole author)

Jul 2000
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“Pediatric Adaptation of Patient Education Leaflets for Anticonvulsant
Medications.” Pediatric Advocacy Group Conference. Poster
Presentation. Kiawah Island, South Carolina. (Primary author)

Oct 1998

Regional
“Faculty Perceptions of Summative Assessments.” IUPUI Assessment
Institute. Platform Presentation. Indianapolis, IN. (Primary Author)

Oct 2018

“Teaching Recommendation and Patient Counseling Skills in a SelfCare Course to Allow Achievement of Competencies in Intermediate
Pharmacy Practice Experiences.” Nonprescription Medicines Academy
Annual Conference. Poster Presentation. Cincinnati, OH. (Co-Author)

Oct 2011

“Selecting Appropriate Classroom Assessment Techniques Based on
Teaching Goals Inventory (TGI)”. IUPUI Assessment Institute. Poster
Presentation. Indianapolis. (Co-Author)

Oct 2008

“Exploring Collaborations.” Kentucky Science and Technology
Conference. Poster Presentation. Frankfort, KY. (Co-Author)

Apr 2008

“Pharmacy Professionals’ Status in Kentucky.” Kentucky Science and
Technology Conference. Poster Presentation. Frankfort, KY. (CoAuthor)

Apr 2008

“Facts and Fiction of Hormone Replacement Therapy.” Michigan
Pharmacists Association Grand Escape 2007. Platform Presentation.
Mackinac Island, Michigan. ACPE Continuing Education Approved.
(Sole author)

Aug 2007

“Patient Assessment, Self Monitoring, and Management.” Michigan
Pharmacists Association Diabetes Care Certificate Program in
Pharmacy. Platform Presentation. Grand Blanc, Michigan. ACPE
Continuing Education Approved. (Co-Author)

Apr 2006

“Hormone Replacement Therapy.” Michigan Pharmacists Association
Education Vacation 2004. Platform Presentation. Traverse City,
Michigan. ACPE Continuing Education Approved. (Sole author)

Aug 2004

“Asthma Treatment in the Adult.” Michigan Pharmacists Association
2004 Annual Convention. Platform Presentation. Dearborn, Michigan.
ACPE Continuing Education Approved. (Sole author)

Feb 2004
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“Late Complications in a 48-year old Male After Ingestion of
Brodifacoum (DeCon) in a Suicide Attempt.” American College of
Physicians Michigan Chapter Scientific Meeting. Poster Presentation.
Acme, Michigan. (Last author)

Sep 2003

“Non-adherence With Multiple Sclerosis Therapies.” Southeast Resident Apr 2002
Conference. Research Presentation. Athens, Georgia. ACPE Continuing
Education Approved. (Primary author)
“Pharmacist Intervention in the Management of Type 2 Diabetes: Does
Apr 2001
It Improve Glycosylated Hemoglobin and Blood Pressure Control?”
Southeast Resident Conference. Research Presentation. Athens, Georgia.
ACPE Continuing Education Approved. (Primary author)
Local
“Planning for Engagement.” Sullivan University Faculty Retreat.
Breakout Session. Louisville, KY. (Co-presenter)

Oct 2019

“What Effects Student Engagement and Why Should We Care?”
Sullivan University Faculty Retreat. Keynote Platform Presentation.
Louisville, KY. (Presenter)

Oct 2019

“Leadership for a Successful Merger.” University of Louisville Spring
Research Conference. Platform Presentation. Louisville, KY.
(Presenter)

Mar 2018

“How to Present a Research Poster.” Sullivan University College of
Pharmacy Seminar Series. Platform Presentation. Louisville, KY.
(Presenter)

Feb 2016

“Large Group Presentations.” Sullivan University College of
Pharmacy Teaching Certificate Seminar. Platform Presentation.
Louisville, KY. (Presenter)

Aug 2015

“Question Writing.” Sullivan University College of Pharmacy
Teaching Certificate Seminar. Platform Presentation. Louisville, KY.
(Presenter)

Jul 2015-2019

“Learning Objectives and Active Learning.” Sullivan University
College of Pharmacy Teaching Certificate Seminar. Platform
Presentation. Louisville, KY. (Presenter)

Jul 2015-2019

“Objectives and Writing Good Assessments.” Sullivan University
College of Pharmacy Teaching Certificate Seminar. Platform
Presentation. Louisville, KY. (Presenter)

Jul 2014
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“Learning Styles.” Sullivan University College of Pharmacy Teaching
Certificate Seminar. Platform Presentation. Louisville, KY.
(Presenter)

Jul 2014

“Learning Objectives: Making Sure it Links.” Sullivan University
Faculty Retreat. Platform Presentation. Florence, IN. (Presenter)

Nov 2012

“Writing Objectives and Quality Examinations Questions.” Kentucky
Pharmacy Residency Network Summer Meeting. Platform
Presentation. Louisville, KY. (Co-presenter)

Jul 2011

“College of Pharmacy Takes Center Stage.” Sullivan University
Faculty Retreat. Panel Discussion. Florence, IN. (Co-presenter)

Nov 2010

“Update on the Treatment of C. Diff.” Kentucky Society of HealthSystem Pharmacy Spring Meeting. Platform Presentation. Louisville,
KY. (Presenter)

May 2010

“Pharmacy 101”. Sullivan University Faculty Retreat. Platform
Presentation. Florence, IN. (Co-presenter)

Nov 2009

“How to Start a Clinical Practice Site.” Sullivan University College of
Pharmacy Faculty Development. Platform Presentation. Louisville,
KY. (Co-presenter)

May 2009

“Teaching Philosophies, Writing Objectives, Teaching Dos and Don’ts,
and Writing Test Questions.” Sullivan University College of Pharmacy
Faculty Development. Platform Presentation. Louisville, KY. (Copresenter)

Dec 2008

“Pharmacy Practice.” Marion County Area Technology Center
Students. Platform Presentation. Louisville, KY. (Co-presenter)

Dec 2008

“Small Group Teaching.” Ferris State University Resident Teaching
Seminar. Platform Presentation (encore). Grand Rapids, MI. (Copresenter)

Sept 2007

“Backward Course Design.” Ferris State University Resident Teaching
Seminar. Platform Presentation. Grand Rapids MI. (Co-presenter)

May 2007

“Small Group Teaching.” Ferris State University Resident Teaching
Seminar. Platform Presentation (encore). Grand Rapids, MI. (Copresenter)

Jan 2007
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“Small Group Teaching.”Ferris State University Resident Teaching
Seminar. Platform Presentation. Grand Rapids, MI. (Co-presenter)

Jun 2006

“Utilization of BMI in Diagnosing Obesity at an Outpatient Clinic.”
GRMERC’s Community Health Research Day. Platform Presentation.
Grand Rapids, Michigan. (Co-Author)

Apr 2006

“Proton Pump Inhibitor Use by Hospital Inpatients as a Risk For
Nosocomial Infection by Clostridium difficile.” GRMERC’s
Community Health Research Day. Platform Presentation. Grand
Rapids, Michigan. (Co-Author)

Apr 2006

Apr 2002
“Non-adherence With Multiple Sclerosis Therapies.” University of
Kentucky Chandler Medical Center. Southeastern Residency
Conference Practice. Platform Presentation. Lexington, Kentucky.
(Primary author)
“Ziprasidone HCl In-service.” Eastern State Hospital. Nursing Inservice. Platform Presentation. Lexington, Kentucky. (Co-Author)

Nov 2001

“Non-adherence To Multiple Sclerosis Therapies.” University of
Oct 2001
Kentucky Chandler Medical Center. Pharmacy Grand Rounds. Platform
Presentation. Lexington, Kentucky. ACPE Continuing Education
Approved. (Primary author)
“Patient Noncompliance With Interferon Beta-1a, Interferon Beta-1b,
and Glatiramer Acetate.” University of Kentucky Chandler Medical
Center. Research Presentation. Lexington, Kentucky. (Primary author)

Oct 2001

“Treatment of Vasomotor Symptoms of Menopause.” University of
Kentucky Chandler Medical Center. Pharmacy Grand Rounds.
Lexington, Kentucky. (Sole author)

Jul 2001

“Pharmacist Intervention in the Management of Type 2 Diabetes: Does
It Improve Glycosylated Hemoglobin and Blood Pressure Control?”
University of Kentucky Chandler Medical Center. Resident Seminar
Series. Lexington, Kentucky. ACPE Continuing Education Approved.
(Primary author)

Mar 2001

“Idiopathic Paresthesia Reaction Associated With Rofecoxib.”
University of Kentucky Chandler Medical Center. Resident Report.
Lexington, Kentucky. (Primary author)

Jan 2001

“Vancomycin Ototoxicity.” University of Kentucky Chandler Medical
Center. Resident Report. Lexington, Kentucky. (Sole author)

Oct 2000
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“Pharmacist Intervention in the Management of Type 2 Diabetes: Does
It Improve Glycosylated Hemoglobin and Blood Pressure Control?”
University of Kentucky Chandler Medical Center. Research
Presentation. Lexington, Kentucky. (Primary author)

Oct 2000

“Cancer Pain Management.” University of Kentucky Chandler Medical
Center. Medical In-service. Lexington, Kentucky. (Sole author)

Sept 2000

“Prevention of Post Operative Atrial Fibrillation.” University of
Kentucky Chandler Medical Center. Pharmacy In-service. Lexington,
Kentucky. (Sole author)

Aug 2000

“Smoking Cessation.” University of Kentucky Chandler Medical
Center. Nursing In-service. Lexington, Kentucky. (Sole author)

Apr 2000

“Diabetes.” University of Kentucky College of Pharmacy. Robinson
Forest Scholars Program. Lexington, Kentucky. (Sole author)

Jul 1999

PUBLICATIONS
Peer-Reviewed
Palmer EC, Esposito ER, Shin M, Raake SE, Malcom DR, and Daugherty KK. Impact
of Intersession Course Remediation on NAPLEX/PCOA Scores in an Accelerated Doctor
of Pharmacy Program. American Journal of Pharmaceutical Education.
2020;84(9):ajpe7827.
Daugherty KK and Malcom DR. Assessing the relationship among PCOA performance,
didactic academic performance, and NAPLEX scores. American Journal of
Pharmaceutical Education. 2020; 84(8):ajpe847712.
Rudolph J, Gortney JS, Brownfield, A, Caldwell D, Castleberry A, Le UM, Medina MS,
Sease JM, Trujillo J, Welch AC, and Daugherty KK. Student perceptions of the utility
of the Pharmacy Curriculum Outcomes Assessment. Currents in Pharmacy Teaching
and Learning. 2020;12(3):255-264.
Daugherty KK and Elder KG. Program evaluation of a pharmacy run resident teaching
and learning curriculum. Currents in Pharmacy Teaching and Learning. 2020;12(2):163173.
Gregory, DF, Boje, KM, Carter RA, Daugherty KK, Hagemeier, NE, Munger MA,
Umland EM, Wager JL. Leading Change in Academic Pharmacy: Report of the 20182019 AACP Academic Affairs Committee. American Journal of Pharmaceutical
Education. 2019;83(10):7661
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Daugherty KK. ARCS motivation model application in a pharmacy elective. Currents
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Drug Information/IT Position Committee (member)

2002-2004

Ferris State University College of Pharmacy
Continuing Education Committee (member)
Accreditation Committee (member)
English in the Curriculum Subcommittee (member)
Curriculum Committee (secretary-2002-Mar 2004)
MBA/PharmD Subcommittee (member)
Ferris State University Senate
Diversity Committee

2005-2007
2005-2007
2005
2002-2005
2003-2004
2003-2006

Professional
AALHE: Grand Challenges: Using Assessment Findings to
Direct Immediate Pedagogical Improvement Taskforce
AAHLE Grand Challenges: Change Over Time Taskforce
AACP Assessment Sig Chair-elect, Chair, Past-Chair
AACP Assessment Sig Research Sub-Committee (Co-Chair)
AACP Assessment Sig Executive Council (member)
AACP Assessment Sig Research Sub-Committee (Co-Chair)
AACP Academic Affairs Committee (member)
Kentucky Pharmacy Education and Research Foundation Advisory
Council (member)
AACP Council of Dean’s Conflict of Interest Policy and Practice
Task Force
AACP Curriculum Sig CAPE Paper Taskforce (member)
KSHP Board (member)
AACP Pharmacy Practice Section Pharmacy Leadership
Development Task Force (member)
AACP Pharmacy Practice Section Program Committee (member)
AACP New Investigator Grant Task Force (member)
Michigan Pharmacists Association Education (member; Chair
2005-2007)
AACP Nominating Committee
KSHP Professional Affairs (member)

2020-present
2020-present
2019-present
2017-present
2017-present
2017-2019
2018-2019
2014-2017
2014-2015
2014-2015
2008-2010
2009-2010
2008-2009
Nov 2008
2003-2007
2004-2005
2000-2002

University of Kentucky Residency
Residency Program Secretary
Pharmacy Grand Rounds (member)
Medication Use Evaluation Subcommittee Of Pharmacy and
Therapeutics (member)
Drug Information Director Search Committee (member)
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2001-2002
2001-2002
2001-2002
2001-2002

Residency Recruitment (1st year-member; 2nd year-co-chair)
Kentucky Konnection (editor)

2000-2002
2000-2002

University of Kentucky College of Pharmacy
College of Pharmacy Admissions (member)

2000-2001

PROFESSIONAL MEMBERSHIPS
American Educational Research Association (AERA)
Association for the Assessment of Learning in Higher Education
(AALHE)
Phi Lambda Sigma (PLS)
Jefferson County Pharmacist Association (JCAP)
Kentucky Pharmacists Association (KPhA)
American Association of Colleges of Pharmacy (AACP)
American College of Clinical Pharmacy (ACCP)
Rho Chi
Kentucky Society of Health-System Pharmacists (KSHP)
American Pharmacists Association (APhA)
Western Michigan Society of Health-System Pharmacists
(WMSHP)
Michigan Society of Health-System Pharmacists (MSHP)
Michigan Pharmacists Association (MPA)
American Society of Health-System Pharmacists (ASHP)
Kentucky Pharmacists Association (KPhA)
Kentucky Society of Health-System Pharmacists (KSHP)
Kentucky Academy of Student Pharmacists

2017-present
2015-present
2013-present
2008-present
2007-present
2002-present
2000-present
1998-present
2007-2017
2000-2018
2002-2007
2002-2007
2002-2007
2001-2002
2000-2002
1996-2002
1996-2000

LEADERSHIP SEMINARS
ACPE Self-Study Workshop

Aug 2015

Student Suicides and Suicide Threats for Colleges:
Expectations, Risks, and Responses

Aug 2013

ACPE Standards 2007 Update Webinar

Feb 2012

ACPE Reviewer Training

Oct 2011

American Association of Colleges of Pharmacy Leadership
Seminar (attendee)

Jul 2008
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TEACHING SEMINARS
AACP Teacher’s Seminar: Inclusive Teaching – A Strategy to
Reach ALL Learners. (attendee)

Jul 2020

AACP Scholarship of Teaching and Learning Institute (team
leader)

Nov 2017

AACP Teacher’s Seminar: Learning is NOT a Spectator Sport:
Active Learning in Pharmacy Curricular. (attendee)

Jul 2017

AACP Teacher’s Seminar: Beginning With the End in Mind:
Developing the Self-Aware Pharmacist. (attendee)

Jul 2015

AACP CAPE Institute. Leesburg, VA. (Team Leader)

May 2014

Exam Soft. “Making the Most From Reporting for Students and
Institutions.” Webinar. (attendee)

Mar 2014

Exam Soft Training. Sullivan University College of Pharmacy.
(attendee)

Nov-Dec 2013

Faculty Retreat. Sullivan University. (attendee)

Nov 2013

Faculty Development: Curriculum Mapping 101. (Presenter)

Sept 2013

Faculty Development: Panopto Usage and other IT Questions.
(attendee)

Apr 2013

Faculty Development: Portal to Portal: Library/DIC Resources
for You. (attendee)

Mar 2013

Faculty Retreat. Sullivan University. (presenter and attendee)

Nov 2012

Spring 2012 KACCS Education Conference. Sullivan University
Lexington Campus. (attendee)

Apr 2012

Faculty Retreat. Sullivan University. (attendee)

Nov 2011

Faculty Development: How to Write Great Test Questions;
Sullivan University College of Pharmacy. (attendee)

July 2011

Web Seminar: Competency Based Education and Performance
Assessment: WGU’s Model for Success

Feb 2010
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Education Scholar: Teaching Excellence and Scholarship
Development Resources for Health Professions Educators
Modules (7 modules)

Dec 2010

Faculty Retreat; Sullivan University (attendee and presenter)

Nov 2010

Faculty Development: Promotion Dossiers; Sullivan University
College of Pharmacy. (attendee)

Oct 2010

Faculty Development: How to Not Get Sued; Sullivan University
College of Pharmacy. (attendee)

Aug 2010

Faculty Retreat; Sullivan University (attendee and presenter)

Nov 2009

Faculty Development: How to Start a Clinical Practice Site;
Sullivan University. (Co-leader)

May 2009

Faculty Development: Teaching Philosophies, Writing Objectives,
Teaching Dos and Don’ts, and Writing Test Questions; Sullivan
University. (Co-leader)

Dec 2008

Faculty Advance: Experiential Learning; Sullivan University
(attendee)

Nov 2008

Faculty Development: Student Advising; Sullivan University
College of Pharmacy (co-leader)

Jun 2008

Faculty Development: Basic Pedagogy and Assessment (Part II);
Sullivan University (attendee)

Mar 2008

Faculty Development: Basic Pedagogy and Assessment (Part I);
Sullivan University (attendee)

Feb 2008

Faculty Advance: Active Learning; Sullivan University (attendee)
American Association of Colleges of Pharmacy Teaching Seminar
(attendee)

Nov 2007

American Association of College of Pharmacy Teaching Seminar
(attendee)

Jul 2007

American Association of College of Pharmacy Teaching Seminar
(attendee)

Jul 2006

Teaching So Everyone Learns: Lilly North Conference on College
Teaching (attendee)

Sept 2005
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American Association of Colleges of Pharmacy Teaching Seminar
(attendee)

Jul 2005

Holding a Cat by the Tail: Active Learning and Assessment in
Pharmacy Practice: American College of Clinical Pharmacy
(attendee)

Apr 2005

American Association of Colleges of Pharmacy Teaching Seminar
(attendee)

Jul 2004

Education Scholar: Teaching Excellence and Scholarship
Development Resources for Health Professions Educators
Modules (6 modules)

Jun 2004

American Association of Colleges of Pharmacy Teaching Seminar
(attendee)

Jul 2003

Introduction to Pharmaceutical Education Workshop
(Coordinator/Moderator)

Jan 2003

Butler University College of Pharmacy and Health Sciences
Primer in Pharmaceutical Education Workshop (attendee)

Aug 2002
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